WO2012118659A1 - Electrical ablation devices and methods - Google Patents
Electrical ablation devices and methods Download PDFInfo
- Publication number
- WO2012118659A1 WO2012118659A1 PCT/US2012/026049 US2012026049W WO2012118659A1 WO 2012118659 A1 WO2012118659 A1 WO 2012118659A1 US 2012026049 W US2012026049 W US 2012026049W WO 2012118659 A1 WO2012118659 A1 WO 2012118659A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sequence
- tissue
- pulses
- electrical pulses
- applying
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/1815—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00613—Irreversible electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
- A61B2018/00672—Sensing and controlling the application of energy using a threshold value lower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00666—Sensing and controlling the application of energy using a threshold value
- A61B2018/00678—Sensing and controlling the application of energy using a threshold value upper
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00702—Power or energy
- A61B2018/00708—Power or energy switching the power on or off
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
Definitions
- Apparatuses, systems, and methods for conventional ablation therapies may include electrical ablation therapies, such as, for example, high temperature thermal therapies including, focused ultrasound ablation, radiofrequency (RF) ablation, and interstitial laser coagulation, chemical therapies in which chemical agents are injected into the undesirable tissue to cause ablation, surgical excision, cryotherapy, radiation, photodynamic therapy, Moh's micrographic surgery, topical treatments with 5-fluorouracil, and laser ablation.
- electrical ablation therapies such as, for example, high temperature thermal therapies including, focused ultrasound ablation, radiofrequency (RF) ablation, and interstitial laser coagulation
- chemical therapies in which chemical agents are injected into the undesirable tissue to cause ablation, surgical excision, cryotherapy, radiation, photodynamic therapy, Moh's micrographic surgery, topical treatments with 5-fluorouracil, and laser ablation.
- Conventional electrical ablation therapies may suffer from some of the following limitations: cost, length of recovery, and extraordinary pain inflicted on the patient.
- one drawback of conventional electrical ablation therapies may be any permanent damage to healthy tissue surrounding the undesirable tissue due to detrimental thermal effects resulting from exposing the tissue to thermal energy generated by the electrical ablation device.
- permanent damage to surrounding healthy tissue may occur when using high temperature thermal therapies to expose undesirable tissue to electric potentials sufficient to cause cell necrosis.
- electrical ablation apparatuses, systems, and methods for the treatment of undesirable tissue having reduced or no detrimental thermal effects to surrounding healthy tissue are desirable.
- FIG. 1 illustrates an electrical ablation system according to certain embodiments described herein.
- FIG. 2 illustrates a bipolar electrical ablation system according to certain embodiments described herein.
- FIG. 3 illustrates an electrical ablation system including sensors according to certain embodiments described herein.
- FIG. 4 illustrates an electrical ablation system including a temperature sensor according to certain embodiments described herein.
- FIG. 5A is a graphical representation of a series of monopolar electrical pulses that may be applied to undesirable tissue.
- FIG. 5B is a graphical representation of a series of bipolar electrical pulses that may be applied to undesirable tissue.
- FIG. 6A illustrates two electrodes in a monopolar electrical ablation system according to certain embodiments described herein.
- FIG. 6B illustrates two electrodes in a bipolar electrical ablation system according to certain embodiments described herein.
- FIG. 7 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIGS. 8A-B are graphical representations of a series of electrical pulses that may be applied to undesirable tissue.
- FIG. 9 is a graphical representation of a series of bipolar electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIGS. 10A-B are graphical representations of a series of bipolar electrical pulses that may be applied to undesirable tissue.
- FIG. 1 1 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue.
- FIG. 12 illustrates the use of an electrical ablation system according to certain embodiments described herein.
- FIG. 13 is a photograph of a porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIG. 14 is a graphical representation of electrode temperature during a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIGS. 15A-D include photographs of porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIG. 16 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue.
- FIG. 17 is a graph illustrating the area of the necrotic zone of a porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIG. 18A is a graph illustrating the average area of the necrotic zone of a porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIG. 18B includes photographs of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIG. 19 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue.
- FIGS. 20A-C include photographs of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIGS. 21 -24 are graphs illustrating the electrode temperature in porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIGS. 25A-C include photographs of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIGS. 26A-F are graphical representations of simulated necrotic zones and thermal zones of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein
- Various embodiments are directed to electrical ablation apparatuses, systems, and methods for the treatment of undesirable tissue having reduced or no detrimental thermal effects to surrounding healthy tissue.
- proximal and distal generally refer to a clinician manipulating one end of an instrument used to treat a patient.
- proximal generally refers to the portion of the instrument closest to the clinician.
- distal generally refers to the portion located furthest from the clinician.
- an ablation apparatus may generally comprise first and second electrodes coupled to an energy source operative to generate and deliver a first sequence of electrical pulses and a second sequence of electrical pulses to tissue having a necrotic threshold, wherein the first sequence of electrical pulses delivers a first energy dose that is less than the necrotic threshold to induce thermal heating in the tissue and the second sequence of electrical pulses delivers a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation.
- the necrotic threshold generally refers the electric field strength that induces cell necrosis by irreversible electroporation.
- the necrotic threshold may relate to at least the following parameters: cell type, temperature, electrical conductivity, pH and tissue perfusion. Table 1 illustrates the necrotic threshold for several cell types.
- electrical ablation devices may generally comprise one or more electrodes configured to be positioned into or proximal to undesirable tissue in a tissue treatment region (e.g., a target site or a worksite).
- the tissue treatment region may have evidence of abnormal tissue growth.
- the electrodes may comprise an electrically conductive portion (e.g., medical grade stainless steel, gold plated, etc.) and may be configured to electrically couple to an energy source.
- an energizing potential may be applied to the electrodes to create an electric field to which the undesirable tissue is exposed.
- the energizing potential (and the resulting electric field) may be characterized by various parameters, such as, for example, frequency, amplitude, pulse width (duration of a pulse or pulse length), and/or polarity.
- a particular electrode may be configured either as an anode or a cathode, or a plurality of electrodes may be configured with at least one electrode configured as an anode and at least one other electrode configured as a cathode. Regardless of the initial polarity configuration, the polarity of the electrodes may be reversed by reversing the polarity of the output of the energy source.
- a suitable energy source may comprise an electrical waveform generator.
- the electrical waveform generator may be configured to create an electric field that is suitable to induce thermal heating in the tissue without inducing cell necrosis in the tissue by irreversible electroporation at various electric field amplitudes and durations.
- the electrical waveform generator may be configured to create an electric field that is suitable to create irreversible electroporation in undesirable tissue at various electric field amplitudes and durations.
- the energy source may be configured to deliver electrical pulses in the form of direct-current (DC) and/or alternating-current (AC) voltage potentials (e.g., time-varying voltage potentials) to the electrodes.
- the energy source may also be configured to reverse the potential between the electrodes.
- the electrical pulses may be characterized by various parameters, such as, for example, frequency, amplitude, pulse width, polarity, total number of pulses, delay between pulses bursts, total number of pulses at a lower voltage, and total number of pulses at high voltage.
- the undesirable tissue may be heated by exposure to the electric potential difference across the electrodes.
- the undesirable tissue may be ablated by exposure to the electric potential difference across the electrodes.
- the apparatuses, systems, and methods may be configured for minimally invasive ablation treatment of undesirable tissue through the use of irreversible electroporation. Minimally invasive ablation treatment of undesirable tissue may be
- Electroporation refers to the application of electric pulses to a cell membrane to cause an increase in the permeabilization of the cell membrane.
- the external electric field i.e., electric potential/per unit length
- applied to the cell may significantly increase the electrical conductivity and permeability of the plasma in the cell membrane.
- the apparatuses, systems, and methods may be configured to ablate undesirable tissue through the use of irreversible electroporation.
- Irreversible electroporation refers to the application of an electric field of a specific magnitude and duration to a cell membrane such that the permeabilization of the cell membrane cannot be reversed.
- One of the primary parameters affecting the transmembrane potential is the potential difference across the cell membrane.
- the destabilizing potential may form pores in the cell membrane when the potential across the cell membrane exceeds its dielectric strength causing the cell to die under a process known as apoptosis and/or necrosis.
- Irreversible electroporation may induce localized heating of the tissue surrounding the electrodes. Irreversible electroporation may lead to cell death without inducing a significant amount of heat in the cell membrane.
- irreversible electroporation pulses may be an effective way for ablating large volumes of undesirable tissue with no or minimal detrimental thermal effects to the surrounding healthy tissue. Without wishing to be bound to any particular theory, it is believed that irreversible electroporation destroys cells with no or minimal heat, and thus, may not destroy the cellular support structure or regional vasculature.
- a destabilizing irreversible electroporation pulse suitable to cause cell death without inducing a significant amount of thermal damage to the surrounding healthy tissue, may have amplitude in the range of several hundred to several thousand volts and may be generally applied across biological membranes over a distance of several millimeters, for example, for a relatively long duration of 1 ⁇ is to 100 ms.
- the undesirable tissue may be ablated in-vivo through the delivery of destabilizing electric fields by quickly causing cell necrosis.
- the apparatuses, systems, and methods for electrical ablation therapy may be adapted for use in minimally invasive surgical procedures to access the tissue treatment region in various anatomic locations, such as, for example, the brain, lungs, breast, liver, gall bladder, pancreas, prostate gland, and various internal body lumen defined by the esophagus, stomach, intestine, colon, arteries, veins, anus, vagina, cervix, fallopian tubes, and the peritoneal cavity.
- Minimally invasive electrical ablation devices may be introduced to the tissue treatment region though a small opening formed in the patient's body using a trocar or through a natural body orifice such as the mouth, anus, or vagina using translumenal access techniques known as Natural Orifice Translumenal Endoscopic Surgery (NOTES)TM.
- NOTES Natural Orifice Translumenal Endoscopic Surgery
- the electrical ablation devices e.g. , electrodes
- electric field potentials may be applied by the energy source to the undesirable tissue.
- the electrical ablation devices may comprise portions that may be inserted into the tissue treatment region percutaneously (e.g. , where access to inner organs or other tissue is done via needle-puncture of the skin).
- portions of the electrical ablation devices may be introduced into the tissue treatment region endoscopically (e.g. , laparoscopically and/or thoracoscopically) through trocars or channels of the endoscope, through small incisions, or transcutaneously (e.g. , where electric pulses are delivered to the tissue treatment region through the skin).
- An electrical ablation device is described in commonly owned U.S. Patent Publication No.
- FIG. 1 illustrates one embodiment of an electrical ablation system 10.
- the electrical ablation system 10 may be employed to ablate undesirable tissue, such as, for example, diseased tissue, cancer, malignant and benign tumors, masses, lesions, and other abnormal tissue growths in a tissue treatment region using electrical energy.
- the electrical ablation system 10 may be configured to treat a number of lesions and ostepathologies comprising metastatic lesions, tumors, fractures, infected sites, and inflamed sites in a tissue treatment region using electrical energy.
- the electrical ablation system 10 may be configured to be positioned within a patient's natural body orifice, e.g., the mouth, anus, and vagina, and/or advanced through internal body lumen or cavities, e.g., the esophagus, stomach, intestines, colon, cervix, and urethra, to reach the tissue treatment region.
- the electrical ablation system 10 may be configured to be positioned and passed through a small incision or keyhole formed through the patient's skin or abdominal wall using a trocar to reach the tissue treatment region.
- the tissue treatment region may be located in the patient's brain, lung, breast, liver, gall bladder, pancreas, prostate gland, various internal body lumen defined by the esophagus, stomach, intestine, colon, arteries, veins, anus, vagina, cervix, fallopian tubes, and the peritoneal cavity.
- the electrical ablation system 10 may be used in conjunction with
- the electrical ablation system 10 may be actuated (e.g., energized) to ablate the undesirable tissue.
- the electrical ablation system 10 may be configured to treat diseased tissue in the gastrointestinal tract, esophagus, lung, and/or stomach that may be accessed orally.
- the electrical ablation system 10 may be adapted to treat undesirable tissue in the liver or other organs that may be accessible using translumenal access techniques, such as, for example, NOTESTM techniques where the electrical ablation devices may be initially introduced through a natural body orifice and then advanced to the tissue treatment site by puncturing the walls of internal body lumen.
- the electrical ablation system 10 may be adapted to treat undesirable tissue in the brain, lung, breast, liver, gall bladder, pancreas, or prostate gland, using one or more electrodes positioned percutaneously, transcutaneously, translumenally, minimally invasively, and/or through open surgical techniques, or any combination thereof.
- the electrical ablation system 10 may be employed in conjunction with a flexible endoscope 12, as well as a rigid endoscope, laparoscope, or thoracoscope, such as the GIF-100 model available from Olympus Corporation.
- the endoscope 12 may be introduced to the tissue treatment region trans-anally through the colon, trans-orally through the esophagus and stomach, trans-vaginally through the cervix, transcutaneously, or via an external incision or keyhole formed in the abdomen in conjunction with a trocar.
- the electrical ablation system 10 may be inserted and guided into or proximate the tissue treatment region using the endoscope 12.
- the endoscope 12 is not utilized, and instead other techniques, such as, for example, ultrasound or a computerized tomography (CT) scan, may be used to determine proper instrument placement during the procedure.
- CT computerized tomography
- the endoscope 12 comprises an endoscope handle 34 and an elongate relatively flexible shaft 32.
- the distal end of the flexible shaft 32 may comprise a light source and a viewing port.
- the flexible shaft 32 may define one or more channels for receiving various instruments therethrough, such as, for example, electrical ablation devices. Images within the field of view of the viewing port may be received by an optical device, such as, for example, a camera comprising a charge coupled device (CCD) usually located within the endoscope 12, and transmitted to a display monitor (not shown) outside the patient.
- CCD charge coupled device
- the electrical ablation system 10 may comprise a plurality of electrical conductors 18, a handpiece 16 comprising an activation switch 62, and an energy source 14, such as, for example, an electrical waveform generator, electrically coupled to the activation switch 62 and the electrical ablation device 20.
- the electrical ablation device 20 may comprise a relatively flexible member or shaft 22 that may be introduced to the tissue treatment region using any of the techniques discussed above, such as, an open incision and a trocar, through one of more of the channels of the endoscope 12, percutaneously, or transcutaneously.
- one or more electrodes such as first and second electrodes 24a, b may extend out from the distal end of the electrical ablation device 20.
- the first electrode 24a may be configured as the positive electrode and the second electrode 24b may be configured as the negative electrode.
- the first electrode 24a may be electrically connected to a first electrical conductor 18a, or similar electrically conductive lead or wire, which may be coupled to the positive terminal of the energy source 14 through the activation switch 62.
- the second electrode 24b may be electrically connected to a second electrical conductor 18b, or similar electrically conductive lead or wire, which may be coupled to the negative terminal of the energy source 14 through the activation switch 62.
- the electrical conductors 18a,b may be electrically insulated from each other and surrounding structures, except for the electrical connections to the respective electrodes 24a, b.
- the electrical ablation device 20 may be configured to be introduced into or proximate the tissue treatment region using the endoscope 12 (laparoscope or thoracoscope), open surgical procedures, and/or external and non-invasive medical procedures.
- the electrodes 24a, b may be referred to herein as endoscopic or laparoscopic electrodes, although variations thereof may be inserted transcutaneously or percutaneously.
- one or both electrodes 24a, b may be adapted and configured to slideably move in and out of a cannula, lumen, or channel defined within the flexible shaft 22.
- the electrodes 24a, b When the electrodes 24a, b are positioned at the desired location into or proximate the tissue treatment region, the electrodes 24a, b may be connected to or disconnected from the energy source 14 by actuating or de-actuating the activation switch 62 on the handpiece 16.
- the activation switch 62 may be operated manually or may be mounted on a foot switch (not shown), for example.
- the electrodes 24a, b may deliver electric field pulses to the undesirable tissue.
- the electric field pulses may be characterized by various parameters, such as, for example, pulse shape, amplitude, frequency, pulse width, polarity, total number of pulses and duration.
- the electric field pulses may be sufficient to induce thermal heating in the undesirable tissue without inducing irreversible electroporation in the undesirable tissue.
- the electric field pulses may be sufficient to induce irreversible electroporation in the undesirable tissue.
- the induced potential may depend on a variety of conditions, such as, for example, tissue type, cell size, and electrical field pulse parameters.
- the transmembrane potential of a specific tissue type may primarily depend on the amplitude of the electric field and pulse width.
- a protective sleeve or sheath 26 may be slidably disposed over the flexible shaft 22 and within a handle 28.
- the sheath 26 may be slidably disposed within the flexible shaft 22 and the handle 28.
- the sheath 26 may be slideable and may be located over the electrodes 24a, b to protect the trocar and prevent accidental piercing when the electrical ablation device 20 is advanced therethrough.
- One or both of the electrodes 24a, b may be adapted and configured to slideably move in and out of a cannula, lumen, or channel formed within the flexible shaft 22.
- One or both of the electrodes 24a, b may be fixed in place.
- One of the electrodes 24a, b may provide a pivot about which the other electrode may be moved in an arc to other points in the tissue treatment region to treat larger portions of the diseased tissue that cannot be treated by fixing both of the electrodes 24a, b in one location.
- one or both of the electrodes 24a, b may be adapted and configured to slideably move in and out of a working channel formed within a flexible shaft 32 of the endoscope 12 or may be located independently of the endoscope 12.
- the first and second electrical conductors 18a,b may be provided through the handle 28.
- the first electrode 24a may be slideably moved in and out of the distal end of the flexible shaft 22 using a slide member 30 to retract and/or advance the first electrode 24a.
- the second electrode 24b may be slideably moved in and out of the distal end of the flexible shaft 22 using the slide member 30 or a different slide member to retract and/or advance the second electrode 24b.
- One or both electrodes 24a, b may be coupled to the slide member 30, or additional slide members, to advance and retract the electrodes 24a, b and position the electrodes 24a, b.
- the first and second electrodes 24a, b which may be slidably movable within the cannula, lumen, or channel defined within the flexible shaft 22, may be advanced and retracted with the slide member 30.
- the first electrical conductor 18a coupled to the first electrode 24a may be coupled to the slide member 30.
- the first electrode 24a which is slidably movable within the cannula, lumen, or channel within the flexible shaft 22, may be advanced and retracted with the slide member 30.
- various slide members, such as the slide member 30, may be rotatable. Thus rotation of the slide member 30 may rotate the corresponding electrode(s) at the distal end of the electrical ablation device 20.
- transducers or sensors 29 may be located in the handle
- the transducers or sensors 29 may provide feedback to the operator, surgeon, or clinician to physically sense when the electrodes 24a, b are placed within the cancerous tumor. The feedback information provided by the transducers or sensors
- the sensor 29 may be processed and displayed by circuits located either internally or externally to the energy source 14.
- the sensor 29 readings may be employed to determine whether the electrodes 24a, b have been properly located within the cancerous tumor thereby assuring that a suitable margin of error has been achieved in locating the electrodes 24a, b.
- the sensor 29 readings may also be employed to determine whether the pulse parameters need to be adjusted to achieve a desired result, such as, for example, reducing the intensity of muscular
- the electrical ablation device 20 may comprise a first flexible shaft 22a housing the first electrode 24a and a second flexible shaft 22b housing the second electrode 24b.
- the electrical ablation device 20 may comprise a first protective sleeve or sheath (not shown) disposed over at least one of the first flexible shaft 22a and second flexible shaft 22b.
- the electrical ablation device 20 may comprise a first protective sleeve or sheath (not shown) disposed over the first flexible shaft 22a and a second protective sleeve or sheath (not shown) disposed over the second flexible shaft 22b.
- the length of the first flexible shaft 22a may be different than the length of the second flexible shaft 22b.
- the length of the first flexible shaft 22a may be greater than or equal to the length of the second flexible shaft 22b.
- the length of the first protective sleeve or sheath may be different than the length of the second protective sleeve or sheath.
- the length of the first protective sleeve or sheath may be greater than or equal to the length of the second protective sleeve or sheath.
- an electrical ablation device for biphasic pulses may have the first flexible shaft 22a disposed over the first electrode 24a having a positive polarity and the second flexible shaft 22b disposed over the second electrode 24b having a negative polarity, and wherein the length of the first flexible shaft 22a is greater than the length of the second flexible shaft 22b.
- the electrical ablation device 20 may be configured to measure at least one of the temperature and pressure.
- the transducers or sensors 29 may comprise at least one of a temperature sensor and a pressure sensor.
- at least one of a temperature sensor and pressure sensor may be located in or proximate the electrical ablation system 10.
- the temperature sensor and/or pressure sensor may be located within the handle 28.
- the temperature sensor and/or pressure sensor may be located within the protective sleeve or sheath 26.
- the temperature sensor 25 and/or pressure sensor 27 may be located within the flexible shaft 22.
- the temperature sensor 25 and/or pressure sensor 27 may be located at the distal end of the flexible shaft 22.
- the protective sleeve or sheath 26 and/or the flexible shaft 22 may comprise one or more vents 31 configured for measuring at least one of the temperature and pressure of the tissue treatment region.
- the temperature sensor and/or pressure sensor may be located within the electrodes 24a, b.
- the pressure sensor 27 may be adjacent to at least one of the vents 31 .
- the pressure sensor 27 may be adjacent at least one of the vents 31 and the temperature sensor 25 may be located at the distal end of the flexible shaft 22.
- FIG. 4 is a photograph of an electrical ablation device comprising an optical temperature sensor 29 located in the electrode 24a at the distal end of the flexible shaft 22.
- the temperature sensor and/or pressure sensor may be separate from the electrical ablation system 10.
- the electrical ablation device 20 may include the temperature sensor 25 and the pressure sensor may be separate from the electrical ablation system 10.
- the electrical ablation device 20 may include the pressure sensor 27 and the temperature sensor may be separate from the electrical ablation system 10.
- the temperature sensor may measure the temperature of the tissue treatment region.
- the temperature sensor may measure the temperature of the undesirable tissue.
- the temperature sensor may measure the temperature of the tissue surrounding the electrodes.
- the temperature sensor may measure the
- the temperature sensor may measure the temperature before, during, and/or after treatment.
- the temperature sensor may measure the temperature before the first sequence of electrical pulses is delivered to the tissue.
- the temperature sensor may measure the temperature after the first sequence of electrical pulses is delivered to the tissue.
- the temperature sensor may measure the temperature before the second sequence of electrical pulses is delivered to the tissue.
- the temperature sensor may measure the temperature after the second sequence of electrical pulses is delivered to the tissue.
- the pressure sensor may measure the pressure of the tissue treatment region.
- the pressure sensor may measure the pressure of the space between the electrodes.
- the pressure sensor may measure the pressure surrounding the electrodes.
- the pressure sensor may measure the pressure before, during, and/or after treatment.
- the pressure sensor may measure the pressure before the first sequence of electrical pulses is delivered to the tissue.
- the pressure sensor may measure the pressure after the first sequence of electrical pulses is delivered to the tissue.
- the pressure sensor may measure the pressure before the second sequence of electrical pulses is delivered to the tissue.
- the pressure sensor may measure the pressure after the second sequence of electrical pulses is delivered to the tissue.
- the temperature sensor and pressure sensor may provide feedback to the operator, surgeon, or clinician to apply an electric field pulse to the undesirable tissue.
- the pressure and/or temperature information may be useful to determine whether the undesirable tissue may be treated having reduced or no detrimental thermal effects to surrounding healthy tissue.
- the feedback information provided by the transducers or sensors 29 may be processed and displayed by circuits located either internally or externally to the energy source 14.
- the input to the energy source 14 may be connected to a commercial power supply by way of a plug (not shown).
- the output of the energy source 14 is coupled to the electrodes 24a, b, which may be energized using the activation switch 62 on the handpiece 16, or an activation switch mounted on a foot activated pedal (not shown).
- the energy source 14 may be configured to produce electrical energy suitable for thermal heating and/or electrical ablation.
- the electrodes 24a, b may be adapted and configured to electrically couple to the energy source 14 (e.g., generator, waveform generator). Once electrical energy is coupled to the electrodes 24a, b, an electric field may be formed at a distal end of the electrodes 24a, b.
- the energy source 14 may be configured to generate electric pulses at a predetermined frequency, amplitude, pulse width, and/or polarity that are suitable to induce thermal heating in the undesirable tissue in the treatment region.
- the energy source 14 may be configured to generate electric pulses at a predetermined frequency, amplitude, pulse width, and/or polarity that are suitable to induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region.
- the energy source 14 may be configured to deliver DC electric pulses having a predetermined frequency, amplitude, pulse width, and/or polarity suitable to induce thermal heating in the undesirable tissue in the treatment region.
- the energy source 14 may be configured to deliver DC electric pulses having a predetermined frequency, amplitude, pulse width, and/or polarity suitable to induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region.
- the DC pulses may be positive or negative relative to a particular reference polarity.
- the polarity of the DC pulses may be reversed or inverted from positive-to-negative or negative-to-positive a predetermined number of times to induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region.
- a timing circuit may be coupled to the output of the energy source 14 to generate electric pulses.
- the timing circuit may comprise one or more suitable switching elements to produce the electric pulses.
- the energy source 14 may produce a series of m electric pulses (where m is any positive integer) of sufficient amplitude and duration less than the necrotic threshold to induce thermal heating in the undesirable tissue when the m electric pulses are applied to the electrodes 24a, b and a series of n electric pulses (where n is any positive integer) of sufficient amplitude and duration to induce irreversible electroporation suitable for tissue ablation when the n electric pulses are applied to the electrodes 24a, b.
- the electric pulses may have a fixed or variable pulse width, amplitude, and/or frequency.
- the electrical ablation device 20 may be operated either in bipolar mode, i.e., monophasic, or monopolar mode, i.e., biphasic.
- FIG. 5A is a graphical representation of a series of monopolar electrical pulses having the same polarity in which each pulse has an amplitude of +3,000 VDC.
- FIG. 6A illustrates two electrodes 24a, b in a monopolar electrical ablation system in which the first electrode 24a has a positive polarity relative to the other electrode 24b. In monopolar mode, a grounding pad may be substituted for one of the electrodes.
- FIG. 5B is a graphical representation of a series of bipolar electrical pulses having opposite polarity in which the first electrical pulse has an amplitude of +3,000 VDC and the second electrical pulse has an amplitude of -3,000 VDC.
- FIG. 6B illustrates two electrodes 24a, b in a bipolar electrical ablation system in which the polarity of each electrodes 24a, b alternates.
- the first electrode 24a may be electrically connected to a first polarity and the second electrode 24b may be electrically connected to the opposite polarity.
- the first electrode 24a may be coupled to a prescribed voltage and the second electrode 24b may be set to ground.
- the energy source 14 may be configured to operate in either the bipolar or monopolar modes with the electrical ablation system 10.
- the first electrode 24a may be electrically connected to a prescribed voltage of one polarity and the second electrode 24b may be electrically connected to a prescribed voltage of the opposite polarity.
- the polarity of the electrodes may be alternated so that any two adjacent electrodes may have either the same or opposite polarities.
- the negative electrode of the energy source 14 may be coupled to an impedance simulation circuit.
- the energy source 14 may be configured to produce RF waveforms at predetermined frequencies, amplitudes, pulse widths, and/or polarities suitable for thermal heating and/or electrical ablation of cells in the tissue treatment region.
- a suitable RF energy source may be a commercially available conventional, bipolar/monopolar electrosurgical RF generator, such as Model Number ICC 350, available from Erbe, GmbH.
- the energy source may comprise a microwave energy source configured to produce microwave waveforms at predetermined frequencies, amplitudes, pulse widths, and/or polarities suitable for thermal heating and/or electrical ablation of cells in the tissue treatment region.
- the microwave power source such as MicroThermx, available from Boston Scientific Corp., may be coupled to a microwave antenna providing microwave energy in the frequency range from 915 MHz to 2.45 GHz.
- the energy source 14 may be configured to produce destabilizing electrical potentials (e.g., fields) suitable to induce thermal heating and/or irreversible
- the destabilizing electrical potentials may be in the form of bipolar/monopolar DC electric pulses suitable for inducing thermal heating and/or irreversible electroporation to ablate tissue undesirable tissue with the electrical ablation device 20.
- a commercially available energy source suitable for generating thermal heating and/or irreversible electroporation electric field pulses in bipolar or monopolar mode is a pulsed DC generator such as Model Number ECM 830, available from BTX Molecular Delivery Systems Boston, MA.
- the first electrode 24a may be electrically coupled to a first polarity and the second electrode 25 may be electrically coupled to a second (e.g., opposite) polarity of the energy source 14.
- Bipolar/ monopolar DC electric pulses may be generated at a variety of frequencies, amplitudes, pulse widths, and/or polarities. Unlike RF ablation systems, which may require high power and energy levels delivered into the tissue to heat and thermally destroy the tissue, irreversible electroporation may require very little energy applied to the tissue to heat and kill the cells of the undesirable tissue using electric field potentials rather than heat. Accordingly, irreversible electroporation systems may avoid the detrimental thermal effects caused by RF ablation systems.
- the energy source may comprise a wireless transmitter to deliver energy to the electrodes using wireless energy transfer techniques via one or more remotely positioned antennas.
- wireless energy transfer or wireless power transmission refers to the process of transmitting electrical energy from an energy source to an electrical load without interconnecting wires.
- the energy source 14 may be coupled to the first and second electrodes 24a, b by a wired or a wireless connection. In a wired connection, the energy source 14 may be coupled to the electrodes 24a, b by way of the electrical conductors 18a,b, as shown.
- the electrical conductors 18a,b may be replaced with a first antenna (not shown) coupled the energy source 14 and a second antenna (not shown) coupled to the electrodes 24a, b, wherein the second antenna may be remotely located from the first antenna.
- the energy source may comprise a wireless transmitter to deliver energy to the electrodes using wireless energy transfer techniques via one or more remotely positioned antennas.
- wireless energy transfer or wireless power transmission is the process of transmitting electrical energy from the energy source 14 to an electrical load, e.g., the abnormal cells in the tissue treatment region, without using the interconnecting electrical conductors 18a,b.
- An electrical transformer is the simplest example of wireless energy transfer. The primary and secondary circuits of a transformer may not be directly connected and the transfer of energy may take place by electromagnetic coupling through a process known as mutual induction. Power also may be transferred wirelessly using RF energy.
- the energy source 14 may be configured to generate DC electric pulses at frequencies in the range of about 1 Hz to about 10,000 Hz, amplitudes in the range of about ⁇ 100 VDC to about ⁇ 6,000 VDC, and pulse width in the range of about 1 ⁇ to about 100 ms.
- the polarity of the electric potentials coupled to the electrodes 24a, b may be reversed during thermal heating and/or electrical ablation therapy.
- the DC electric pulses may have a positive polarity and an amplitude in the range of about +100 VDC to about +6,000 VDC.
- the polarity of the DC electric pulses may be reversed such that the amplitude is in the range of about -100 VDC to about -6,000 VDC.
- the undesirable cells in the tissue treatment region may be electrically ablated with DC pulses suitable to induce irreversible electroporation at frequencies of about 10 Hz to about 100 Hz, amplitudes in the range of about +700 VDC to about +3,000 VDC, and pulse widths of about 10 ⁇ to about 50 ⁇ .
- an electric field strength of about 800 V/cm to 1 ,000 V/cm is suitable for destroying living tissue by inducing irreversible electroporation.
- the electrodes 24a, b may have a diameter or radius from 0.5 mm to 1 .5 mm, such as, for example, 0.5 mm, 0.75 mm, 1 mm, and 1 .5 mm.
- the diameter of the first electrode 24a may by different from the diameter of the second electrode 24b.
- the electrode spacing may be from 0.5 cm to 3 cm.
- the distance from the first electrode 24a to the second electrode 24b may be from 0.5 cm to 3 cm, such as, for example, 1 cm, 1.5 cm, 2.0 cm, and 3 cm.
- the electrical ablation device 20 may comprise multiple needle electrodes.
- the electrical ablation device 20 may be introduced into the tissue treatment region through a trocar, for example, or inserted to a tissue treatment region transcutaneously, percutaneously, or other suitable techniques.
- the cannula, lumen, or channel defined within the flexible shaft 22 may comprise a cutting edge, such as a bevel or other sharp edge, to aid in the puncturing/piercing of tissue.
- a method of treating tissue may generally comprise obtaining an ablation apparatus comprising first and second electrodes coupled to an energy source operative to generate and deliver a first sequence of electrical pulses and a second sequence of electrical pulses to tissue having a necrotic threshold, wherein the first sequence of electrical pulses deliver a first energy dose that is less than the necrotic threshold to induce thermal heating in the tissue and the second sequence of electrical pulses deliver a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation, inserting the first electrode into a mass of tissue having a necrotic threshold, applying a first sequence of electrical pulses to the first electrode less than the necrotic threshold to induce thermal heating, applying a second sequence of electrical pulses to the first electrode to induce cell necrosis by irreversible electroporation, and applying a ground potential to the second electrode, wherein the ablation apparatus is operative to reduce the necrotic threshold of the tissue relative to a corresponding ablation apparatus having
- the ablation apparatus may reduce the necrotic threshold by 0-500 mV, such as, for example, 50-400 mV, 100-300 mV, and 150-250 mV relative to a corresponding ablation apparatus having an energy source configured to deliver a first sequence of electrical pulses to induce cell necrosis by irreversible electroporation.
- the ablation apparatus may reduce the necrotic threshold by 0-50%, such as, for example, 10%, 20%, 30%, and 40%, relative to a corresponding ablation apparatus having an energy source configured to deliver a first sequence of electrical pulses to induce cell necrosis by irreversible electroporation.
- a method of treating tissue may generally comprise applying a first sequence of electrical pulses to undesirable tissue to induce thermal heating and applying a second sequence of electrical pulses to undesirable tissue to induce cell necrosis by irreversible electroporation.
- the first energy dose may be less than the necrotic threshold, less than the critical membrane voltage, less than the threshold for muscle contraction, and/or less than the threshold for ventricular arrhythmia.
- the first energy dose may reduce the necrotic threshold of the tissue.
- the first energy dose may reduce the necrotic threshold by 0-500 mV, such as, for example, 50-400 mV, 100-300 mV, and 150-250 mV.
- the first energy dose may reduce the necrotic threshold by 0-50%, such as, for example, 10%, 20%, 30%, and 40%.
- the first energy dose and/or second energy dose may be synchronized with the patient's cardiac cycle to prevent ventricular arrhythmia.
- the ablation apparatus may reduce the risk of ventricular arrhythmia relative to a similar ablation apparatus comprising a first sequence of electrical pulses to induce cell necrosis in the tissue by irreversible electroporation.
- a method of treating tissue may generally comprise inserting the first electrode into a mass of tissue having a membrane potential and a necrotic threshold, applying a first sequence of electrical pulses to the first electrode less than the necrotic threshold to induce thermal heating, applying a second sequence of electrical pulses to the first electrode to induce cell necrosis by irreversible electroporation, and applying a ground potential to the second electrode.
- the method may comprise re-applying the sequence of electrical pulses to the first electrode.
- the energy source may be operative to generate and deliver a sequence interval between the first sequence and second sequence.
- the first sequence of electrical pulses may comprise a series of first pulse trains each having a first pulse train amplitude, a first pulse train pulse width, and a first pulse train frequency
- the second sequence of electrical pulses may comprise a series of second pulse trains each comprising a second pulse train amplitude, a second pulse train pulse width, and a second pulse train frequency
- the first pulse trains may comprise a plurality of first pulses each having a first amplitude, a first pulse width, and a first frequency
- each of the second pulse trains may comprise a plurality of second pulses each having a second amplitude, a second pulse width, and a second frequency.
- FIG. 7 is a graphical representation of a first sequence of electrical pulses that deliver a first energy dose less than the necrotic threshold to induce thermal heating and a second sequence of electrical pulses that deliver a second energy dose to induce cell necrosis by irreversible electroporation.
- Time (t) is shown along the horizontal axis and voltage (VDC) is shown along the vertical axis.
- the undesirable tissue may be exposed to a series of first pulse trains 70 each having a first pulse train amplitude V-i , a first pulse train pulse width T w1 , and a first pulse train frequency F-i sufficient to induce thermal heating in the tissue.
- first pulse trains 70 each having a first pulse train amplitude V-i , a first pulse train pulse width T w1 , and a first pulse train frequency F-i sufficient to induce thermal heating in the tissue.
- the undesirable tissue 48 may be exposed to a series of second pulse trains 72.
- the undesirable tissue may be exposed to a series of second pulse trains 72 each having a second pulse train amplitude V 2 , a second pulse train pulse width T w2 , and a second pulse train frequency F 2 sufficient to induce thermal necrosis and/or irreversible electroporation in the tissue.
- the series of first pulse trains 70 may comprise at least one first pulse train and the series of second pulse trains 72 may comprise at least one second pulse train.
- At least one of the first pulse train amplitude V-i , the first pulse train pulse width T w1 , and the first pulse train frequency F-i may be greater than or equal to the second pulse train amplitude V 2 , the second pulse train pulse width T w2 , and the second pulse train frequency F 2 .
- the first pulse train amplitude V-i may be less than or equal to the second pulse train amplitude V 2 .
- the first pulse train pulse width T w1 may be less than, greater than, or equal to the second pulse train pulse width T w2 .
- the first pulse train frequency F-i may be greater than or equal to the second pulse train frequency F 2 .
- the first sequence duration D-i may be greater than or equal to the second sequence duration D 2 .
- the total number of first pulse trains may be 70 may be greater than or equal to the total number of second pulse trains 72.
- the first pulse train amplitude may be less than the second pulse train amplitude
- the first pulse train pulse width may be equal to the second pulse train pulse width
- the first pulse train frequency may be greater than the second pulse train frequency.
- the energy source may operative to generate and deliver a sequence interval Si between the first sequence and second sequence.
- the sequence interval may be from 0 to 10 seconds, 1 second to 10 seconds, such as, for example, 0.5 seconds, 1 second, and 2 seconds.
- FIGS. 8A-B are graphical representations of a first pulse train 70 and a second pulse train 72, respectively.
- Time (t) is shown along the horizontal axis and voltage (VDC) is shown along the vertical axis.
- Each of the first pulse trains 70 may comprise a plurality of first pulses 70a each having a first amplitude v-i , a first pulse width t w1 , and a first frequency f-i
- each of the second pulse trains 72 may comprise a plurality of second pulses 72a each having a second amplitude v 2 , a second pulse width t w2 , and a second frequency f 2 .
- the first pulses and the second pulses may be each independently characterized by first and second amplitudes in the range of about ⁇ 100 VDC to about ⁇ 10,000 VDC, first and second pulse widths in the range of about 1 ⁇ is to about 100 ms, and first and second frequencies in the range of about 1 Hz to about 10,000 Hz.
- the energy source 14 may be configured to generate and deliver DC first pulses and the second pulses at frequencies in the range of 1 Hz to 10,000 Hz, amplitudes in the range of ⁇ 100 VDC to ⁇ 3000 VDC, and pulse width in the range of about 1 ⁇ is to about 100 ms.
- the first amplitude may be less than or equal to the second amplitude v 2 .
- the first pulse width t w1 may be less than, greater than, or equal to the second pulse width t w2 .
- the first frequency fi may be greater than or equal to the second frequency f 2 .
- the total number of first pulses may be greater than or equal to the total number of second pulses.
- the first amplitude may be less than the second amplitude
- the first pulse width may be equal to the second pulse width
- the first frequency may be equal to the second frequency.
- a first pulse train 70 comprising high-voltage DC electrical pulses having a first pulse train amplitude V-i of 500 VDC and a first pulse train pulse width T w1 of 50 ⁇ is may be applied to the first and second electrodes 24a, b by the energy source 14 to induce thermal heating in the tissue.
- a second pulse train 72 comprising higher high-voltage DC electrical pulses having a second pulse train amplitude V 2 of 1000 V and a second pulse train pulse width T w2 of 50 ⁇ is may be applied to the first and second electrodes 24a, b by the energy source 14 to induce cell necrosis in the tissue by irreversible electroporation.
- the polarity of at least one of the first pulse train 70 and the second pulse train 72 may be inverted or reversed by the energy source 14 during the thermal heating and/or ablation processes.
- the series of second pulses 72 may comprise multiple electrical pulses, for example, 20 to 40 electric pulses, having a second amplitude v 2 of 1500 to 3000 VDC, a second pulse width t w2 of 10 ⁇ is to 50 ⁇ is, and a period t 2 of 10 ⁇ is.
- the undesirable cells in the tissue treatment region may be electrically ablated with DC pulses suitable to induce irreversible electroporation at frequencies of about 10 Hz to about 100 Hz, amplitudes in the range of about +700 VDC to about +1500 VDC, and pulse widths of about 10 ⁇ is to about 50 ⁇ is.
- a total dose average power may comprise the average power of the first sequence of electrical pulses, the average power of the second sequence of electrical pulses, and the sequence interval.
- the first energy dose may have an average power from 5 Watts to 10 Watts.
- the second first energy dose may have an average power from 10 Watts to 15 Watts.
- the total dose average power may be 1 Watt to 5 Watts.
- a total dose average power from 5 Watts to 10 Watts may cause thermal coagulation.
- the first and second sequences of electrical pulses may be configured to reduce or eliminate thermal coagulation at the electrode/tissue interface.
- the polarity of the electric potentials coupled to the electrodes 24a, b may be reversed during the electrical ablation therapy.
- the series of first pulse trains 70 may comprise multiple biphasic pulse trains each having a positive first pulse train amplitude +Vi or a negative first pulse train amplitude -V-i , a first pulse train pulse width T w1 , and a first pulse train frequency F-i
- the series of second pulse trains 72 may comprise multiple biphasic pulse trains each having a positive second pulse train amplitude +V 2 or a negative second pulse train amplitude -V 2 , a second pulse train pulse width T ⁇ , and a second pulse train frequency F 2 .
- the first pulses and the second pulses may be each independently characterized by first and second amplitudes in the range of about ⁇ 100 VDC to about ⁇ 10,000 VDC, first and second pulse widths in the range of about 1 ⁇ is to about 100 ms, and first and second frequencies in the range of about 1 Hz to about 10,000 Hz.
- the first sequence of electrical pulses and the second sequence of electrical pulses may comprise biphasic pulses.
- the first sequence of electrical pulses may comprise biphasic pulses and the second sequence of electrical pulses may not comprise biphasic pulses.
- the first sequence of electrical pulses may not comprise biphasic pulses and the second sequence of electrical pulses may comprise biphasic pulses.
- each of the first pulse trains may comprise a plurality of first pulses 70a each having a positive first amplitude +v-i or a negative first amplitude -v-i , a first pulse width t w1 , and a first frequency f-i
- each of the second pulse trains comprise a plurality of second pulses 72a each having a positive second amplitude +v 2 or a negative second amplitude -v 2 , a second pulse width t w2 , and a second frequency f 2
- the first sequence of electrical pulses and the second sequence of electrical pulses may comprise biphasic pulses.
- the plurality of first pulses may comprise biphasic pulses and the plurality of second pulses may not comprise biphasic pulses. In one embodiment, the plurality of first pulses may not comprise biphasic pulses and the plurality of second pulses may comprise biphasic pulses.
- the energy source 14 may be configured to generate and deliver DC first pulses and the second pulses at frequencies in the range of 1 Hz to 10,000 Hz, amplitudes in the range of ⁇ 100 VDC to ⁇ 3000 VDC, and pulse width in the range of about 1 ⁇ is to about 100 ms.
- the first pulse trains may comprise a plurality of DC first pulses having a positive polarity and an amplitude in the range of about +100 VDC to about +6000 VDC and a negative polarity and an amplitude in the range of about -100 VDC to about -6000 VDC
- the second pulse trains may comprise a plurality of second pulses having a positive polarity and an amplitude in the range of about +100 VDC to about +6000 VDC and a negative polarity and an amplitude in the range of about -100 VDC to about -6000 VDC.
- the method may comprise applying a sequence of electrical pulses having a first polarity to induce cell thermal heating and applying a sequence of electrical pulses having an opposite polarity to induce cell necrosis by irreversible electroporation.
- biphasic pulses may reduce the skeletal muscle contractions by reducing or eliminating the action potential caused by a positive monophasic pulse. Biphasic pulses may reduce or eliminate skeletal muscle contractions and caradic events.
- poration of the cell membrane occurs when the pulse increases the membrane voltage. A person skilled in the art may expect the poration to be reversed by a negative going pulse.
- hyperpolarization occurs on each side of the cell. For example, the opposite side of the cell membrane may be hyperpolarized when the electric field switches orientation due to a negative-going pulse. In other words, the polarization of the cell may be dependent on the orientation of the electric field.
- the method of treating tissue may comprise heating the tissue by applying an electric field that is less than the necrotic threshold to lower the necrotic threshold before inducing cell necrosis.
- the method may comprise lowering the necrotic threshold by heating the tissue by applying an electric field that is less than about 700 V/cm, such as, for example, less than about 500 V/cm and less than about 300 V/cm.
- the method may comprise lowering the necrotic threshold by 30% by heating the tissue by applying an electric field that is less than about 700 V/cm.
- the method may comprise heating the tissue by applying an electric field that is less than the necrotic threshold to lower the necrotic threshold and inducing cell necrosis by irreversible electroporation by applying an electric filed that is greater than or equal to the necrotic threshold.
- the method may comprise heating the tissue by applying an electric field that is less than 700 V/cm to lower the necrotic threshold and inducing cell necrosis by irreversible electroporation by applying an electric filed that is greater than about 700 V/cm.
- the method of treating tissue may comprise applying a sequence of electrical pulses to increase a membrane potential to less than the necrotic threshold and applying a sequence of electrical pulses to increase a membrane potential to greater than or equal to the necrotic threshold.
- the method may comprise applying a sequence of electrical pulses to increase a membrane potential from less than zero to greater than zero, applying a sequence of electrical pulses to increase a membrane potential from greater than zero to less than the necrotic threshold, and applying a sequence of electrical pulses to increase a membrane potential from less than the necrotic threshold to the necrotic threshold.
- the method may comprise applying a sequence of electrical pulses to increase a membrane potential from less than zero to 100 mV, applying a sequence of electrical pulses to increase a membrane potential from 100 mV to 500 mV, and applying a sequence of electrical pulses to increase a membrane potential from 500 mV to the necrotic threshold.
- the first sequence of electrical pulses may have a pulse width of 50 ⁇ or less and subsequent pulses may have higher voltages and pulse widths less than 50 ⁇ .
- the pulses may increase the membrane potential from -70 mV to +100 mV
- the next sequence of pulses may increase the membrane potential from 100 mV to 500 mV
- the final sequence of pulses may have pulse width of 1 ⁇ is to increase the membrane potential to cause cell necrosis.
- the synergistic effect of applying the first sequence of pulses to induce thermal heating and applying the second sequence of pulses to induce cell necrosis by irreversible electroporation may decrease the membrane threshold from 1 V to 0.7 V.
- the method may comprise forming a pre-heated zone in the undesirable tissue by applying an electric field that is less than the necrotic threshold.
- the method may comprise forming a pre-heated zone in the undesirable tissue by applying an electric field that is less than the necrotic threshold and forming a necrotic zone by applying an electric field that is equal to or greater than the necrotic threshold to induce cell necrosis by irreversible electroporation.
- the method may comprise forming a pre-heated zone by applying an electric field that is less than about 700 V/cm and forming a necrotic zone by applying an electric filed that is equal to or greater than about 700 V/cm.
- FIG. 1 1 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue.
- FIG. 1 1 illustrates the relationship between the pulse parameters and electrode temperature and the size and proportion of the necrotic zone.
- the size and proportion of the necrotic zone may generally increase as the voltage and/or temperature increases.
- the size and proportion of the necrotic zone and thermal zone may be related to the pulse parameters, such as, for example, energy, peak power, and average power, and electrode spacing.
- the contribution of voltage and temperature to the size and proportion of the necrotic zone and thermal zone may be related to the peak pulsed power and average power.
- a pre-heated thermal zone may be formed in the tissue immediately surrounding the electrodes 24a, b at the tissue-electrode-interface by applying an electric field less than the necrotic threshold.
- the method of treating tissue may comprise applying a combination of a series of first electrical pulses 70 having substantially lower voltage (in the range of 1000 V to 2000 V) and a series of second electrical pulses 72 having a higher voltage to induce cell necrosis.
- a first series of pulses 70 may be applied to create a pre-heated thermal zone to increase the temperature of the tissue and then a second series of pulses 72 to induce cell necrosis at a lower voltage then otherwise would be necessary without the thermal heating of the tissue before inducing irreversible electroporation.
- the method of treating tissue may comprise applying a combination of a series of first electrical pulses 70 having substantially lower voltage to increase the size of the pre-heated thermal zone at the same voltage.
- the electrodes may be energized to form a pre-heated zone having a first shape in the tissue treatment region.
- the shape of the pre-heated zone may be dependent on the position of the first and second electrodes.
- a necrotic zone having a second shape may be formed in the tissue treatment region.
- the size of the pre-heated zone may be less than or equal to the size of the necrotic zone. This process may be repeated as often as necessary to create any number of necrotic zones using the electrical ablation apparatus.
- the ablation apparatus may increase the size of the necrotic zone relative to a similar ablation apparatus comprising a first sequence of electrical pulses to induce cell necrosis in the tissue by irreversible electroporation.
- the surgeon or clinician may reposition the electrical ablation apparatus within the tissue treatment region and begin the process anew.
- the method of treating tissue may comprise applying a first sequence of electrical pulses to induce thermal heating and applying a second sequence of electrical pulses to induce cell necrosis by irreversible electroporation, wherein the first and second sequences of electrical pulses create a ratio of thermal volume to non-thermal volume of 5 to 1.
- the thermal volume may comprise the volume of the pre-heated zone.
- at least one of the first sequence of electrical pulses, the second sequence of electrical pulses, and sequence interval may be configured to create a ratio of thermal volume to non-thermal volume of 2 to 1 .
- at least one of the first sequence of electrical pulses, the second sequence of electrical pulses, and sequence interval may be configured to create a ratio of thermal zone volume to necrotic zone volume of 1 to 1.
- the method may comprise measuring at least one of temperature and pressure of the tissue treatment region.
- the method may comprise measuring at least one of temperature and pressure of the undesirable tissue.
- the method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes.
- the method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes and applying a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved.
- the method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes and stopping a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved.
- the method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes and applying a sequence of electrical pulses to achieve at least one of a predetermined temperature and a predetermined pressure.
- the critical membrane voltage of a cell is inversely proportional to the cell's temperature.
- the cell's critical membrane voltage may decrease as the cell's temperature increases.
- a lower electric field may be applied to pre-heated undesirable tissue to induce cell necrosis by irreversible electroporation than to the same undesirable tissue without pre-heating.
- the predetermined temperature may be 40°C to 50°C.
- an electrical pulse or sequence of electrical pulses may be applied when the temperature of the tissue falls below 50°C.
- the method may comprise stopping a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved.
- an electrical pulse or sequence of electrical pulses may be stopped when the temperature of the tissue reaches 60°C.
- the first and second sequences of electrical pulses may be configured to maintain the tissue at a temperature sufficient to induce thermal coagulation.
- the first and second sequences of electrical pulses may be configured to maintain the tissue at a temperature between 50-60°C.
- the predetermined pressure may be atmospheric pressure.
- the ablation apparatus may reduce the risk of an electrical arc relative to a similar ablation apparatus comprising a first sequence of electrical pulses to induce cell necrosis in the tissue by irreversible electroporation.
- an arc may form between the two electrodes.
- high voltage may cause a breakdown in air in the space between the un-insulated conductive portions of the electrodes that are not fully embedded in the tissue.
- An electrical arc at high voltages (>10k VDC) may occur when the un-insulated conductive portions of the two electrodes are not fully embedded into the tissue or the tissue moves away from the electrode tip and the high voltage causes an electrical breakdown of the gas surrounding the electrode tip.
- the first and second sequences of electrical pulses may be configured to reduce or eliminate the creation of an arc.
- a gel may be
- the gel may be any water-based, water-soluble lubricant, such as, for example, KY® Jelly available from Johnson & Johnson.
- FIG. 12 illustrates one embodiment of the electrical ablation system 10 shown in FIG. 1 in use to treat undesirable tissue 48 located on the surface of the liver 50.
- the undesirable tissue 48 may be representative of diseased tissue, cancer, malignant and benign tumors, masses, lesions, and other abnormal tissue growths.
- the electrical ablation device 20 may be introduced into or proximate the tissue treatment region through a port 52 of a trocar 54.
- the trocar 54 may be introduced into the patient via a small incision 59 formed in the skin 56.
- the endoscope 12 may be introduced into the patient trans-anally through the colon, trans- orally down the esophagus and through the stomach using translumenal techniques, or through a small incision or keyhole formed through the patient's abdominal wall (e.g., the peritoneal wall).
- the endoscope 12 may be employed to guide and locate the distal end of the electrical ablation device 20 into or proximate the undesirable tissue 48.
- the sheath 26 Prior to introducing the flexible shaft 22 through the trocar 54, the sheath 26 may be slid over the flexible shaft 22 in a direction toward the distal end thereof to cover the electrodes 24a, b until the distal end of the electrical ablation device 20 reaches the undesirable tissue 48.
- the sheath 26 may be retracted to expose the electrodes 24a, b to treat the undesirable tissue 48.
- the treat the undesirable tissue 48 the operator initially may locate the first electrode 24a at a first position and the second electrode 24b at a second position using endoscopic visualization and maintaining the undesirable tissue 48 within the field of view of the flexible endoscope 12.
- the first position may be near a perimeter edge of the undesirable tissue 48.
- the electrodes 24a, b may be energized with a first sequence of electrical pulses to deliver a first energy dose that is less than the necrotic threshold to induce thermal heating in the tissue surrounding the electrode/tissue interface.
- the electrodes 24a, b may be energized with a second sequence of electrical pulses to deliver a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation to create a necrotic zone 65.
- the undesirable tissue 48 may be exposed to an electric field generated by energizing the first and second electrodes 24a, b with the energy source 14.
- the electric field created by the first sequence of electrical pulses may have a magnitude, frequency, pulse width suitable to increase the temperature of the undesirable tissue to a predetermined threshold.
- the electric field created by the second sequence of electrical pulses may have a magnitude, frequency, and pulse width suitable to induce irreversible electroporation in the undesirable tissue 48 within the necrotic zone 65. Without wishing to be bound to any particular theory, it is believed that increasing the temperature of the undesirable tissue to a predetermined threshold may reduce the magnitude, frequency, and/or pulse width of the electric field suitable to induce irreversible electroporation in the undesirable tissue 48.
- the size of the necrotic zone may be substantially dependent on the size and separation of the electrodes 24a, b.
- the treatment time may be defined as the time that the electrodes 24a, b are activated or energized to generate the electric pulses suitable for inducing thermal heating and/or irreversible electroporation in the undesirable tissue 48.
- the electrical ablation device may comprise multiple needle electrodes that may be employed to treat the undesirable tissue 48.
- similar techniques may be employed to ablate any other undesirable tissues that may be accessible trans-anally through the colon, and/or orally through the esophagus and the stomach using translumenal access techniques.
- the embodiments of the electrical ablation devices described herein may be introduced inside a patient using minimally invasive or open surgical techniques. In some instances it may be advantageous to introduce the electrical ablation devices inside the patient using a combination of minimally invasive and open surgical techniques. Minimally invasive techniques may provide more accurate and effective access to the treatment region for diagnostic and treatment procedures. To reach internal treatment regions within the patient, the electrical ablation devices described herein may be inserted through natural openings of the body such as the mouth, anus, and/or vagina, for example. Minimally invasive procedures performed by the introduction of various medical devices into the patient through a natural opening of the patient are known in the art as NOTESTM procedures.
- Surgical devices such as an electrical ablation devices, may be introduced to the treatment region through the channels of the endoscope to perform key surgical activities (KSA), including, for example, electrical ablation of tissues using irreversible electroporation energy.
- KSA key surgical activities
- Some portions of the electrical ablation devices may be introduced to the tissue treatment region percutaneously or through small - keyhole - incisions.
- Endoscopic minimally invasive surgical and diagnostic medical procedures are used to evaluate and treat internal organs by inserting a small tube into the body.
- the endoscope may have a rigid or a flexible tube.
- a flexible endoscope may be introduced either through a natural body opening (e.g., mouth, anus, and/or vagina).
- a rigid endoscope may be introduced via trocar through a relatively small - keyhole - incision incisions (usually 0.5 cm to 1 .5 cm).
- the endoscope can be used to observe surface conditions of internal organs, including abnormal or diseased tissue such as lesions and other surface conditions and capture images for visual inspection and photography.
- the endoscope may be adapted and configured with channels for introducing medical instruments to the treatment region for taking biopsies, retrieving foreign objects, and/or performing surgical procedures.
- an electrical ablation device is inserted in the human body internal organs may be reached using trans-organ or translumenal surgical procedures.
- the electrical ablation device may be advanced to the treatment site using endoscopic translumenal access techniques to perforate a lumen, and then, advance the electrical ablation device and the endoscope into the peritoneal cavity.
- Translumenal access procedures for perforating a lumen wall, inserting, and advancing an endoscope therethrough, and pneumoperitoneum devices for insufflating the peritoneal cavity and closing or suturing the perforated lumen wall are well known.
- a puncture must be formed in the stomach wall or in the gastrointestinal tract to access the peritoneal cavity.
- One device often used to form such a puncture is a needle knife which is inserted through the channel of the endoscope, and which utilizes energy to penetrate through the tissue.
- a guidewire is then feed through the endoscope and is passed through the puncture in the stomach wall and into the peritoneal cavity.
- the needle knife is removed, leaving the guidewire as a placeholder.
- a balloon catheter is then passed over the guidewire and through the channel of the endoscope to position the balloon within the opening in the stomach wall.
- the balloon can then be inflated to increase the size of the opening, thereby enabling the endoscope to push against the rear of the balloon and to be feed through the opening and into the peritoneal cavity.
- the endoscope may be connected to a video camera (single chip or multiple chips) and may be attached to a fiber-optic cable system connected to a "cold" light source (halogen or xenon), to illuminate the operative field.
- the video camera provides a direct line-of-sight view of the treatment region.
- the abdomen may be insufflated with carbon dioxide (C0 2 ) gas to create a working and viewing space.
- C0 2 gas is used because it is common to the human body and can be removed by the respiratory system if it is absorbed through tissue.
- the diseased tissue may be electrically ablated or destroyed using the various embodiments of electrodes discussed herein.
- the placement and location of the electrodes can be important for effective and efficient electrical ablation therapy.
- the electrodes may be positioned proximal to a treatment region (e.g., target site or worksite) either endoscopically or transcutaneously
- Electrodes may be introduced to the tissue treatment region through a channel of the endoscope, an overtube, or a trocar and, in some implementations, may be introduced through percutaneously or through small - keyhole - incisions.
- the various embodiments of the devices described herein will be processed before surgery.
- a new or used instrument is obtained and if necessary cleaned.
- the instrument can then be sterilized.
- the instrument is placed in a closed and sealed container, such as a plastic or TYVEK® bag.
- the container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons.
- the radiation kills bacteria on the instrument and in the container.
- the sterilized instrument can then be stored in the sterile container.
- the sealed container keeps the instrument sterile until it is opened in the medical facility.
- the device is sterilized prior to use. This can be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, steam. [0103]
- beta or gamma radiation ethylene oxide, steam.
- An ablation apparatus comprising two electrodes coupled to a energy source and a temperature sensor according to certain embodiments was used to deliver a series of electrical pulses ex vivo to healthy porcine liver to induce irreversible electroporation (Dose 1 ).
- the Dose 1 pulse parameters may include a 3,000 V amplitude, a 10 ⁇ is pulse width, 10 total number of pulses per burst, a frequency of 200 Hz, 6 total number of bursts, and a 3 s delay between each burst.
- Dose 1 is generally characterized by low energy and high voltage. Dose 1 was not suitable for synchronizing to a patient's cardiac cycle.
- FIG. 13 is a photograph of the porcine liver after receiving Dose 1 .
- the necrotic zone 100 is generally indicated by the discoloration of the tissue.
- the temperature was monitored using the temperature sensor illustrated in FIG. 4.
- FIG. 14 is a graphical representation of temperature during Dose 1 . Without wishing to be bound to any particular theory, it is believed that temperature is related to the distance between the electrodes. As shown in FIG. 14, an electrode spacing of 1 .5 cm generated a maximum temperature of about 51 °C at the positive electrode and an electrode spacing of 1 .0 cm generated a maximum temperature of about 59°C at the positive electrode. As shown in FIG. 14, the temperature increases as the distance between the electrodes decreases.
- FIGS. 15A-D include photographs of porcine liver after receiving a series of electrical pulses having an amplitude of 3 kV that may be applied to undesirable tissue to induce irreversible electroporation.
- FIG. 15A is a photograph of porcine liver after receiving a first sequence of electrical pulses.
- FIG. 15B is a photograph of the porcine liver after receiving the second sequence of electrical pulses. The temperature of the porcine tissue after the second sequence of electrical pulses was 40°C.
- FIG. 15C is a photograph of the porcine liver after receiving the third sequence of electrical pulses. The temperature of the porcine tissue after the third sequence of electrical pulses was 37°C.
- FIG. 15D is a photograph of the porcine liver after receiving the fourth sequence of electrical pulses.
- the temperature of the porcine tissue after the fourth sequence of electrical pulses was 45°C.
- the necrotic zone caused by each sequence of electrical pulses is generally indicated by the discoloration of the tissue.
- the sequence interval between each series of electrical pulses was 5 seconds.
- the total dose time was 20 seconds.
- An ablation apparatus comprising two electrodes coupled to a energy source and a temperature sensor according to certain embodiments was used to deliver a series of electrical pulses ex vivo to healthy porcine liver to induce irreversible electroporation (Dose 2).
- the Dose 2 parameters may include a first series of bursts including a 1000 V amplitude, a 5 ⁇ is pulse width, 500 total number of pulses per burst, a total of 30 first series bursts, a 0.1 s delay between each burst followed by a second series of bursts pulses including a 1500 V amplitude, a 5 ⁇ is pulse width, 500 total number of pulses per burst, a total of 20 second bursts, a 0.1 s delay between each burst followed by a third series of bursts including a 3000 V amplitude, a 10 ⁇ is pulse width, 10 total number of pulses per burst, a total of 10 third series bursts, a 3 s delay between each burst.
- the frequency may be 200 Hz.
- Dose 2 is generally characterized by a multi-train dose at a higher energy than Dose 1 . Dose 2 was not suitable for synchronizing to a patient's cardiac cycle.
- the first pulse train included 500 pulses per burst at a pulse width of 5 ⁇ , a frequency of 200 Hz, and an amplitude of 1 kV
- the second pulse train included 500 pulses per burst at a pulse width of 5 ⁇ , a frequency of 200 Hz, and an amplitude of 1 .5 kV
- the third pulse train included 10 pulses per burst at a pulse width of 10 ⁇ , a frequency of 200 Hz, and an amplitude of 3 kV.
- FIG. 17 is a graph illustrating the average area of the necrotic zone for Dose 1 and the average area of the necrotic zone for Dose 2. As shown in FIG. 17, Dose 1 exhibited a smaller average area of the necrotic zone than Dose 2.
- FIG. 18A is a graph illustrating the average area of the necrotic zone for Dose 1 and the average area of the necrotic zone for Doses 2a, b. As shown in FIG. 18A, the average necrotic zone dimensions and area for Dose 1 was 1 cm x 2.5 cm and 2.5 cm 2 , respectively.
- FIG. 18B includes photographs of the necrotic zone produced by Doses 1 , 2a, and 2b. As shown in FIGS. 17 and 18, the size and area of the necrotic zone generally increases as the energy increases.
- FIG. 19 is a graphical representation of a series of electrical pulses that may be delivered to undesirable tissue to induce irreversible electroporation.
- the multi-train electrical sequence may be synchronized with a patient's cardiac cycle.
- the pulse train may include up to 180 pulses per burst at a pulse width of 10 ⁇ , a frequency of 200 Hz, and an amplitude of 3 kV.
- the total burst time of each burst may fit within the latent period, or the period of electrical inactivity of the cardiac cycle.
- the latent period may also be known as the refractory period.
- the temperature may be measured between each burst.
- the pulse parameters and maximum temperature may be adjusted to achieve a non-thermal zone of cell death ("IRE Dose").
- the IRE Dose may include a maximum temperature of 50°C and a typical sequence time of about 1 minute.
- the IRE Dose parameters may include a 3,000 V amplitude, a 10 ⁇ is pulse width, 15 total number of pulses per burst, frequency of each 10 ⁇ is pulse within the bursts of 200 Hz, a 3 s delay between each burst, and 20 total number of bursts.
- the IRE Dose may be
- the pulse parameters and maximum temperature may be adjusted to slowly increase the temperature of the tissue ("IRE+ Dose").
- the IRE+ Dose may increase the temperature of a large volume of tissue by a few degrees, such as, for example, 0-10°C and 1 - 5°C, over a relatively longer period of time.
- the IRE+ Dose may include a typical sequence time of about 8 minutes.
- the IRE+ Dose parameters may include a 3,000 V amplitude, a 10 ⁇ is pulse width, 20 total number of pulses per burst, frequency of each 10 ⁇ is pulse within the bursts of 200 Hz, a 3 s delay between each burst, and 90 total number of bursts at a maximum temperature of 60°C.
- the electrode spacing may be 2 cm.
- the IRE+ Dose may be characterized by a large necrosis zone.
- the pulse parameters and maximum temperature may be adjusted to rapidly increase the temperature of the tissue ("IRE+Heat Dose").
- the IRE+Heat Dose may increase the temperature of a large volume of tissue by a few degrees, such as, for example, 0-10°C and 1 -5°C, over a relatively shorter period of time.
- the IRE+Heat Dose may include a typical sequence time of about 4 minutes.
- the IRE+Heat Dose parameters may include a 3,000 V amplitude, a 10 ⁇ is pulse width, 20 total number of pulses per burst, frequency of each 10 ⁇ is pulse within the bursts of 200 Hz, a 0.1 s delay between each burst, and 90 total number of bursts at a maximum temperature of 60°C.
- the higher temperature in the tissue surrounding the electrodes may cause thermal coagulation.
- thermal coagulation may occur at a higher average power and same energy.
- the IRE+Heat Dose may be characterized by a larger necrotic zone than the IRE Dose and a shorter time than the IRE+ Dose.
- FIGS. 20A-C are photographs of a healthy porcine liver after receiving the IRE Dose, IRE+ Dose, and IRE+Heat Dose, respectively.
- the IRE Dose has a necrotic zone having a size of 1 .2 cm x 2.3 cm and an area of 2.76 cm 2 .
- the IRE+ Dose has a necrotic zone having a size of 2.1 cm x 3.7 cm and an area of 7.77 cm 2 .
- the IRE+Heat Dose has a necrotic zone having a size of 1 .6 cm x 3.6 cm and an area of 5.76 cm 2 .
- FIG. 21 is a graphical representation of the electrode temperature during the IRE Dose having a maximum temperature limit of 50°C. As shown in FIG. 21 , the maximum temperature at the positive electrode was about 47°C at 69 seconds.
- FIG. 22 is a graphical representation of the temperature during the IRE+ Dose having a maximum temperature limit of 90°C. As shown in FIG. 22, the maximum temperature at the positive electrode was about 62°C at about 430 seconds.
- FIG. 21 is a graphical representation of the electrode temperature during the IRE Dose having a maximum temperature limit of 50°C. As shown in FIG. 21 , the maximum temperature at the positive electrode was about 47°C at 69 seconds.
- FIG. 22 is a graphical representation of the temperature during the IRE+ Dose having a maximum temperature limit of 90°C. As shown in FIG. 22, the maximum temperature at the positive electrode was about 62°C at about 430 seconds.
- FIG. 21 is a graphical representation of the electrode temperature during the IRE Dose having
- FIG. 23 is a graphical representation of the temperature during the IRE+Heat Dose having a maximum temperature limit of 90°C. As shown in FIG. 23, the maximum temperature at the positive electrode was about 88°C at about 220 seconds.
- FIG. 24 is a graphical representation of the temperature during the IRE+Heat Dose having a maximum temperature limit of 90°C. As shown in FIG. 24, the maximum temperature at the positive electrode was about 96°C at about 259 seconds.
- FIGS. 25A-C include photographs of healthy porcine liver after receiving an IRE Dose having an electrode spacing of 1.5 cm, an IRE+ Dose having an electrode spacing of 2.0 cm, an IRE+Heat Dose having an electrode spacing of 2.0 cm.
- the IRE+ Dose has the largest necrotic zone and the IRE Dose has the smallest necrotic zone.
- the IRE+Heat Dose has a necrotic zone intermediate the IRE Dose and IRE+ Dose.
- the IRE+Heat Dose has a thermal zone (lighter area) is smaller than the necrotic zone.
- FIGS. 26A-F are graphical representations of simulated necrotic zones (white) and thermal zones (gray) of porcine livers (black) after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
- FIGS. 26A,B include computer simulation of an IRE Dose having an electrode spacing of 1 .5 cm and 2.0 cm, respectively.
- a necrotic zone of 2.3 cm x 1.02 cm is predicted for an IRE Dose having an electrode spacing of 1.5 cm.
- a necrotic zone of 2.8 cm wide is predicted for an IRE Dose having an electrode spacing of 2.0 cm.
- 26C,D include computer simulation of an IRE+ Dose having an electrode spacing of 1 .5 cm and 2.0 cm, respectively.
- a necrotic zone of 3.4 cm x 2.09 cm is predicted for an IRE+ Dose having an electrode spacing of 2.0 cm and a 400 V/cm threshold.
- a necrotic zone of 2.92 cm x 2.04 cm is predicted for an IRE+ Dose having an electrode spacing of 1.5 cm and a 400 V/cm threshold.
- decreasing the necrotic threshold may increase the size of the necrotic zone. As shown in FIGS. 26A,C, the size of the necrotic zone in FIG. 26A is smaller than the size of the necrotic zone in FIG. 26C.
- 26E,F include computer simulation of an IRE+Heat Dose having an electrode spacing of 2.0 cm and 3.0 cm, respectively.
- an IRE+Heat Dose having an electrode spacing of 2.0 cm produces a thermal zone (gray region).
- the width of the necrotic zone of an IRE+Heat Dose having an electrode spacing of 2.0 cm is less than the width of the necrotic zone of an IRE+ Dose having an electrode spacing of 2.0 cm.
- an IRE+Heat Dose having an electrode spacing of 3.0 cm produces thermal zones around each electrode.
- the width of the necrotic zone of an IRE+Heat Dose having an electrode spacing of 3.0 cm is less than the width of the necrotic zone of an IRE+Heat Dose having an electrode spacing of 2.0 cm.
- the ratio of the necrotic zone length and necrotic zone width generally corresponds to the electric field pattern.
- the electric field pattern generally becomes long and narrow as the electrode spacing increases.
Abstract
An electrical ablation device may generally comprise first and second electrodes coupled to an energy source operative to generate and deliver a first sequence of electrical pulses and a second sequence of electrical pulses to tissue having a necrotic threshold, wherein the first sequence of electrical pulses delivers a first energy dose that is less than the necrotic threshold to induce thermal heating in the tissue and the second sequence of electrical pulses delivers a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation. The first sequence of electrical pulses may each be independently characterized by a first amplitude, a first pulse width, and a first frequency. The second sequence of electrical pulses may be characterized by a second amplitude, a second pulse width, and a second frequency.
Description
TITLE
ELECTRICAL ABLATION DEVICES AND METHODS BACKGROUND
[0001] Electrical ablation therapy has been used in medicine for the treatment of undesirable tissue, such as, for example, diseased tissue, cancer, malignant and benign tumors, masses, lesions, and other abnormal tissue growths. Apparatuses, systems, and methods for conventional ablation therapies may include electrical ablation therapies, such as, for example, high temperature thermal therapies including, focused ultrasound ablation, radiofrequency (RF) ablation, and interstitial laser coagulation, chemical therapies in which chemical agents are injected into the undesirable tissue to cause ablation, surgical excision, cryotherapy, radiation, photodynamic therapy, Moh's micrographic surgery, topical treatments with 5-fluorouracil, and laser ablation. Conventional electrical ablation therapies may suffer from some of the following limitations: cost, length of recovery, and extraordinary pain inflicted on the patient. In particular, one drawback of conventional electrical ablation therapies may be any permanent damage to healthy tissue surrounding the undesirable tissue due to detrimental thermal effects resulting from exposing the tissue to thermal energy generated by the electrical ablation device. For example, permanent damage to surrounding healthy tissue may occur when using high temperature thermal therapies to expose undesirable tissue to electric potentials sufficient to cause cell necrosis. Accordingly, electrical ablation apparatuses, systems, and methods for the treatment of undesirable tissue having reduced or no detrimental thermal effects to surrounding healthy tissue are desirable.
FIGURES
[0002] The various embodiments of electrical ablation devices and methods thereof described herein may be better understood by considering the following description in conjunction with the accompanying drawings.
[0003] FIG. 1 illustrates an electrical ablation system according to certain embodiments described herein.
[0004] FIG. 2 illustrates a bipolar electrical ablation system according to certain embodiments described herein.
[0005] FIG. 3 illustrates an electrical ablation system including sensors according to certain embodiments described herein.
[0006] FIG. 4 illustrates an electrical ablation system including a temperature sensor according to certain embodiments described herein.
[0007] FIG. 5A is a graphical representation of a series of monopolar electrical pulses that may be applied to undesirable tissue.
[0008] FIG. 5B is a graphical representation of a series of bipolar electrical pulses that may be applied to undesirable tissue.
[0009] FIG. 6A illustrates two electrodes in a monopolar electrical ablation system according to certain embodiments described herein.
[0010] FIG. 6B illustrates two electrodes in a bipolar electrical ablation system according to certain embodiments described herein.
[0011] FIG. 7 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0012] FIGS. 8A-B are graphical representations of a series of electrical pulses that may be applied to undesirable tissue.
[0013] FIG. 9 is a graphical representation of a series of bipolar electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0014] FIGS. 10A-B are graphical representations of a series of bipolar electrical pulses that may be applied to undesirable tissue.
[0015] FIG. 1 1 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue.
[0016] FIG. 12 illustrates the use of an electrical ablation system according to certain embodiments described herein.
[0017] FIG. 13 is a photograph of a porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0018] FIG. 14 is a graphical representation of electrode temperature during a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0019] FIGS. 15A-D include photographs of porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0020] FIG. 16 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue.
[0021] FIG. 17 is a graph illustrating the area of the necrotic zone of a porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0022] FIG. 18A is a graph illustrating the average area of the necrotic zone of a porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0023] FIG. 18B includes photographs of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0024] FIG. 19 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue.
[0025] FIGS. 20A-C include photographs of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0026] FIGS. 21 -24 are graphs illustrating the electrode temperature in porcine liver after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0027] FIGS. 25A-C include photographs of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein.
[0028] FIGS. 26A-F are graphical representations of simulated necrotic zones and thermal zones of porcine livers after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein
DESCRIPTION
[0029] Various embodiments are directed to electrical ablation apparatuses, systems, and methods for the treatment of undesirable tissue having reduced or no detrimental thermal effects to surrounding healthy tissue.
[0030] This disclosure describes various elements, features, aspects, and advantages of various embodiments of electrical ablation devices and methods thereof. It is to be understood that certain descriptions of the various embodiments have been simplified to illustrate only those elements, features and aspects that are relevant to a more clear understanding of the disclosed embodiments, while eliminating, for purposes of brevity or clarity, other elements, features and aspects. Any references to "various embodiments," "some embodiments," "one embodiment," or "an embodiment" generally means that a particular element, feature and/or aspect described in the embodiment is included in at least one embodiment. The phrases "in various
embodiments," "in some embodiments," "in one embodiment," or "in an embodiment" may not
refer to the same embodiment. Persons having ordinary skill in the art, upon considering the description herein, will recognize that various combinations or sub-combinations of the various embodiments and other elements, features, and aspects may be desirable in particular implementations or applications. However, because such other elements, features, and aspects may be readily ascertained by persons having ordinary skill in the art upon considering the description herein, and are not necessary for a complete understanding of the disclosed embodiments, a description of such elements, features, and aspects may not be provided. As such, it is to be understood that the description set forth herein is merely exemplary and illustrative of the disclosed embodiments and is not intended to limit the scope of the invention as defined solely by the claims.
[0031] All numerical quantities stated herein are approximate unless stated otherwise, meaning that the term "about" may be inferred when not expressly stated. The numerical quantities disclosed herein are to be understood as not being strictly limited to the exact numerical values recited. Instead, unless stated otherwise, each numerical value is intended to mean both the recited value and a functionally equivalent range surrounding that value. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
Notwithstanding the approximations of numerical quantities stated herein, the numerical quantities described in specific examples of actual measured values are reported as precisely as possible.
[0032] All numerical ranges stated herein include all sub-ranges subsumed therein. For example, a range of "1 to 10" is intended to include all sub-ranges between and including the recited minimum value of 1 and the recited maximum value of 10. Any maximum numerical limitation recited herein is intended to include all lower numerical limitations. Any minimum numerical limitation recited herein is intended to include all higher numerical limitations.
[0033] As generally used herein, the terms "proximal" and "distal" generally refer to a clinician manipulating one end of an instrument used to treat a patient. The term "proximal" generally refers to the portion of the instrument closest to the clinician. The term "distal" generally refers to the portion located furthest from the clinician. It will be further appreciated that for conciseness and clarity, spatial terms such as "vertical," "horizontal," "up," and "down" may be used herein with respect to the illustrated embodiments. However, surgical instruments may be used in many orientations and positions, and these terms are not intended to be limiting and absolute.
[0034] According to certain embodiments, an ablation apparatus may generally comprise first and second electrodes coupled to an energy source operative to generate and deliver a first sequence of electrical pulses and a second sequence of electrical pulses to tissue having a necrotic threshold, wherein the first sequence of electrical pulses delivers a first energy dose that is less than the necrotic threshold to induce thermal heating in the tissue and the second sequence of electrical pulses delivers a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation. The necrotic threshold generally refers the electric field strength that induces cell necrosis by irreversible electroporation. The necrotic threshold may relate to at least the following parameters: cell type, temperature, electrical conductivity, pH and tissue perfusion. Table 1 illustrates the necrotic threshold for several cell types.
[0035] In certain embodiments, electrical ablation devices may generally comprise one or more electrodes configured to be positioned into or proximal to undesirable tissue in a tissue treatment region (e.g., a target site or a worksite). The tissue treatment region may have evidence of abnormal tissue growth. In general, the electrodes may comprise an electrically
conductive portion (e.g., medical grade stainless steel, gold plated, etc.) and may be configured to electrically couple to an energy source. Once the electrodes are positioned into or proximal to the undesirable tissue, an energizing potential may be applied to the electrodes to create an electric field to which the undesirable tissue is exposed. The energizing potential (and the resulting electric field) may be characterized by various parameters, such as, for example, frequency, amplitude, pulse width (duration of a pulse or pulse length), and/or polarity.
Depending on the diagnostic or therapeutic treatment to be rendered, a particular electrode may be configured either as an anode or a cathode, or a plurality of electrodes may be configured with at least one electrode configured as an anode and at least one other electrode configured as a cathode. Regardless of the initial polarity configuration, the polarity of the electrodes may be reversed by reversing the polarity of the output of the energy source.
[0036] In certain embodiments, a suitable energy source may comprise an electrical waveform generator. The electrical waveform generator may be configured to create an electric field that is suitable to induce thermal heating in the tissue without inducing cell necrosis in the tissue by irreversible electroporation at various electric field amplitudes and durations. The electrical waveform generator may be configured to create an electric field that is suitable to create irreversible electroporation in undesirable tissue at various electric field amplitudes and durations. The energy source may be configured to deliver electrical pulses in the form of direct-current (DC) and/or alternating-current (AC) voltage potentials (e.g., time-varying voltage potentials) to the electrodes. The energy source may also be configured to reverse the potential between the electrodes. The electrical pulses may be characterized by various parameters, such as, for example, frequency, amplitude, pulse width, polarity, total number of pulses, delay between pulses bursts, total number of pulses at a lower voltage, and total number of pulses at high voltage. The undesirable tissue may be heated by exposure to the electric potential difference across the electrodes. The undesirable tissue may be ablated by exposure to the electric potential difference across the electrodes.
[0037] In certain embodiments, the apparatuses, systems, and methods may be configured for minimally invasive ablation treatment of undesirable tissue through the use of irreversible electroporation. Minimally invasive ablation treatment of undesirable tissue may be
characterized by the ability to ablate undesirable tissue in a controlled and focused manner having reduced or no thermally damaging effects to the surrounding healthy tissue. The apparatuses, systems, and methods may be configured to ablate undesirable tissue through the use of electroporation or electropermeabilization. Electroporation refers to the application of electric pulses to a cell membrane to cause an increase in the permeabilization of the cell membrane. The external electric field (i.e., electric potential/per unit length) applied to the cell may significantly increase the electrical conductivity and permeability of the plasma in the cell membrane.
[0038] More specifically, the apparatuses, systems, and methods may be configured to ablate undesirable tissue through the use of irreversible electroporation. Irreversible electroporation refers to the application of an electric field of a specific magnitude and duration to a cell membrane such that the permeabilization of the cell membrane cannot be reversed. One of the primary parameters affecting the transmembrane potential is the potential difference across the cell membrane. The destabilizing potential may form pores in the cell membrane when the potential across the cell membrane exceeds its dielectric strength causing the cell to die under a process known as apoptosis and/or necrosis. Irreversible electroporation may induce localized heating of the tissue surrounding the electrodes. Irreversible electroporation may lead to cell death without inducing a significant amount of heat in the cell membrane.
[0039] The application of irreversible electroporation pulses to cells may be an effective way for ablating large volumes of undesirable tissue with no or minimal detrimental thermal effects to the surrounding healthy tissue. Without wishing to be bound to any particular theory, it is believed that irreversible electroporation destroys cells with no or minimal heat, and thus, may not destroy the cellular support structure or regional vasculature. A destabilizing irreversible
electroporation pulse, suitable to cause cell death without inducing a significant amount of thermal damage to the surrounding healthy tissue, may have amplitude in the range of several hundred to several thousand volts and may be generally applied across biological membranes over a distance of several millimeters, for example, for a relatively long duration of 1 \is to 100 ms. Thus, the undesirable tissue may be ablated in-vivo through the delivery of destabilizing electric fields by quickly causing cell necrosis.
[0040] The apparatuses, systems, and methods for electrical ablation therapy may be adapted for use in minimally invasive surgical procedures to access the tissue treatment region in various anatomic locations, such as, for example, the brain, lungs, breast, liver, gall bladder, pancreas, prostate gland, and various internal body lumen defined by the esophagus, stomach, intestine, colon, arteries, veins, anus, vagina, cervix, fallopian tubes, and the peritoneal cavity. Minimally invasive electrical ablation devices may be introduced to the tissue treatment region though a small opening formed in the patient's body using a trocar or through a natural body orifice such as the mouth, anus, or vagina using translumenal access techniques known as Natural Orifice Translumenal Endoscopic Surgery (NOTES)™. Once the electrical ablation devices (e.g. , electrodes) are located into or proximal to the undesirable tissue in the treatment region, electric field potentials may be applied by the energy source to the undesirable tissue. The electrical ablation devices may comprise portions that may be inserted into the tissue treatment region percutaneously (e.g. , where access to inner organs or other tissue is done via needle-puncture of the skin). Other portions of the electrical ablation devices may be introduced into the tissue treatment region endoscopically (e.g. , laparoscopically and/or thoracoscopically) through trocars or channels of the endoscope, through small incisions, or transcutaneously (e.g. , where electric pulses are delivered to the tissue treatment region through the skin). An electrical ablation device is described in commonly owned U.S. Patent Publication No.
20100179530, entitled, "ELECTRICAL ABLATION DEVICES" filed January 12, 2009.
[0041] FIG. 1 illustrates one embodiment of an electrical ablation system 10. The electrical ablation system 10 may be employed to ablate undesirable tissue, such as, for example, diseased tissue, cancer, malignant and benign tumors, masses, lesions, and other abnormal tissue growths in a tissue treatment region using electrical energy. The electrical ablation system 10 may be configured to treat a number of lesions and ostepathologies comprising metastatic lesions, tumors, fractures, infected sites, and inflamed sites in a tissue treatment region using electrical energy. The electrical ablation system 10 may be configured to be positioned within a patient's natural body orifice, e.g., the mouth, anus, and vagina, and/or advanced through internal body lumen or cavities, e.g., the esophagus, stomach, intestines, colon, cervix, and urethra, to reach the tissue treatment region. The electrical ablation system 10 may be configured to be positioned and passed through a small incision or keyhole formed through the patient's skin or abdominal wall using a trocar to reach the tissue treatment region. The tissue treatment region may be located in the patient's brain, lung, breast, liver, gall bladder, pancreas, prostate gland, various internal body lumen defined by the esophagus, stomach, intestine, colon, arteries, veins, anus, vagina, cervix, fallopian tubes, and the peritoneal cavity. The electrical ablation system 10 may be used in conjunction with
endoscopic, laparoscopic, thoracoscopic, open surgical procedures via small incisions or keyholes, percutaneous techniques, transcutaneous techniques, and/or external non-invasive techniques, and any combinations thereof.
[0042] Once positioned into or proximate the tissue treatment region, the electrical ablation system 10 may be actuated (e.g., energized) to ablate the undesirable tissue. In one embodiment, the electrical ablation system 10 may be configured to treat diseased tissue in the gastrointestinal tract, esophagus, lung, and/or stomach that may be accessed orally. In another embodiment, the electrical ablation system 10 may be adapted to treat undesirable tissue in the liver or other organs that may be accessible using translumenal access techniques, such as, for example, NOTES™ techniques where the electrical ablation devices may be initially introduced
through a natural body orifice and then advanced to the tissue treatment site by puncturing the walls of internal body lumen. In various embodiments, the electrical ablation system 10 may be adapted to treat undesirable tissue in the brain, lung, breast, liver, gall bladder, pancreas, or prostate gland, using one or more electrodes positioned percutaneously, transcutaneously, translumenally, minimally invasively, and/or through open surgical techniques, or any combination thereof.
[0043] In one embodiment, the electrical ablation system 10 may be employed in conjunction with a flexible endoscope 12, as well as a rigid endoscope, laparoscope, or thoracoscope, such as the GIF-100 model available from Olympus Corporation. In one embodiment, the endoscope 12 may be introduced to the tissue treatment region trans-anally through the colon, trans-orally through the esophagus and stomach, trans-vaginally through the cervix, transcutaneously, or via an external incision or keyhole formed in the abdomen in conjunction with a trocar. The electrical ablation system 10 may be inserted and guided into or proximate the tissue treatment region using the endoscope 12. In other embodiments, the endoscope 12 is not utilized, and instead other techniques, such as, for example, ultrasound or a computerized tomography (CT) scan, may be used to determine proper instrument placement during the procedure.
[0044] In the embodiment illustrated in FIG. 1 , the endoscope 12 comprises an endoscope handle 34 and an elongate relatively flexible shaft 32. The distal end of the flexible shaft 32 may comprise a light source and a viewing port. Optionally, the flexible shaft 32 may define one or more channels for receiving various instruments therethrough, such as, for example, electrical ablation devices. Images within the field of view of the viewing port may be received by an optical device, such as, for example, a camera comprising a charge coupled device (CCD) usually located within the endoscope 12, and transmitted to a display monitor (not shown) outside the patient. In one embodiment, the electrical ablation system 10 may comprise a plurality of electrical conductors 18, a handpiece 16 comprising an activation switch 62, and an energy source 14, such as, for example, an electrical waveform generator, electrically
coupled to the activation switch 62 and the electrical ablation device 20. The electrical ablation device 20 may comprise a relatively flexible member or shaft 22 that may be introduced to the tissue treatment region using any of the techniques discussed above, such as, an open incision and a trocar, through one of more of the channels of the endoscope 12, percutaneously, or transcutaneously.
[0045] In one embodiment, one or more electrodes (e.g., needle electrodes, balloon electrodes), such as first and second electrodes 24a, b may extend out from the distal end of the electrical ablation device 20. In one embodiment, the first electrode 24a may be configured as the positive electrode and the second electrode 24b may be configured as the negative electrode. The first electrode 24a may be electrically connected to a first electrical conductor 18a, or similar electrically conductive lead or wire, which may be coupled to the positive terminal of the energy source 14 through the activation switch 62. The second electrode 24b may be electrically connected to a second electrical conductor 18b, or similar electrically conductive lead or wire, which may be coupled to the negative terminal of the energy source 14 through the activation switch 62. The electrical conductors 18a,b may be electrically insulated from each other and surrounding structures, except for the electrical connections to the respective electrodes 24a, b.
[0046] In certain embodiments, the electrical ablation device 20 may be configured to be introduced into or proximate the tissue treatment region using the endoscope 12 (laparoscope or thoracoscope), open surgical procedures, and/or external and non-invasive medical procedures. The electrodes 24a, b may be referred to herein as endoscopic or laparoscopic electrodes, although variations thereof may be inserted transcutaneously or percutaneously. In various embodiments, one or both electrodes 24a, b may be adapted and configured to slideably move in and out of a cannula, lumen, or channel defined within the flexible shaft 22.
[0047] When the electrodes 24a, b are positioned at the desired location into or proximate the tissue treatment region, the electrodes 24a, b may be connected to or disconnected from the
energy source 14 by actuating or de-actuating the activation switch 62 on the handpiece 16. The activation switch 62 may be operated manually or may be mounted on a foot switch (not shown), for example. The electrodes 24a, b may deliver electric field pulses to the undesirable tissue. The electric field pulses may be characterized by various parameters, such as, for example, pulse shape, amplitude, frequency, pulse width, polarity, total number of pulses and duration. The electric field pulses may be sufficient to induce thermal heating in the undesirable tissue without inducing irreversible electroporation in the undesirable tissue. The electric field pulses may be sufficient to induce irreversible electroporation in the undesirable tissue. The induced potential may depend on a variety of conditions, such as, for example, tissue type, cell size, and electrical field pulse parameters. The transmembrane potential of a specific tissue type may primarily depend on the amplitude of the electric field and pulse width.
[0048] In certain embodiments, a protective sleeve or sheath 26 may be slidably disposed over the flexible shaft 22 and within a handle 28. In another embodiment, the sheath 26 may be slidably disposed within the flexible shaft 22 and the handle 28. The sheath 26 may be slideable and may be located over the electrodes 24a, b to protect the trocar and prevent accidental piercing when the electrical ablation device 20 is advanced therethrough. One or both of the electrodes 24a, b may be adapted and configured to slideably move in and out of a cannula, lumen, or channel formed within the flexible shaft 22. One or both of the electrodes 24a, b may be fixed in place. One of the electrodes 24a, b may provide a pivot about which the other electrode may be moved in an arc to other points in the tissue treatment region to treat larger portions of the diseased tissue that cannot be treated by fixing both of the electrodes 24a, b in one location. In one embodiment, one or both of the electrodes 24a, b may be adapted and configured to slideably move in and out of a working channel formed within a flexible shaft 32 of the endoscope 12 or may be located independently of the endoscope 12.
[0049] In one embodiment, the first and second electrical conductors 18a,b may be provided through the handle 28. The first electrode 24a may be slideably moved in and out of the distal
end of the flexible shaft 22 using a slide member 30 to retract and/or advance the first electrode 24a. The second electrode 24b may be slideably moved in and out of the distal end of the flexible shaft 22 using the slide member 30 or a different slide member to retract and/or advance the second electrode 24b. One or both electrodes 24a, b may be coupled to the slide member 30, or additional slide members, to advance and retract the electrodes 24a, b and position the electrodes 24a, b. In this manner, the first and second electrodes 24a, b, which may be slidably movable within the cannula, lumen, or channel defined within the flexible shaft 22, may be advanced and retracted with the slide member 30. As shown in FIG. 1 , the first electrical conductor 18a coupled to the first electrode 24a may be coupled to the slide member 30. In this manner, the first electrode 24a, which is slidably movable within the cannula, lumen, or channel within the flexible shaft 22, may be advanced and retracted with the slide member 30. In one embodiment, various slide members, such as the slide member 30, may be rotatable. Thus rotation of the slide member 30 may rotate the corresponding electrode(s) at the distal end of the electrical ablation device 20.
[0050] In various other embodiments, transducers or sensors 29 may be located in the handle
28 (or other suitable location) of the electrical ablation device 20 to sense the force with which the electrodes 24a, b penetrate the tissue in the tissue treatment region. This feedback information may be useful to determine whether one or both of the electrodes 24a, b have been properly inserted in the tissue treatment region. As is particularly well known, cancerous tumor tissue tends to be denser than healthy tissue, and thus greater force may be typically required to insert the electrodes 24a, b therein. The transducers or sensors 29 may provide feedback to the operator, surgeon, or clinician to physically sense when the electrodes 24a, b are placed within the cancerous tumor. The feedback information provided by the transducers or sensors
29 may be processed and displayed by circuits located either internally or externally to the energy source 14. The sensor 29 readings may be employed to determine whether the electrodes 24a, b have been properly located within the cancerous tumor thereby assuring that a
suitable margin of error has been achieved in locating the electrodes 24a, b. The sensor 29 readings may also be employed to determine whether the pulse parameters need to be adjusted to achieve a desired result, such as, for example, reducing the intensity of muscular
contractions in the patient.
[0051] Referring to FIG. 2, in one embodiment, the electrical ablation device 20 may comprise a first flexible shaft 22a housing the first electrode 24a and a second flexible shaft 22b housing the second electrode 24b. The electrical ablation device 20 may comprise a first protective sleeve or sheath (not shown) disposed over at least one of the first flexible shaft 22a and second flexible shaft 22b. The electrical ablation device 20 may comprise a first protective sleeve or sheath (not shown) disposed over the first flexible shaft 22a and a second protective sleeve or sheath (not shown) disposed over the second flexible shaft 22b. The length of the first flexible shaft 22a may be different than the length of the second flexible shaft 22b. The length of the first flexible shaft 22a may be greater than or equal to the length of the second flexible shaft 22b. The length of the first protective sleeve or sheath may be different than the length of the second protective sleeve or sheath. The length of the first protective sleeve or sheath may be greater than or equal to the length of the second protective sleeve or sheath. In one embodiment, an electrical ablation device for biphasic pulses may have the first flexible shaft 22a disposed over the first electrode 24a having a positive polarity and the second flexible shaft 22b disposed over the second electrode 24b having a negative polarity, and wherein the length of the first flexible shaft 22a is greater than the length of the second flexible shaft 22b.
[0052] Referring to FIGS. 1 and 3, the electrical ablation device 20 may be configured to measure at least one of the temperature and pressure. The transducers or sensors 29 may comprise at least one of a temperature sensor and a pressure sensor. In certain embodiments, at least one of a temperature sensor and pressure sensor may be located in or proximate the electrical ablation system 10. The temperature sensor and/or pressure sensor may be located within the handle 28. The temperature sensor and/or pressure sensor may be located within the
protective sleeve or sheath 26. The temperature sensor 25 and/or pressure sensor 27 may be located within the flexible shaft 22. The temperature sensor 25 and/or pressure sensor 27 may be located at the distal end of the flexible shaft 22. The protective sleeve or sheath 26 and/or the flexible shaft 22 may comprise one or more vents 31 configured for measuring at least one of the temperature and pressure of the tissue treatment region. The temperature sensor and/or pressure sensor may be located within the electrodes 24a, b. The pressure sensor 27 may be adjacent to at least one of the vents 31 . In one embodiment, the pressure sensor 27 may be adjacent at least one of the vents 31 and the temperature sensor 25 may be located at the distal end of the flexible shaft 22. FIG. 4 is a photograph of an electrical ablation device comprising an optical temperature sensor 29 located in the electrode 24a at the distal end of the flexible shaft 22.
[0053] In certain embodiments, the temperature sensor and/or pressure sensor may be separate from the electrical ablation system 10. The electrical ablation device 20 may include the temperature sensor 25 and the pressure sensor may be separate from the electrical ablation system 10. The electrical ablation device 20 may include the pressure sensor 27 and the temperature sensor may be separate from the electrical ablation system 10.
[0054] According to certain embodiments, the temperature sensor may measure the temperature of the tissue treatment region. The temperature sensor may measure the temperature of the undesirable tissue. The temperature sensor may measure the temperature of the tissue surrounding the electrodes. The temperature sensor may measure the
temperature before, during, and/or after treatment. The temperature sensor may measure the temperature before the first sequence of electrical pulses is delivered to the tissue. The temperature sensor may measure the temperature after the first sequence of electrical pulses is delivered to the tissue. The temperature sensor may measure the temperature before the second sequence of electrical pulses is delivered to the tissue. The temperature sensor may
measure the temperature after the second sequence of electrical pulses is delivered to the tissue.
[0055] According to certain embodiments, the pressure sensor may measure the pressure of the tissue treatment region. The pressure sensor may measure the pressure of the space between the electrodes. The pressure sensor may measure the pressure surrounding the electrodes. The pressure sensor may measure the pressure before, during, and/or after treatment. The pressure sensor may measure the pressure before the first sequence of electrical pulses is delivered to the tissue. The pressure sensor may measure the pressure after the first sequence of electrical pulses is delivered to the tissue. The pressure sensor may measure the pressure before the second sequence of electrical pulses is delivered to the tissue. The pressure sensor may measure the pressure after the second sequence of electrical pulses is delivered to the tissue.
[0056] The temperature sensor and pressure sensor may provide feedback to the operator, surgeon, or clinician to apply an electric field pulse to the undesirable tissue. The pressure and/or temperature information may be useful to determine whether the undesirable tissue may be treated having reduced or no detrimental thermal effects to surrounding healthy tissue. The feedback information provided by the transducers or sensors 29 may be processed and displayed by circuits located either internally or externally to the energy source 14.
[0057] In one embodiment, the input to the energy source 14 may be connected to a commercial power supply by way of a plug (not shown). The output of the energy source 14 is coupled to the electrodes 24a, b, which may be energized using the activation switch 62 on the handpiece 16, or an activation switch mounted on a foot activated pedal (not shown). The energy source 14 may be configured to produce electrical energy suitable for thermal heating and/or electrical ablation.
[0058] In one embodiment, the electrodes 24a, b may be adapted and configured to electrically couple to the energy source 14 (e.g., generator, waveform generator). Once
electrical energy is coupled to the electrodes 24a, b, an electric field may be formed at a distal end of the electrodes 24a, b. The energy source 14 may be configured to generate electric pulses at a predetermined frequency, amplitude, pulse width, and/or polarity that are suitable to induce thermal heating in the undesirable tissue in the treatment region. The energy source 14 may be configured to generate electric pulses at a predetermined frequency, amplitude, pulse width, and/or polarity that are suitable to induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region. For example, the energy source 14 may be configured to deliver DC electric pulses having a predetermined frequency, amplitude, pulse width, and/or polarity suitable to induce thermal heating in the undesirable tissue in the treatment region. For example, the energy source 14 may be configured to deliver DC electric pulses having a predetermined frequency, amplitude, pulse width, and/or polarity suitable to induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region. The DC pulses may be positive or negative relative to a particular reference polarity. The polarity of the DC pulses may be reversed or inverted from positive-to-negative or negative-to-positive a predetermined number of times to induce irreversible electroporation to ablate substantial volumes of undesirable tissue in the treatment region.
[0059] In one embodiment, a timing circuit may be coupled to the output of the energy source 14 to generate electric pulses. The timing circuit may comprise one or more suitable switching elements to produce the electric pulses. For example, the energy source 14 may produce a series of m electric pulses (where m is any positive integer) of sufficient amplitude and duration less than the necrotic threshold to induce thermal heating in the undesirable tissue when the m electric pulses are applied to the electrodes 24a, b and a series of n electric pulses (where n is any positive integer) of sufficient amplitude and duration to induce irreversible electroporation suitable for tissue ablation when the n electric pulses are applied to the electrodes 24a, b. In one embodiment, the electric pulses may have a fixed or variable pulse width, amplitude, and/or frequency.
[0060] The electrical ablation device 20 may be operated either in bipolar mode, i.e., monophasic, or monopolar mode, i.e., biphasic. FIG. 5A is a graphical representation of a series of monopolar electrical pulses having the same polarity in which each pulse has an amplitude of +3,000 VDC. FIG. 6A illustrates two electrodes 24a, b in a monopolar electrical ablation system in which the first electrode 24a has a positive polarity relative to the other electrode 24b. In monopolar mode, a grounding pad may be substituted for one of the electrodes. FIG. 5B is a graphical representation of a series of bipolar electrical pulses having opposite polarity in which the first electrical pulse has an amplitude of +3,000 VDC and the second electrical pulse has an amplitude of -3,000 VDC. FIG. 6B illustrates two electrodes 24a, b in a bipolar electrical ablation system in which the polarity of each electrodes 24a, b alternates. In bipolar mode, the first electrode 24a may be electrically connected to a first polarity and the second electrode 24b may be electrically connected to the opposite polarity. In monopolar mode, the first electrode 24a may be coupled to a prescribed voltage and the second electrode 24b may be set to ground. The energy source 14 may be configured to operate in either the bipolar or monopolar modes with the electrical ablation system 10. In bipolar mode, the first electrode 24a may be electrically connected to a prescribed voltage of one polarity and the second electrode 24b may be electrically connected to a prescribed voltage of the opposite polarity. When more than two electrodes are used, the polarity of the electrodes may be alternated so that any two adjacent electrodes may have either the same or opposite polarities. In bipolar mode, the negative electrode of the energy source 14 may be coupled to an impedance simulation circuit.
[0061] In one embodiment, the energy source 14 may be configured to produce RF waveforms at predetermined frequencies, amplitudes, pulse widths, and/or polarities suitable for thermal heating and/or electrical ablation of cells in the tissue treatment region. One example of a suitable RF energy source may be a commercially available conventional, bipolar/monopolar electrosurgical RF generator, such as Model Number ICC 350, available from Erbe, GmbH. In
one embodiment, the energy source may comprise a microwave energy source configured to produce microwave waveforms at predetermined frequencies, amplitudes, pulse widths, and/or polarities suitable for thermal heating and/or electrical ablation of cells in the tissue treatment region. The microwave power source, such as MicroThermx, available from Boston Scientific Corp., may be coupled to a microwave antenna providing microwave energy in the frequency range from 915 MHz to 2.45 GHz.
[0062] In one embodiment, the energy source 14 may be configured to produce destabilizing electrical potentials (e.g., fields) suitable to induce thermal heating and/or irreversible
electroporation. The destabilizing electrical potentials may be in the form of bipolar/monopolar DC electric pulses suitable for inducing thermal heating and/or irreversible electroporation to ablate tissue undesirable tissue with the electrical ablation device 20. A commercially available energy source suitable for generating thermal heating and/or irreversible electroporation electric field pulses in bipolar or monopolar mode is a pulsed DC generator such as Model Number ECM 830, available from BTX Molecular Delivery Systems Boston, MA. In bipolar mode, the first electrode 24a may be electrically coupled to a first polarity and the second electrode 25 may be electrically coupled to a second (e.g., opposite) polarity of the energy source 14.
Bipolar/ monopolar DC electric pulses may be generated at a variety of frequencies, amplitudes, pulse widths, and/or polarities. Unlike RF ablation systems, which may require high power and energy levels delivered into the tissue to heat and thermally destroy the tissue, irreversible electroporation may require very little energy applied to the tissue to heat and kill the cells of the undesirable tissue using electric field potentials rather than heat. Accordingly, irreversible electroporation systems may avoid the detrimental thermal effects caused by RF ablation systems.
[0063] In certain embodiments, the energy source may comprise a wireless transmitter to deliver energy to the electrodes using wireless energy transfer techniques via one or more remotely positioned antennas. Those skilled in the art will appreciate that wireless energy
transfer or wireless power transmission refers to the process of transmitting electrical energy from an energy source to an electrical load without interconnecting wires. In one embodiment, the energy source 14 may be coupled to the first and second electrodes 24a, b by a wired or a wireless connection. In a wired connection, the energy source 14 may be coupled to the electrodes 24a, b by way of the electrical conductors 18a,b, as shown. In a wireless connection, the electrical conductors 18a,b may be replaced with a first antenna (not shown) coupled the energy source 14 and a second antenna (not shown) coupled to the electrodes 24a, b, wherein the second antenna may be remotely located from the first antenna. In one embodiment, the energy source may comprise a wireless transmitter to deliver energy to the electrodes using wireless energy transfer techniques via one or more remotely positioned antennas. As previously discussed, wireless energy transfer or wireless power transmission is the process of transmitting electrical energy from the energy source 14 to an electrical load, e.g., the abnormal cells in the tissue treatment region, without using the interconnecting electrical conductors 18a,b. An electrical transformer is the simplest example of wireless energy transfer. The primary and secondary circuits of a transformer may not be directly connected and the transfer of energy may take place by electromagnetic coupling through a process known as mutual induction. Power also may be transferred wirelessly using RF energy.
[0064] In one embodiment, the energy source 14 may be configured to generate DC electric pulses at frequencies in the range of about 1 Hz to about 10,000 Hz, amplitudes in the range of about ±100 VDC to about ±6,000 VDC, and pulse width in the range of about 1 με to about 100 ms. The polarity of the electric potentials coupled to the electrodes 24a, b may be reversed during thermal heating and/or electrical ablation therapy. For example, initially, the DC electric pulses may have a positive polarity and an amplitude in the range of about +100 VDC to about +6,000 VDC. Subsequently, the polarity of the DC electric pulses may be reversed such that the amplitude is in the range of about -100 VDC to about -6,000 VDC. In one embodiment, the undesirable cells in the tissue treatment region may be electrically ablated with DC pulses
suitable to induce irreversible electroporation at frequencies of about 10 Hz to about 100 Hz, amplitudes in the range of about +700 VDC to about +3,000 VDC, and pulse widths of about 10 με to about 50 με. In another embodiment, the abnormal cells in the tissue treatment region may be electrically ablated with an electrical waveform having an amplitude of about +500 VDC and pulse duration of about 20 με delivered at a pulse period T or repetition rate, frequency f = 1/T, of about 10 Hz. Without wishing to be bound to any particular theory, it is believed that an electric field strength of about 800 V/cm to 1 ,000 V/cm is suitable for destroying living tissue by inducing irreversible electroporation.
[0065] The electrodes 24a, b may have a diameter or radius from 0.5 mm to 1 .5 mm, such as, for example, 0.5 mm, 0.75 mm, 1 mm, and 1 .5 mm. In various embodiments, the diameter of the first electrode 24a may by different from the diameter of the second electrode 24b. The electrode spacing may be from 0.5 cm to 3 cm. In various embodiments, the distance from the first electrode 24a to the second electrode 24b may be from 0.5 cm to 3 cm, such as, for example, 1 cm, 1.5 cm, 2.0 cm, and 3 cm. In one embodiment, the electrical ablation device 20 may comprise multiple needle electrodes.
[0066] According to certain embodiments, the electrical ablation device 20 may be introduced into the tissue treatment region through a trocar, for example, or inserted to a tissue treatment region transcutaneously, percutaneously, or other suitable techniques. In one embodiment, the cannula, lumen, or channel defined within the flexible shaft 22 may comprise a cutting edge, such as a bevel or other sharp edge, to aid in the puncturing/piercing of tissue.
[0067] According to certain embodiments, a method of treating tissue may generally comprise obtaining an ablation apparatus comprising first and second electrodes coupled to an energy source operative to generate and deliver a first sequence of electrical pulses and a second sequence of electrical pulses to tissue having a necrotic threshold, wherein the first sequence of electrical pulses deliver a first energy dose that is less than the necrotic threshold to induce
thermal heating in the tissue and the second sequence of electrical pulses deliver a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation, inserting the first electrode into a mass of tissue having a necrotic threshold, applying a first sequence of electrical pulses to the first electrode less than the necrotic threshold to induce thermal heating, applying a second sequence of electrical pulses to the first electrode to induce cell necrosis by irreversible electroporation, and applying a ground potential to the second electrode, wherein the ablation apparatus is operative to reduce the necrotic threshold of the tissue relative to a corresponding ablation apparatus having an energy source configured to deliver a first sequence of electrical pulses to induce cell necrosis by irreversible electroporation.
[0068] In certain embodiments, the ablation apparatus may reduce the necrotic threshold by 0-500 mV, such as, for example, 50-400 mV, 100-300 mV, and 150-250 mV relative to a corresponding ablation apparatus having an energy source configured to deliver a first sequence of electrical pulses to induce cell necrosis by irreversible electroporation. The ablation apparatus may reduce the necrotic threshold by 0-50%, such as, for example, 10%, 20%, 30%, and 40%, relative to a corresponding ablation apparatus having an energy source configured to deliver a first sequence of electrical pulses to induce cell necrosis by irreversible electroporation.
[0069] According to certain embodiments, a method of treating tissue may generally comprise applying a first sequence of electrical pulses to undesirable tissue to induce thermal heating and applying a second sequence of electrical pulses to undesirable tissue to induce cell necrosis by irreversible electroporation. The first energy dose may be less than the necrotic threshold, less than the critical membrane voltage, less than the threshold for muscle contraction, and/or less than the threshold for ventricular arrhythmia. The first energy dose may reduce the necrotic threshold of the tissue. The first energy dose may reduce the necrotic threshold by 0-500 mV, such as, for example, 50-400 mV, 100-300 mV, and 150-250 mV. The first energy dose may
reduce the necrotic threshold by 0-50%, such as, for example, 10%, 20%, 30%, and 40%. The first energy dose and/or second energy dose may be synchronized with the patient's cardiac cycle to prevent ventricular arrhythmia. According to certain embodiments, the ablation apparatus may reduce the risk of ventricular arrhythmia relative to a similar ablation apparatus comprising a first sequence of electrical pulses to induce cell necrosis in the tissue by irreversible electroporation.
[0070] In certain embodiments, a method of treating tissue may generally comprise inserting the first electrode into a mass of tissue having a membrane potential and a necrotic threshold, applying a first sequence of electrical pulses to the first electrode less than the necrotic threshold to induce thermal heating, applying a second sequence of electrical pulses to the first electrode to induce cell necrosis by irreversible electroporation, and applying a ground potential to the second electrode. In one embodiment, the method may comprise re-applying the sequence of electrical pulses to the first electrode. In one embodiment, the energy source may be operative to generate and deliver a sequence interval between the first sequence and second sequence. The first sequence of electrical pulses may comprise a series of first pulse trains each having a first pulse train amplitude, a first pulse train pulse width, and a first pulse train frequency, and the second sequence of electrical pulses may comprise a series of second pulse trains each comprising a second pulse train amplitude, a second pulse train pulse width, and a second pulse train frequency. The first pulse trains may comprise a plurality of first pulses each having a first amplitude, a first pulse width, and a first frequency, and each of the second pulse trains may comprise a plurality of second pulses each having a second amplitude, a second pulse width, and a second frequency. Each of the first pulses and the second pulses may independently have amplitudes in the range of about ±100 VDC to about ±10,000 VDC, pulse widths in the range of about 1 \is to about 100 ms, and frequencies in the range of about 1 Hz to about 10,000 Hz.
[0071] FIG. 7 is a graphical representation of a first sequence of electrical pulses that deliver a first energy dose less than the necrotic threshold to induce thermal heating and a second sequence of electrical pulses that deliver a second energy dose to induce cell necrosis by irreversible electroporation. Time (t) is shown along the horizontal axis and voltage (VDC) is shown along the vertical axis. Initially, the undesirable tissue may be exposed to a series of first pulse trains 70 each having a first pulse train amplitude V-i , a first pulse train pulse width Tw1 , and a first pulse train frequency F-i sufficient to induce thermal heating in the tissue. When the tissue achieves a predetermined temperature and/or pressure, the undesirable tissue 48 may be exposed to a series of second pulse trains 72. The undesirable tissue may be exposed to a series of second pulse trains 72 each having a second pulse train amplitude V2, a second pulse train pulse width Tw2, and a second pulse train frequency F2 sufficient to induce thermal necrosis and/or irreversible electroporation in the tissue. The series of first pulse trains 70 may comprise at least one first pulse train and the series of second pulse trains 72 may comprise at least one second pulse train.
[0072] In certain embodiments, at least one of the first pulse train amplitude V-i , the first pulse train pulse width Tw1, and the first pulse train frequency F-i may be greater than or equal to the second pulse train amplitude V2, the second pulse train pulse width Tw2, and the second pulse train frequency F2. The first pulse train amplitude V-i may be less than or equal to the second pulse train amplitude V2. The first pulse train pulse width Tw1 may be less than, greater than, or equal to the second pulse train pulse width Tw2. The first pulse train frequency F-i may be greater than or equal to the second pulse train frequency F2. The first sequence duration D-i may be greater than or equal to the second sequence duration D2. The total number of first pulse trains may be 70 may be greater than or equal to the total number of second pulse trains 72. In one embodiment, the first pulse train amplitude may be less than the second pulse train amplitude, the first pulse train pulse width may be equal to the second pulse train pulse width, and the first pulse train frequency may be greater than the second pulse train frequency. The
energy source may operative to generate and deliver a sequence interval Si between the first sequence and second sequence. The sequence interval may be from 0 to 10 seconds, 1 second to 10 seconds, such as, for example, 0.5 seconds, 1 second, and 2 seconds.
[0073] FIGS. 8A-B are graphical representations of a first pulse train 70 and a second pulse train 72, respectively. Time (t) is shown along the horizontal axis and voltage (VDC) is shown along the vertical axis. Each of the first pulse trains 70 may comprise a plurality of first pulses 70a each having a first amplitude v-i , a first pulse width tw1 , and a first frequency f-i , and each of the second pulse trains 72 may comprise a plurality of second pulses 72a each having a second amplitude v2, a second pulse width tw2, and a second frequency f2. The first pulses and the second pulses may be each independently characterized by first and second amplitudes in the range of about ±100 VDC to about ±10,000 VDC, first and second pulse widths in the range of about 1 \is to about 100 ms, and first and second frequencies in the range of about 1 Hz to about 10,000 Hz. In one embodiment, the energy source 14 may be configured to generate and deliver DC first pulses and the second pulses at frequencies in the range of 1 Hz to 10,000 Hz, amplitudes in the range of ±100 VDC to ±3000 VDC, and pulse width in the range of about 1 \is to about 100 ms. The first amplitude may be less than or equal to the second amplitude v2. The first pulse width tw1 may be less than, greater than, or equal to the second pulse width tw2. The first frequency fi may be greater than or equal to the second frequency f2. The total number of first pulses may be greater than or equal to the total number of second pulses. In one embodiment, the first amplitude may be less than the second amplitude, the first pulse width may be equal to the second pulse width, and the first frequency may be equal to the second frequency.
[0074] In one embodiment, a first pulse train 70 comprising high-voltage DC electrical pulses having a first pulse train amplitude V-i of 500 VDC and a first pulse train pulse width Tw1 of 50 \is may be applied to the first and second electrodes 24a, b by the energy source 14 to induce thermal heating in the tissue. A second pulse train 72 comprising higher high-voltage DC
electrical pulses having a second pulse train amplitude V2 of 1000 V and a second pulse train pulse width Tw2 of 50 \is may be applied to the first and second electrodes 24a, b by the energy source 14 to induce cell necrosis in the tissue by irreversible electroporation. In one
embodiment, the polarity of at least one of the first pulse train 70 and the second pulse train 72 may be inverted or reversed by the energy source 14 during the thermal heating and/or ablation processes.
[0075] In one embodiment, the series of first pulses 70 may comprises a single pulse 70a or multiple pulses having a first amplitude v-i of 500 VDC, a first pulse width tw1 of 10 με to 15 \is, and a period t-ι of about 100 ms (f i = 10 Hz) sufficient to induce thermal heating in the tissue proximate the electrode-tissue-interface immediately surrounding the respective electrodes 24a, b. In one embodiment, the series of second pulses 72 may comprise 20 to 40 electric pulses 72a having a second amplitude v2 of 1000 VDC, a second pulse width tw2 of 10 με to 15 \is, and a period t2 of 100 \is (f2 = 10,000 Hz) sufficient to induce irreversible electroporation. In one embodiment, the series of second pulses 72 may comprise multiple electrical pulses, for example, 20 to 40 electric pulses, having a second amplitude v2 of 1500 to 3000 VDC, a second pulse width tw2 of 10 \is to 50 \is, and a period t2 of 10 \is. In one embodiment, the undesirable cells in the tissue treatment region may be electrically ablated with DC pulses suitable to induce irreversible electroporation at frequencies of about 10 Hz to about 100 Hz, amplitudes in the range of about +700 VDC to about +1500 VDC, and pulse widths of about 10 \is to about 50 \is. In another embodiment, the abnormal cells in the tissue treatment region may be heated with an electrical waveform having an amplitude of about +500 VDC and pulse duration of about 20 ms delivered at a pulse period or repetition rate, frequency f = 1/T, of about 10 Hz.
[0076] In certain embodiments, a total dose average power may comprise the average power of the first sequence of electrical pulses, the average power of the second sequence of electrical pulses, and the sequence interval. The first energy dose may have an average power
from 5 Watts to 10 Watts. The second first energy dose may have an average power from 10 Watts to 15 Watts. The total dose average power may be 1 Watt to 5 Watts. In one
embodiment, a total dose average power from 5 Watts to 10 Watts may cause thermal coagulation. The first and second sequences of electrical pulses may be configured to reduce or eliminate thermal coagulation at the electrode/tissue interface.
[0077] In certain embodiments, the polarity of the electric potentials coupled to the electrodes 24a, b may be reversed during the electrical ablation therapy. As shown in FIG. 9, the series of first pulse trains 70 may comprise multiple biphasic pulse trains each having a positive first pulse train amplitude +Vi or a negative first pulse train amplitude -V-i , a first pulse train pulse width Tw1 , and a first pulse train frequency F-i , and the series of second pulse trains 72 may comprise multiple biphasic pulse trains each having a positive second pulse train amplitude +V2 or a negative second pulse train amplitude -V2, a second pulse train pulse width T^, and a second pulse train frequency F2. The first pulses and the second pulses may be each independently characterized by first and second amplitudes in the range of about ±100 VDC to about ±10,000 VDC, first and second pulse widths in the range of about 1 \is to about 100 ms, and first and second frequencies in the range of about 1 Hz to about 10,000 Hz. In one embodiment, the first sequence of electrical pulses and the second sequence of electrical pulses may comprise biphasic pulses. In one embodiment, the first sequence of electrical pulses may comprise biphasic pulses and the second sequence of electrical pulses may not comprise biphasic pulses. In one embodiment, the first sequence of electrical pulses may not comprise biphasic pulses and the second sequence of electrical pulses may comprise biphasic pulses.
[0078] As shown in FIGS. 10A-B, each of the first pulse trains may comprise a plurality of first pulses 70a each having a positive first amplitude +v-i or a negative first amplitude -v-i , a first pulse width tw1 , and a first frequency f-i , and each of the second pulse trains comprise a plurality of second pulses 72a each having a positive second amplitude +v2 or a negative second
amplitude -v2, a second pulse width tw2, and a second frequency f2. In one embodiment, the first sequence of electrical pulses and the second sequence of electrical pulses may comprise biphasic pulses. In one embodiment, the plurality of first pulses may comprise biphasic pulses and the plurality of second pulses may not comprise biphasic pulses. In one embodiment, the plurality of first pulses may not comprise biphasic pulses and the plurality of second pulses may comprise biphasic pulses.
[0079] In one embodiment, the energy source 14 may be configured to generate and deliver DC first pulses and the second pulses at frequencies in the range of 1 Hz to 10,000 Hz, amplitudes in the range of ±100 VDC to ±3000 VDC, and pulse width in the range of about 1 \is to about 100 ms. In one embodiment, the first pulse trains may comprise a plurality of DC first pulses having a positive polarity and an amplitude in the range of about +100 VDC to about +6000 VDC and a negative polarity and an amplitude in the range of about -100 VDC to about -6000 VDC, the second pulse trains may comprise a plurality of second pulses having a positive polarity and an amplitude in the range of about +100 VDC to about +6000 VDC and a negative polarity and an amplitude in the range of about -100 VDC to about -6000 VDC. In one embodiment, the method may comprise applying a sequence of electrical pulses having a first polarity to induce cell thermal heating and applying a sequence of electrical pulses having an opposite polarity to induce cell necrosis by irreversible electroporation.
[0080] Without wishing to be bound to any particular theory, it is believed that biphasic pulses may reduce the skeletal muscle contractions by reducing or eliminating the action potential caused by a positive monophasic pulse. Biphasic pulses may reduce or eliminate skeletal muscle contractions and caradic events. A person skilled in the art will understand that poration of the cell membrane occurs when the pulse increases the membrane voltage. A person skilled in the art may expect the poration to be reversed by a negative going pulse. Without wishing to be bound to any particular theory, however, it is believed that hyperpolarization occurs on each side of the cell. For example, the opposite side of the cell membrane may be hyperpolarized
when the electric field switches orientation due to a negative-going pulse. In other words, the polarization of the cell may be dependent on the orientation of the electric field.
[0081] According to certain embodiments, the method of treating tissue may comprise heating the tissue by applying an electric field that is less than the necrotic threshold to lower the necrotic threshold before inducing cell necrosis. The method may comprise lowering the necrotic threshold by heating the tissue by applying an electric field that is less than about 700 V/cm, such as, for example, less than about 500 V/cm and less than about 300 V/cm. The method may comprise lowering the necrotic threshold by 30% by heating the tissue by applying an electric field that is less than about 700 V/cm. The method may comprise heating the tissue by applying an electric field that is less than the necrotic threshold to lower the necrotic threshold and inducing cell necrosis by irreversible electroporation by applying an electric filed that is greater than or equal to the necrotic threshold. The method may comprise heating the tissue by applying an electric field that is less than 700 V/cm to lower the necrotic threshold and inducing cell necrosis by irreversible electroporation by applying an electric filed that is greater than about 700 V/cm.
[0082] According to certain embodiment, the method of treating tissue may comprise applying a sequence of electrical pulses to increase a membrane potential to less than the necrotic threshold and applying a sequence of electrical pulses to increase a membrane potential to greater than or equal to the necrotic threshold. The method may comprise applying a sequence of electrical pulses to increase a membrane potential from less than zero to greater than zero, applying a sequence of electrical pulses to increase a membrane potential from greater than zero to less than the necrotic threshold, and applying a sequence of electrical pulses to increase a membrane potential from less than the necrotic threshold to the necrotic threshold. The method may comprise applying a sequence of electrical pulses to increase a membrane potential from less than zero to 100 mV, applying a sequence of electrical pulses to increase a
membrane potential from 100 mV to 500 mV, and applying a sequence of electrical pulses to increase a membrane potential from 500 mV to the necrotic threshold.
[0083] In one embodiment, the first sequence of electrical pulses may have a pulse width of 50 μιη or less and subsequent pulses may have higher voltages and pulse widths less than 50 μιη. The pulses may increase the membrane potential from -70 mV to +100 mV, the next sequence of pulses may increase the membrane potential from 100 mV to 500 mV, and the final sequence of pulses may have pulse width of 1 \is to increase the membrane potential to cause cell necrosis. Without wishing to be bound to any particular theory, it is believed that the synergistic effect of applying the first sequence of pulses to induce thermal heating and applying the second sequence of pulses to induce cell necrosis by irreversible electroporation may decrease the membrane threshold from 1 V to 0.7 V.
[0084] According to certain embodiments, the method may comprise forming a pre-heated zone in the undesirable tissue by applying an electric field that is less than the necrotic threshold. The method may comprise forming a pre-heated zone in the undesirable tissue by applying an electric field that is less than the necrotic threshold and forming a necrotic zone by applying an electric field that is equal to or greater than the necrotic threshold to induce cell necrosis by irreversible electroporation. The method may comprise forming a pre-heated zone by applying an electric field that is less than about 700 V/cm and forming a necrotic zone by applying an electric filed that is equal to or greater than about 700 V/cm.
[0085] FIG. 1 1 is a graphical representation of a series of electrical pulses that may be applied to undesirable tissue. FIG. 1 1 illustrates the relationship between the pulse parameters and electrode temperature and the size and proportion of the necrotic zone. As shown in FIG. 1 1 , the size and proportion of the necrotic zone may generally increase as the voltage and/or temperature increases. The size and proportion of the necrotic zone and thermal zone may be related to the pulse parameters, such as, for example, energy, peak power, and average power, and electrode spacing. The contribution of voltage and temperature to the size and proportion
of the necrotic zone and thermal zone may be related to the peak pulsed power and average power.
[0086] In one embodiment, a pre-heated thermal zone may be formed in the tissue immediately surrounding the electrodes 24a, b at the tissue-electrode-interface by applying an electric field less than the necrotic threshold. Without wishing to be bound to any particular theory, it is believed that increasing the temperature of the tissue may reduce the electric field necessary to cause cell necrosis in the undesirable tissue 48. Thus, the method of treating tissue may comprise applying a combination of a series of first electrical pulses 70 having substantially lower voltage (in the range of 1000 V to 2000 V) and a series of second electrical pulses 72 having a higher voltage to induce cell necrosis. In one embodiment, a first series of pulses 70 may be applied to create a pre-heated thermal zone to increase the temperature of the tissue and then a second series of pulses 72 to induce cell necrosis at a lower voltage then otherwise would be necessary without the thermal heating of the tissue before inducing irreversible electroporation. In one embodiment, the method of treating tissue may comprise applying a combination of a series of first electrical pulses 70 having substantially lower voltage to increase the size of the pre-heated thermal zone at the same voltage.
[0087] Once positioned by the user, the electrodes may be energized to form a pre-heated zone having a first shape in the tissue treatment region. The shape of the pre-heated zone may be dependent on the position of the first and second electrodes. When the electrodes are reenergized, a necrotic zone having a second shape may be formed in the tissue treatment region. The size of the pre-heated zone may be less than or equal to the size of the necrotic zone. This process may be repeated as often as necessary to create any number of necrotic zones using the electrical ablation apparatus. Various parameters, such as, for example, pressure, temperature, and duration, may be altered or adjusted according to the type of tissue in the tissue treatment region and the desired size of the pre-heated zone and/or necrotic zone. In one embodiment, the ablation apparatus may increase the size of the necrotic zone relative
to a similar ablation apparatus comprising a first sequence of electrical pulses to induce cell necrosis in the tissue by irreversible electroporation. At anytime, the surgeon or clinician may reposition the electrical ablation apparatus within the tissue treatment region and begin the process anew.
[0088] According to certain embodiments, the method of treating tissue may comprise applying a first sequence of electrical pulses to induce thermal heating and applying a second sequence of electrical pulses to induce cell necrosis by irreversible electroporation, wherein the first and second sequences of electrical pulses create a ratio of thermal volume to non-thermal volume of 5 to 1. The thermal volume may comprise the volume of the pre-heated zone. In one embodiment, at least one of the first sequence of electrical pulses, the second sequence of electrical pulses, and sequence interval may be configured to create a ratio of thermal volume to non-thermal volume of 2 to 1 . In one embodiment, at least one of the first sequence of electrical pulses, the second sequence of electrical pulses, and sequence interval may be configured to create a ratio of thermal zone volume to necrotic zone volume of 1 to 1.
[0089] According to certain embodiments, the method may comprise measuring at least one of temperature and pressure of the tissue treatment region. The method may comprise measuring at least one of temperature and pressure of the undesirable tissue. The method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes. The method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes and applying a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved. The method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes and stopping a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved. The method may comprise measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes and applying a sequence of
electrical pulses to achieve at least one of a predetermined temperature and a predetermined pressure.
[0090] Without wishing to be bound to any particular theory, it is believed that the critical membrane voltage of a cell is inversely proportional to the cell's temperature. In other words, the cell's critical membrane voltage may decrease as the cell's temperature increases. As a result, a lower electric field may be applied to pre-heated undesirable tissue to induce cell necrosis by irreversible electroporation than to the same undesirable tissue without pre-heating. The predetermined temperature may be 40°C to 50°C. For example, an electrical pulse or sequence of electrical pulses may be applied when the temperature of the tissue falls below 50°C. The method may comprise stopping a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved. For example, an electrical pulse or sequence of electrical pulses may be stopped when the temperature of the tissue reaches 60°C. In one embodiment, the first and second sequences of electrical pulses may be configured to maintain the tissue at a temperature sufficient to induce thermal coagulation. For example, the first and second sequences of electrical pulses may be configured to maintain the tissue at a temperature between 50-60°C. The predetermined pressure may be atmospheric pressure.
[0091] According to certain embodiments, the ablation apparatus may reduce the risk of an electrical arc relative to a similar ablation apparatus comprising a first sequence of electrical pulses to induce cell necrosis in the tissue by irreversible electroporation. Under certain conditions, an arc may form between the two electrodes. For example, high voltage may cause a breakdown in air in the space between the un-insulated conductive portions of the electrodes that are not fully embedded in the tissue. An electrical arc at high voltages (>10k VDC) may occur when the un-insulated conductive portions of the two electrodes are not fully embedded into the tissue or the tissue moves away from the electrode tip and the high voltage causes an electrical breakdown of the gas surrounding the electrode tip. The first and second sequences
of electrical pulses may be configured to reduce or eliminate the creation of an arc. As described in commonly owned U.S. patent application No. 12/651 ,181 , a gel may be
continuously supplied to the space to displace the air in the space and prevent an arc from forming. The gel may be any water-based, water-soluble lubricant, such as, for example, KY® Jelly available from Johnson & Johnson.
[0092] FIG. 12 illustrates one embodiment of the electrical ablation system 10 shown in FIG. 1 in use to treat undesirable tissue 48 located on the surface of the liver 50. The undesirable tissue 48 may be representative of diseased tissue, cancer, malignant and benign tumors, masses, lesions, and other abnormal tissue growths. In use, the electrical ablation device 20 may be introduced into or proximate the tissue treatment region through a port 52 of a trocar 54. The trocar 54 may be introduced into the patient via a small incision 59 formed in the skin 56. The endoscope 12 may be introduced into the patient trans-anally through the colon, trans- orally down the esophagus and through the stomach using translumenal techniques, or through a small incision or keyhole formed through the patient's abdominal wall (e.g., the peritoneal wall). The endoscope 12 may be employed to guide and locate the distal end of the electrical ablation device 20 into or proximate the undesirable tissue 48. Prior to introducing the flexible shaft 22 through the trocar 54, the sheath 26 may be slid over the flexible shaft 22 in a direction toward the distal end thereof to cover the electrodes 24a, b until the distal end of the electrical ablation device 20 reaches the undesirable tissue 48.
[0093] Once the electrical ablation device 20 has been suitably introduced into or proximate the undesirable tissue 48, the sheath 26 may be retracted to expose the electrodes 24a, b to treat the undesirable tissue 48. The treat the undesirable tissue 48, the operator initially may locate the first electrode 24a at a first position and the second electrode 24b at a second position using endoscopic visualization and maintaining the undesirable tissue 48 within the field of view of the flexible endoscope 12. The first position may be near a perimeter edge of the undesirable tissue 48. Once the electrodes 24a, b are located into or proximate the undesirable
tissue 48, the electrodes 24a, b may be energized with a first sequence of electrical pulses to deliver a first energy dose that is less than the necrotic threshold to induce thermal heating in the tissue surrounding the electrode/tissue interface. Once the temperature and/or pressure of the undesirable tissue 48 achieves a predetermined threshold, the electrodes 24a, b may be energized with a second sequence of electrical pulses to deliver a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation to create a necrotic zone 65. For example, once the first and second electrodes 24a, b are located in the desired positions, the undesirable tissue 48 may be exposed to an electric field generated by energizing the first and second electrodes 24a, b with the energy source 14.
[0094] The electric field created by the first sequence of electrical pulses may have a magnitude, frequency, pulse width suitable to increase the temperature of the undesirable tissue to a predetermined threshold. The electric field created by the second sequence of electrical pulses may have a magnitude, frequency, and pulse width suitable to induce irreversible electroporation in the undesirable tissue 48 within the necrotic zone 65. Without wishing to be bound to any particular theory, it is believed that increasing the temperature of the undesirable tissue to a predetermined threshold may reduce the magnitude, frequency, and/or pulse width of the electric field suitable to induce irreversible electroporation in the undesirable tissue 48. The size of the necrotic zone may be substantially dependent on the size and separation of the electrodes 24a, b. The treatment time may be defined as the time that the electrodes 24a, b are activated or energized to generate the electric pulses suitable for inducing thermal heating and/or irreversible electroporation in the undesirable tissue 48.
[0095] This procedure may be repeated to destroy relatively larger portions of the undesirable tissue 48. At anytime, the surgeon or clinician may reposition the first and second electrodes 24a, b and begin the process anew. In other embodiments, the electrical ablation device may comprise multiple needle electrodes that may be employed to treat the undesirable tissue 48.
Those skilled in the art will appreciate that similar techniques may be employed to ablate any other undesirable tissues that may be accessible trans-anally through the colon, and/or orally through the esophagus and the stomach using translumenal access techniques.
[0096] The embodiments of the electrical ablation devices described herein may be introduced inside a patient using minimally invasive or open surgical techniques. In some instances it may be advantageous to introduce the electrical ablation devices inside the patient using a combination of minimally invasive and open surgical techniques. Minimally invasive techniques may provide more accurate and effective access to the treatment region for diagnostic and treatment procedures. To reach internal treatment regions within the patient, the electrical ablation devices described herein may be inserted through natural openings of the body such as the mouth, anus, and/or vagina, for example. Minimally invasive procedures performed by the introduction of various medical devices into the patient through a natural opening of the patient are known in the art as NOTES™ procedures. Surgical devices, such as an electrical ablation devices, may be introduced to the treatment region through the channels of the endoscope to perform key surgical activities (KSA), including, for example, electrical ablation of tissues using irreversible electroporation energy. Some portions of the electrical ablation devices may be introduced to the tissue treatment region percutaneously or through small - keyhole - incisions.
[0097] Endoscopic minimally invasive surgical and diagnostic medical procedures are used to evaluate and treat internal organs by inserting a small tube into the body. The endoscope may have a rigid or a flexible tube. A flexible endoscope may be introduced either through a natural body opening (e.g., mouth, anus, and/or vagina). A rigid endoscope may be introduced via trocar through a relatively small - keyhole - incision incisions (usually 0.5 cm to 1 .5 cm). The endoscope can be used to observe surface conditions of internal organs, including abnormal or diseased tissue such as lesions and other surface conditions and capture images for visual inspection and photography. The endoscope may be adapted and configured with channels for
introducing medical instruments to the treatment region for taking biopsies, retrieving foreign objects, and/or performing surgical procedures.
[0098] Once an electrical ablation device is inserted in the human body internal organs may be reached using trans-organ or translumenal surgical procedures. The electrical ablation device may be advanced to the treatment site using endoscopic translumenal access techniques to perforate a lumen, and then, advance the electrical ablation device and the endoscope into the peritoneal cavity. Translumenal access procedures for perforating a lumen wall, inserting, and advancing an endoscope therethrough, and pneumoperitoneum devices for insufflating the peritoneal cavity and closing or suturing the perforated lumen wall are well known. During a translumenal access procedure, a puncture must be formed in the stomach wall or in the gastrointestinal tract to access the peritoneal cavity. One device often used to form such a puncture is a needle knife which is inserted through the channel of the endoscope, and which utilizes energy to penetrate through the tissue. A guidewire is then feed through the endoscope and is passed through the puncture in the stomach wall and into the peritoneal cavity. The needle knife is removed, leaving the guidewire as a placeholder. A balloon catheter is then passed over the guidewire and through the channel of the endoscope to position the balloon within the opening in the stomach wall. The balloon can then be inflated to increase the size of the opening, thereby enabling the endoscope to push against the rear of the balloon and to be feed through the opening and into the peritoneal cavity. Once the endoscope is positioned within the peritoneal cavity, numerous procedures can be performed through the channel of the endoscope.
[0099] The endoscope may be connected to a video camera (single chip or multiple chips) and may be attached to a fiber-optic cable system connected to a "cold" light source (halogen or xenon), to illuminate the operative field. The video camera provides a direct line-of-sight view of the treatment region. If working in the abdomen, the abdomen may be insufflated with carbon dioxide (C02) gas to create a working and viewing space. The abdomen is essentially blown up
like a balloon (insufflated), elevating the abdominal wall above the internal organs like a dome. C02 gas is used because it is common to the human body and can be removed by the respiratory system if it is absorbed through tissue.
[0100] Once the electrical ablation devices are located at the target site, the diseased tissue may be electrically ablated or destroyed using the various embodiments of electrodes discussed herein. The placement and location of the electrodes can be important for effective and efficient electrical ablation therapy. For example, the electrodes may be positioned proximal to a treatment region (e.g., target site or worksite) either endoscopically or transcutaneously
(percutaneously). In some implementations, it may be necessary to introduce the electrodes inside the patient using a combination of endoscopic, transcutaneous, and/or open techniques. The electrodes may be introduced to the tissue treatment region through a channel of the endoscope, an overtube, or a trocar and, in some implementations, may be introduced through percutaneously or through small - keyhole - incisions.
[0101] Preferably, the various embodiments of the devices described herein will be processed before surgery. First, a new or used instrument is obtained and if necessary cleaned. The instrument can then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK® bag. The container and instrument are then placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation kills bacteria on the instrument and in the container. The sterilized instrument can then be stored in the sterile container. The sealed container keeps the instrument sterile until it is opened in the medical facility.
[0102] It is preferred that the device is sterilized prior to use. This can be done by any number of ways known to those skilled in the art including beta or gamma radiation, ethylene oxide, steam.
[0103] The various embodiments described herein may be better understood when read in conjunction with the following representative examples. The following examples are included for purposes of illustration and not limitation.
[0104] An ablation apparatus comprising two electrodes coupled to a energy source and a temperature sensor according to certain embodiments was used to deliver a series of electrical pulses ex vivo to healthy porcine liver to induce irreversible electroporation (Dose 1 ). In one embodiment, the Dose 1 pulse parameters may include a 3,000 V amplitude, a 10 \is pulse width, 10 total number of pulses per burst, a frequency of 200 Hz, 6 total number of bursts, and a 3 s delay between each burst. Dose 1 is generally characterized by low energy and high voltage. Dose 1 was not suitable for synchronizing to a patient's cardiac cycle. FIG. 13 is a photograph of the porcine liver after receiving Dose 1 . The necrotic zone 100 is generally indicated by the discoloration of the tissue. The temperature was monitored using the temperature sensor illustrated in FIG. 4. FIG. 14 is a graphical representation of temperature during Dose 1 . Without wishing to be bound to any particular theory, it is believed that temperature is related to the distance between the electrodes. As shown in FIG. 14, an electrode spacing of 1 .5 cm generated a maximum temperature of about 51 °C at the positive electrode and an electrode spacing of 1 .0 cm generated a maximum temperature of about 59°C at the positive electrode. As shown in FIG. 14, the temperature increases as the distance between the electrodes decreases.
[0105] FIGS. 15A-D include photographs of porcine liver after receiving a series of electrical pulses having an amplitude of 3 kV that may be applied to undesirable tissue to induce irreversible electroporation. FIG. 15A is a photograph of porcine liver after receiving a first sequence of electrical pulses. FIG. 15B is a photograph of the porcine liver after receiving the second sequence of electrical pulses. The temperature of the porcine tissue after the second sequence of electrical pulses was 40°C. FIG. 15C is a photograph of the porcine liver after receiving the third sequence of electrical pulses. The temperature of the porcine tissue after the
third sequence of electrical pulses was 37°C. FIG. 15D is a photograph of the porcine liver after receiving the fourth sequence of electrical pulses. The temperature of the porcine tissue after the fourth sequence of electrical pulses was 45°C. The necrotic zone caused by each sequence of electrical pulses is generally indicated by the discoloration of the tissue. The sequence interval between each series of electrical pulses was 5 seconds. The total dose time was 20 seconds.
[0106] An ablation apparatus comprising two electrodes coupled to a energy source and a temperature sensor according to certain embodiments was used to deliver a series of electrical pulses ex vivo to healthy porcine liver to induce irreversible electroporation (Dose 2). In one embodiment, the Dose 2 parameters may include a first series of bursts including a 1000 V amplitude, a 5 \is pulse width, 500 total number of pulses per burst, a total of 30 first series bursts, a 0.1 s delay between each burst followed by a second series of bursts pulses including a 1500 V amplitude, a 5 \is pulse width, 500 total number of pulses per burst, a total of 20 second bursts, a 0.1 s delay between each burst followed by a third series of bursts including a 3000 V amplitude, a 10 \is pulse width, 10 total number of pulses per burst, a total of 10 third series bursts, a 3 s delay between each burst. The frequency may be 200 Hz. Dose 2 is generally characterized by a multi-train dose at a higher energy than Dose 1 . Dose 2 was not suitable for synchronizing to a patient's cardiac cycle. As shown in FIG. 16, the first pulse train included 500 pulses per burst at a pulse width of 5 με, a frequency of 200 Hz, and an amplitude of 1 kV, the second pulse train included 500 pulses per burst at a pulse width of 5 με, a frequency of 200 Hz, and an amplitude of 1 .5 kV, and the third pulse train included 10 pulses per burst at a pulse width of 10 με, a frequency of 200 Hz, and an amplitude of 3 kV.
[0107] The size and area of the necrotic zone of Dose 1 was compared to the size and area of the necrotic zone of Dose 2. FIG. 17 is a graph illustrating the average area of the necrotic zone for Dose 1 and the average area of the necrotic zone for Dose 2. As shown in FIG. 17,
Dose 1 exhibited a smaller average area of the necrotic zone than Dose 2. FIG. 18A is a graph illustrating the average area of the necrotic zone for Dose 1 and the average area of the necrotic zone for Doses 2a, b. As shown in FIG. 18A, the average necrotic zone dimensions and area for Dose 1 was 1 cm x 2.5 cm and 2.5 cm2, respectively. The average necrotic zone dimensions and area for Dose 2 was 2.0 cm x 3.67 cm and 7.34 cm2, respectively. FIG. 18B includes photographs of the necrotic zone produced by Doses 1 , 2a, and 2b. As shown in FIGS. 17 and 18, the size and area of the necrotic zone generally increases as the energy increases.
[0108] FIG. 19 is a graphical representation of a series of electrical pulses that may be delivered to undesirable tissue to induce irreversible electroporation. The multi-train electrical sequence may be synchronized with a patient's cardiac cycle. As shown in FIG. 19, the pulse train may include up to 180 pulses per burst at a pulse width of 10 με, a frequency of 200 Hz, and an amplitude of 3 kV. The total burst time of each burst may fit within the latent period, or the period of electrical inactivity of the cardiac cycle. The latent period may also be known as the refractory period. The temperature may be measured between each burst. In one embodiment, the pulse parameters and maximum temperature may be adjusted to achieve a non-thermal zone of cell death ("IRE Dose"). The IRE Dose may include a maximum temperature of 50°C and a typical sequence time of about 1 minute. In one embodiment, for example, the IRE Dose parameters may include a 3,000 V amplitude, a 10 \is pulse width, 15 total number of pulses per burst, frequency of each 10 \is pulse within the bursts of 200 Hz, a 3 s delay between each burst, and 20 total number of bursts. The IRE Dose may be
characterized by no or reduced thermal damage to the tissue surrounding the electrode. In one embodiment, the pulse parameters and maximum temperature may be adjusted to slowly increase the temperature of the tissue ("IRE+ Dose"). The IRE+ Dose may increase the temperature of a large volume of tissue by a few degrees, such as, for example, 0-10°C and 1 - 5°C, over a relatively longer period of time. The IRE+ Dose may include a typical sequence
time of about 8 minutes. For example, the IRE+ Dose parameters may include a 3,000 V amplitude, a 10 \is pulse width, 20 total number of pulses per burst, frequency of each 10 \is pulse within the bursts of 200 Hz, a 3 s delay between each burst, and 90 total number of bursts at a maximum temperature of 60°C. The electrode spacing may be 2 cm. The IRE+ Dose may be characterized by a large necrosis zone. In one embodiment, the pulse parameters and maximum temperature may be adjusted to rapidly increase the temperature of the tissue ("IRE+Heat Dose"). The IRE+Heat Dose may increase the temperature of a large volume of tissue by a few degrees, such as, for example, 0-10°C and 1 -5°C, over a relatively shorter period of time. The IRE+Heat Dose may include a typical sequence time of about 4 minutes. In one embodiment, for example, the IRE+Heat Dose parameters may include a 3,000 V amplitude, a 10 \is pulse width, 20 total number of pulses per burst, frequency of each 10 \is pulse within the bursts of 200 Hz, a 0.1 s delay between each burst, and 90 total number of bursts at a maximum temperature of 60°C. The higher temperature in the tissue surrounding the electrodes may cause thermal coagulation. Without wishing to be bound to any particular theory, it is believed that thermal coagulation may occur at a higher average power and same energy. The IRE+Heat Dose may be characterized by a larger necrotic zone than the IRE Dose and a shorter time than the IRE+ Dose.
[0109] FIGS. 20A-C are photographs of a healthy porcine liver after receiving the IRE Dose, IRE+ Dose, and IRE+Heat Dose, respectively. As shown in the FIG. 20A, the IRE Dose has a necrotic zone having a size of 1 .2 cm x 2.3 cm and an area of 2.76 cm2. As shown in the FIG. 20B, the IRE+ Dose has a necrotic zone having a size of 2.1 cm x 3.7 cm and an area of 7.77 cm2. As shown in the FIG. 20C, the IRE+Heat Dose has a necrotic zone having a size of 1 .6 cm x 3.6 cm and an area of 5.76 cm2. The IRE+Heat Dose has a thermal zone located within the necrotic zone. The size and area of the thermal zone (lighter area) is smaller than the size and area of the necrotic zone.
[0110] FIG. 21 is a graphical representation of the electrode temperature during the IRE Dose having a maximum temperature limit of 50°C. As shown in FIG. 21 , the maximum temperature at the positive electrode was about 47°C at 69 seconds. FIG. 22 is a graphical representation of the temperature during the IRE+ Dose having a maximum temperature limit of 90°C. As shown in FIG. 22, the maximum temperature at the positive electrode was about 62°C at about 430 seconds. FIG. 23 is a graphical representation of the temperature during the IRE+Heat Dose having a maximum temperature limit of 90°C. As shown in FIG. 23, the maximum temperature at the positive electrode was about 88°C at about 220 seconds. FIG. 24 is a graphical representation of the temperature during the IRE+Heat Dose having a maximum temperature limit of 90°C. As shown in FIG. 24, the maximum temperature at the positive electrode was about 96°C at about 259 seconds.
[0111] The size and proportion of the necrosis zone may be also related to electrode spacing. FIGS. 25A-C include photographs of healthy porcine liver after receiving an IRE Dose having an electrode spacing of 1.5 cm, an IRE+ Dose having an electrode spacing of 2.0 cm, an IRE+Heat Dose having an electrode spacing of 2.0 cm. As shown in FIGS. 25A-C, the IRE+ Dose has the largest necrotic zone and the IRE Dose has the smallest necrotic zone. The IRE+Heat Dose has a necrotic zone intermediate the IRE Dose and IRE+ Dose. The IRE+Heat Dose has a thermal zone (lighter area) is smaller than the necrotic zone.
[0112] FIGS. 26A-F are graphical representations of simulated necrotic zones (white) and thermal zones (gray) of porcine livers (black) after receiving a series of electrical pulses that may be applied to undesirable tissue to induce irreversible electroporation according to certain embodiments described herein. FIGS. 26A,B include computer simulation of an IRE Dose having an electrode spacing of 1 .5 cm and 2.0 cm, respectively. A necrotic zone of 2.3 cm x 1.02 cm is predicted for an IRE Dose having an electrode spacing of 1.5 cm. A necrotic zone of 2.8 cm wide is predicted for an IRE Dose having an electrode spacing of 2.0 cm. FIGS. 26C,D include computer simulation of an IRE+ Dose having an electrode spacing of 1 .5 cm and 2.0
cm, respectively. A necrotic zone of 3.4 cm x 2.09 cm is predicted for an IRE+ Dose having an electrode spacing of 2.0 cm and a 400 V/cm threshold. A necrotic zone of 2.92 cm x 2.04 cm is predicted for an IRE+ Dose having an electrode spacing of 1.5 cm and a 400 V/cm threshold. Without wishing to be bound to any particular theory, it is believed that decreasing the necrotic threshold may increase the size of the necrotic zone. As shown in FIGS. 26A,C, the size of the necrotic zone in FIG. 26A is smaller than the size of the necrotic zone in FIG. 26C. FIGS. 26E,F include computer simulation of an IRE+Heat Dose having an electrode spacing of 2.0 cm and 3.0 cm, respectively. As shown in FIG. 26E, an IRE+Heat Dose having an electrode spacing of 2.0 cm produces a thermal zone (gray region). The width of the necrotic zone of an IRE+Heat Dose having an electrode spacing of 2.0 cm is less than the width of the necrotic zone of an IRE+ Dose having an electrode spacing of 2.0 cm. As shown in FIG. 26F, an IRE+Heat Dose having an electrode spacing of 3.0 cm produces thermal zones around each electrode. The width of the necrotic zone of an IRE+Heat Dose having an electrode spacing of 3.0 cm is less than the width of the necrotic zone of an IRE+Heat Dose having an electrode spacing of 2.0 cm. Without wishing to be bound to any particular theory, it is believed that the ratio of the necrotic zone length and necrotic zone width generally corresponds to the electric field pattern. The electric field pattern generally becomes long and narrow as the electrode spacing increases.
[0113] Although the various embodiments of the devices have been described herein in connection with certain disclosed embodiments, many modifications and variations to those embodiments may be implemented. For example, different types of end effectors may be employed. Also, where materials are disclosed for certain components, other materials may be used. The foregoing description and following claims are intended to cover all such modification and variations.
[0114] Any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the
incorporated materials does not conflict with existing definitions, statements, or other disclosure
material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
Claims
1. An ablation apparatus, comprising:
first and second electrodes coupled to an energy source operative to generate and deliver a first sequence of electrical pulses and a second sequence of electrical pulses to tissue having a necrotic threshold, wherein the first sequence of electrical pulses delivers a first energy dose that is less than the necrotic threshold to induce thermal heating in the tissue and the second sequence of electrical pulses delivers a second energy dose equal to or greater than the necrotic threshold to induce cell necrosis in the tissue by irreversible electroporation.
2. The ablation apparatus of claim 1 , wherein the energy source is operative to generate and deliver a sequence interval between the first sequence and second sequence.
3. The ablation apparatus of claim 1 , wherein the first sequence has a first sequence duration and the second sequence has a second sequence duration, and wherein the first sequence duration is greater than the second sequence duration.
4. The ablation apparatus of claim 1 , wherein the first sequence has a first sequence total number of pulses and the second sequence has a second sequence total number of pulses, and wherein the first sequence total number of pulses is greater than the second sequence total number of pulses.
5. The ablation apparatus of claim 1 , wherein the first sequence comprises a series of first pulse trains each having a first pulse train amplitude, a first pulse train pulse width, and a first pulse train frequency, and the second sequence comprises a series of second pulse trains each comprising a second pulse train amplitude, a second pulse train pulse width, and a second pulse train frequency.
6. The ablation apparatus of claim 5, wherein the first pulse train amplitude is less than the second pulse train amplitude, the first pulse train pulse width is equal to the second pulse train pulse width, and the first pulse train frequency is greater than the second pulse train frequency.
7. The ablation apparatus of claim 5, wherein each of the first pulse trains comprise a plurality of first pulses each having a first amplitude, a first pulse width, and a first frequency, and each of the second pulse trains comprise a plurality of second pulses each having a second amplitude, a second pulse width, and a second frequency.
8. The ablation apparatus of claim 7, wherein the first pulses and the second pulses are each independently characterized by first and second amplitudes in the range of about ±100 VDC to about ±10,000 VDC, first and second pulse widths in the range of about 1 \is to about 100 ms, and first and second frequencies in the range of about 1 Hz to about 10,000 Hz.
9. The ablation apparatus of claim 7, wherein the first amplitude is less than the second amplitude, the first pulse width is equal to the second pulse width, and the first frequency is equal to the second frequency.
10. The ablation apparatus of claim 7, wherein the plurality of second pulses comprise biphasic pulses.
1 1 . The ablation apparatus of claim 1 comprising at least one of a temperature sensor and a pressure sensor adjacent at least one of the first and second electrodes.
12. The ablation apparatus of claim 1 comprising:
a housing for supporting the first and second electrodes; and
at least one of a temperature sensor and a pressure sensor located within the housing.
13. The ablation apparatus of claim 1 comprising:
a housing having a distal end, a proximal end, and a body extending therebetween for supporting the first and second electrodes;
a temperature sensor located within the housing at the distal end; and
a pressure sensor located within the housing along the body.
14. The ablation apparatus of claim 1 comprising:
a housing having a plurality of vents for supporting the first and second electrodes; and a pressure sensor located adjacent the plurality of vents.
15. The ablation apparatus of claim 1 comprising:
a sleeve having a distal end for supporting the first and second electrodes;
a first electrode having a positive polarity located at the distal end of the sleeve; and a second electrode having a negative polarity not located at the distal end of the sleeve.
16. The ablation apparatus of claim 1 , wherein the energy source is operative to generate and deliver the second sequence when at least one of a predetermined temperature and a predetermined pressure is achieved.
17. The ablation apparatus of claim 1 , wherein the energy source is operative to not generate and not deliver the second sequence when at least one of a predetermined temperature and a predetermined pressure is achieved.
18. A method of treating tissue, comprising:
obtaining the apparatus of claim 1 ;
inserting the first electrode into the tissue having a necrotic threshold;
applying a first sequence of electrical pulses to the first electrode less than the necrotic threshold to induce thermal heating;
applying a second sequence of electrical pulses to the first electrode to induce cell necrosis by irreversible electroporation; and
applying a ground potential to the second electrode,
wherein the ablation apparatus is operative to reduce the necrotic threshold relative to a corresponding ablation apparatus having an energy source configured to deliver a first sequence of electrical pulses to induce cell necrosis by irreversible electroporation.
19. A method of treating tissue, comprising:
inserting the first electrode into the tissue having a membrane potential and a necrotic threshold;
applying a first sequence of electrical pulses to the first electrode less than the necrotic threshold to induce thermal heating;
applying a second sequence of electrical pulses to the first electrode to induce cell necrosis by irreversible electroporation; and
applying a ground potential to the second electrode.
20. The method of claim 19 comprising:
forming a pre-heated zone by applying an electric field that is less than about 700 V/cm; and
forming a necrotic zone by applying an electric filed that is greater than about 700 V/cm.
21 . The method of claim 19 comprising:
heating the mass of tissue by applying an electric field that is less than about 700V/cm to lower the necrotic threshold; and
inducing cell necrosis by irreversible electroporation by applying an electric filed that is greater than about 700 V/cm.
22. The method of claim 19 comprising:
applying a first sequence of electrical pulses to the first electrode less than the necrotic threshold to lower the necrotic threshold;
applying a second sequence of electrical pulses to the first electrode to induce cell necrosis by irreversible electroporation.
23. The method of claim 19 comprising:
lowering the necrotic threshold by heating the tissue by applying an electric field that is less than about 700 V/cm.
24. The method of claim 19 comprising:
lowering the necrotic threshold by 30 % by heating the tissue by applying an electric field that is less than about 700 V/cm.
25. The method of claim 19 comprising:
applying a sequence of electrical pulses to increase a membrane potential from less than zero to 100 mV;
applying a sequence of electrical pulses to increase a membrane potential from 100 mV to 500 mV; and
applying a sequence of electrical pulses to increase a membrane potential from 500 mV to the necrotic threshold.
26. The method of claim 19 comprising:
measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes; and
applying a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved.
27. The method of claim 19 comprising:
measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes; and
stopping a sequence of electrical pulses when at least one of a predetermined temperature and a predetermined pressure is achieved.
28. The method of claim 19 comprising:
measuring at least one of temperature and pressure adjacent at least one of the first and second electrodes; and
applying a sequence of electrical pulses to achieve at least one of a predetermined temperature and a predetermined pressure.
29. The method of claim 19 comprising:
applying a sequence of electrical pulses to the first electrode, the sequence of electrical pulses having amplitudes in the range of about ±100 VDC to about ±10,000 VDC, pulse widths in the range of about 1 \is to about 100 ms, and frequencies in the range of about 1 Hz to about 10,000 Hz; and
re-applying the sequence of electrical pulses to the first electrode.
30. The method of claim 19 comprising:
applying a sequence of electrical pulses having a first polarity to induce cell necrosis by irreversible electroporation;
applying a sequence of electrical pulses having an opposite polarity to induce cell necrosis by irreversible electroporation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/036,908 US9314620B2 (en) | 2011-02-28 | 2011-02-28 | Electrical ablation devices and methods |
US13/036,908 | 2011-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012118659A1 true WO2012118659A1 (en) | 2012-09-07 |
Family
ID=45894651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/026049 WO2012118659A1 (en) | 2011-02-28 | 2012-02-22 | Electrical ablation devices and methods |
Country Status (2)
Country | Link |
---|---|
US (1) | US9314620B2 (en) |
WO (1) | WO2012118659A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11786300B2 (en) | 2021-04-07 | 2023-10-17 | Btl Medical Technologies S.R.O. | Pulsed field ablation device and method |
US11896298B2 (en) | 2021-07-06 | 2024-02-13 | Btl Medical Development A.S. | Pulsed field ablation device and method |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7655004B2 (en) | 2007-02-15 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Electroporation ablation apparatus, system, and method |
US8579897B2 (en) | 2007-11-21 | 2013-11-12 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
US20090112059A1 (en) | 2007-10-31 | 2009-04-30 | Nobis Rudolph H | Apparatus and methods for closing a gastrotomy |
US8480657B2 (en) | 2007-10-31 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Detachable distal overtube section and methods for forming a sealable opening in the wall of an organ |
US8771260B2 (en) | 2008-05-30 | 2014-07-08 | Ethicon Endo-Surgery, Inc. | Actuating and articulating surgical device |
US8679003B2 (en) | 2008-05-30 | 2014-03-25 | Ethicon Endo-Surgery, Inc. | Surgical device and endoscope including same |
US8906035B2 (en) | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
US8403926B2 (en) | 2008-06-05 | 2013-03-26 | Ethicon Endo-Surgery, Inc. | Manually articulating devices |
US8888792B2 (en) | 2008-07-14 | 2014-11-18 | Ethicon Endo-Surgery, Inc. | Tissue apposition clip application devices and methods |
US8409200B2 (en) | 2008-09-03 | 2013-04-02 | Ethicon Endo-Surgery, Inc. | Surgical grasping device |
US8157834B2 (en) | 2008-11-25 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Rotational coupling device for surgical instrument with flexible actuators |
US8361066B2 (en) | 2009-01-12 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8903488B2 (en) | 2009-05-28 | 2014-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US20110098704A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8608652B2 (en) | 2009-11-05 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Vaginal entry surgical devices, kit, system, and method |
US8496574B2 (en) | 2009-12-17 | 2013-07-30 | Ethicon Endo-Surgery, Inc. | Selectively positionable camera for surgical guide tube assembly |
US8506564B2 (en) | 2009-12-18 | 2013-08-13 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US9028483B2 (en) | 2009-12-18 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
WO2012051433A2 (en) | 2010-10-13 | 2012-04-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US10092291B2 (en) | 2011-01-25 | 2018-10-09 | Ethicon Endo-Surgery, Inc. | Surgical instrument with selectively rigidizable features |
US9254169B2 (en) | 2011-02-28 | 2016-02-09 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
WO2012125785A1 (en) | 2011-03-17 | 2012-09-20 | Ethicon Endo-Surgery, Inc. | Hand held surgical device for manipulating an internal magnet assembly within a patient |
JP2014522714A (en) * | 2011-08-08 | 2014-09-08 | ルース,リチャード,ビー. | Method and apparatus for treating cancer |
US9486625B2 (en) * | 2011-08-08 | 2016-11-08 | Medamp Electronics, Llc | Method for treating benign prostate hyperplasia |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
US9427255B2 (en) | 2012-05-14 | 2016-08-30 | Ethicon Endo-Surgery, Inc. | Apparatus for introducing a steerable camera assembly into a patient |
US9078662B2 (en) | 2012-07-03 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Endoscopic cap electrode and method for using the same |
US9545290B2 (en) | 2012-07-30 | 2017-01-17 | Ethicon Endo-Surgery, Inc. | Needle probe guide |
US10314649B2 (en) | 2012-08-02 | 2019-06-11 | Ethicon Endo-Surgery, Inc. | Flexible expandable electrode and method of intraluminal delivery of pulsed power |
US9572623B2 (en) | 2012-08-02 | 2017-02-21 | Ethicon Endo-Surgery, Inc. | Reusable electrode and disposable sheath |
EP3603501A1 (en) | 2012-08-09 | 2020-02-05 | University of Iowa Research Foundation | Catheter systems for surrounding a tissue structure |
US9277957B2 (en) | 2012-08-15 | 2016-03-08 | Ethicon Endo-Surgery, Inc. | Electrosurgical devices and methods |
US20140221877A1 (en) * | 2013-02-01 | 2014-08-07 | Moshe Ein-Gal | Pressure-assisted irreversible electroporation |
US10098527B2 (en) | 2013-02-27 | 2018-10-16 | Ethidcon Endo-Surgery, Inc. | System for performing a minimally invasive surgical procedure |
US10154869B2 (en) * | 2013-08-02 | 2018-12-18 | Gary M. Onik | System and method for creating radio-frequency energy electrical membrane breakdown for tissue ablation |
US10709491B2 (en) | 2013-08-06 | 2020-07-14 | Memorial Sloan-Kettering Cancer Center | System, method and computer-accessible medium for in-vivo tissue ablation and/or damage |
US10390874B2 (en) * | 2013-11-14 | 2019-08-27 | Rm2 Technology Llc | Methods, systems, and apparatuses for tissue ablation using electrolysis and permeabilization |
AU2014360318B2 (en) * | 2013-12-05 | 2019-10-31 | Rfemb Holdings, Llc | Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB) |
EP3091921B1 (en) | 2014-01-06 | 2019-06-19 | Farapulse, Inc. | Apparatus for renal denervation ablation |
WO2015171921A2 (en) | 2014-05-07 | 2015-11-12 | Mickelson Steven R | Methods and apparatus for selective tissue ablation |
WO2015192018A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective tissue ablation with cooling |
WO2015192027A1 (en) | 2014-06-12 | 2015-12-17 | Iowa Approach Inc. | Method and apparatus for rapid and selective transurethral tissue ablation |
EP3206613B1 (en) | 2014-10-14 | 2019-07-03 | Farapulse, Inc. | Apparatus for rapid and safe pulmonary vein cardiac ablation |
JP6723249B2 (en) | 2015-01-30 | 2020-07-15 | アールエフイーエムビー ホールディングス リミテッド ライアビリティ カンパニー | System and method for ablating soft tissue |
US20180028260A1 (en) * | 2015-02-04 | 2018-02-01 | Rfemb Holdings, Llc | Radio-frequency electrical membrane breakdown for the treatment of adipose tissue and removal of unwanted body fat |
WO2016178697A1 (en) | 2015-05-01 | 2016-11-10 | Inter Science Gmbh | Methods, systems, and apparatuses for tissue ablation using pulse shape designs |
EP3294172B9 (en) * | 2015-05-12 | 2023-04-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Asymmetric balanced waveform for ac cardiac irreversible electroporation |
US10531914B2 (en) * | 2015-08-06 | 2020-01-14 | Medtronic, Inc. | Cardiac pulsed field ablation |
US20170105762A1 (en) * | 2015-10-15 | 2017-04-20 | Medtronic Advanced Energy Llc | Lead extraction |
US10130423B1 (en) | 2017-07-06 | 2018-11-20 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US10172673B2 (en) | 2016-01-05 | 2019-01-08 | Farapulse, Inc. | Systems devices, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
US10660702B2 (en) | 2016-01-05 | 2020-05-26 | Farapulse, Inc. | Systems, devices, and methods for focal ablation |
US20170189097A1 (en) * | 2016-01-05 | 2017-07-06 | Iowa Approach Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
EP3402517A4 (en) | 2016-01-15 | 2020-01-15 | RFEMB Holdings, LLC | Immunologic treatment of cancer |
ITUB20160508A1 (en) * | 2016-01-22 | 2017-07-22 | Bios S R L Unipersonale | Radiofrequency device for laxity and vaginal remodeling |
US20170319260A1 (en) * | 2016-05-05 | 2017-11-09 | Analog Devices, Inc. | Coordination/control of multiple medical devices at a site |
WO2017218734A1 (en) | 2016-06-16 | 2017-12-21 | Iowa Approach, Inc. | Systems, apparatuses, and methods for guide wire delivery |
AU2017289267B2 (en) * | 2016-06-27 | 2021-08-12 | Galvanize Therapeutics, Inc. | Generator and a catheter with an electrode and a method for treating a lung passageway |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US10124182B2 (en) * | 2017-02-28 | 2018-11-13 | Medtronic, Inc. | Mitigating implantable device power drain associated with stalled telemetry sessions |
US10569081B2 (en) | 2017-03-03 | 2020-02-25 | Medtronic, Inc. | Stacked potential electroporation |
US9987081B1 (en) | 2017-04-27 | 2018-06-05 | Iowa Approach, Inc. | Systems, devices, and methods for signal generation |
US10617867B2 (en) | 2017-04-28 | 2020-04-14 | Farapulse, Inc. | Systems, devices, and methods for delivery of pulsed electric field ablative energy to esophageal tissue |
JP2020533050A (en) | 2017-09-12 | 2020-11-19 | ファラパルス,インコーポレイテッド | Systems, devices, and methods for ventricular focal ablation |
WO2019071269A2 (en) | 2017-10-06 | 2019-04-11 | Powell Charles Lee | System and method to treat obstructive sleep apnea |
AU2018397685A1 (en) | 2017-12-26 | 2020-07-23 | Galvanize Therapeutics, Inc. | Methods, apparatuses, and systems for the treatment of disease states and disorders |
JP2021508533A (en) | 2017-12-26 | 2021-03-11 | ギャラリー,インコーポレイテッド | Optimizing energy delivery for a variety of applications |
EP3790486A1 (en) | 2018-05-07 | 2021-03-17 | Farapulse, Inc. | Systems, apparatuses and methods for delivery of ablative energy to tissue |
JP7399881B2 (en) | 2018-05-07 | 2023-12-18 | ファラパルス,インコーポレイテッド | epicardial ablation catheter |
CN112118798A (en) | 2018-05-07 | 2020-12-22 | 法拉普尔赛股份有限公司 | Systems, devices, and methods for filtering high voltage noise induced by pulsed electric field ablation |
WO2020061359A1 (en) | 2018-09-20 | 2020-03-26 | Farapulse, Inc. | Systems, apparatuses, and methods for delivery of pulsed electric field ablative energy to endocardial tissue |
EP4025130A1 (en) * | 2019-09-04 | 2022-07-13 | Arga' Medtech Sa | Ablation assembly to treat target regions of tissue in organs |
US10625080B1 (en) | 2019-09-17 | 2020-04-21 | Farapulse, Inc. | Systems, apparatuses, and methods for detecting ectopic electrocardiogram signals during pulsed electric field ablation |
US11497541B2 (en) | 2019-11-20 | 2022-11-15 | Boston Scientific Scimed, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
US11065047B2 (en) | 2019-11-20 | 2021-07-20 | Farapulse, Inc. | Systems, apparatuses, and methods for protecting electronic components from high power noise induced by high voltage pulses |
EP4061206A4 (en) * | 2019-11-22 | 2023-12-20 | Acutus Medical, Inc. | Tissue treatment systems, devices, and methods |
US10842572B1 (en) | 2019-11-25 | 2020-11-24 | Farapulse, Inc. | Methods, systems, and apparatuses for tracking ablation devices and generating lesion lines |
US11540877B2 (en) * | 2019-12-03 | 2023-01-03 | Biosense Webster (Israel) Ltd. | Pulse generator for irreversible electroporation |
US11903638B2 (en) * | 2019-12-11 | 2024-02-20 | Biosense Webster (Israel) Ltd. | Regulating delivery of irreversible electroporation pulses according to transferred energy |
JP2023528084A (en) * | 2020-06-07 | 2023-07-03 | アルガ′ メドテック エスア | Ablation device for treating target areas of tissue within an organ |
CN116322541A (en) * | 2020-07-24 | 2023-06-23 | 波士顿科学医学有限公司 | Esophageal catheter for irreversible electroporation |
CN113098448B (en) * | 2021-04-01 | 2023-07-04 | 杭州维纳安可医疗科技有限责任公司 | Pulse generating method, pulse generating device, storage medium, and electronic apparatus |
CN113116511B (en) * | 2021-04-16 | 2023-04-07 | 杭州维纳安可医疗科技有限责任公司 | Electric signal output method, device, equipment, system and storage medium |
US20230009191A1 (en) | 2021-07-09 | 2023-01-12 | Biosense Webster (Israel) Ltd. | Irreversible electroporation and thermal ablation by focal catheter |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007035537A2 (en) * | 2005-09-20 | 2007-03-29 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
WO2008101086A2 (en) * | 2007-02-15 | 2008-08-21 | Ethicon Endo-Surgery, Inc | Electroporation ablation apparatus, system, and method |
US20080300571A1 (en) * | 2007-05-30 | 2008-12-04 | Lepivert Patrick | Process and device for selectively treating interstitial tissue |
US20100179530A1 (en) | 2009-01-12 | 2010-07-15 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
Family Cites Families (1523)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2493108A (en) | 1950-01-03 | Akticle handler | ||
US645576A (en) | 1897-09-02 | 1900-03-20 | Nikola Tesla | System of transmission of electrical energy. |
US787412A (en) | 1900-05-16 | 1905-04-18 | Nikola Tesla | Art of transmitting electrical energy through the natural mediums. |
US1039354A (en) | 1910-03-29 | 1912-09-24 | Pasquale Bonadio | Hose-coupling. |
US1127948A (en) | 1914-12-31 | 1915-02-09 | Reinhold H Wappler | Cystoscope. |
US1482653A (en) | 1923-01-16 | 1924-02-05 | William E Lilly | Gripping device |
US1625602A (en) | 1926-04-06 | 1927-04-19 | Harold G Gould | Surgical appliance |
GB330629A (en) | 1929-03-14 | 1930-06-16 | Edward Baron | Improvements in and connected with vaginal specula and like instruments |
US1916722A (en) | 1931-06-15 | 1933-07-04 | Frank M Ende | Diathermy |
US2031682A (en) | 1932-11-18 | 1936-02-25 | Wappler Frederick Charles | Method and means for electrosurgical severance of adhesions |
US2028635A (en) | 1933-09-11 | 1936-01-21 | Wappler Frederick Charles | Forcipated surgical instrument |
US2113246A (en) | 1937-05-17 | 1938-04-05 | Wappler Frederick Charles | Endoscopic forceps |
US2155365A (en) | 1938-03-07 | 1939-04-18 | Kearney James R Corp | Pick-up tongs |
US2196620A (en) | 1938-10-25 | 1940-04-09 | Sarkis T Attarian | Hook attaching device and spreader |
US2191858A (en) | 1939-06-09 | 1940-02-27 | William H Moore | Paper and trash picker tongs and the like |
US2388137A (en) | 1945-05-07 | 1945-10-30 | George D Graumlich | Device for installing and removing tubular lamps and the like |
US2504152A (en) | 1945-12-14 | 1950-04-18 | Robert T Riker | Gripper |
US2938382A (en) | 1955-04-29 | 1960-05-31 | Vloeistofmeetapp Nfabriek Nv | Fluid meter |
US2952206A (en) | 1957-05-10 | 1960-09-13 | Austin Powder Co | Fuse connector |
US3069195A (en) | 1959-05-18 | 1962-12-18 | Buck Frank | Device for changing tubular lights |
US3070088A (en) | 1961-02-02 | 1962-12-25 | Brahos Nicholas George | Surgical retractor device |
US3170471A (en) | 1962-04-23 | 1965-02-23 | Schnitzer Emanuel | Inflatable honeycomb |
US3470876A (en) | 1966-09-28 | 1969-10-07 | John Barchilon | Dirigible catheter |
US3435824A (en) | 1966-10-27 | 1969-04-01 | Herminio Gamponia | Surgical apparatus and related process |
US3595239A (en) | 1969-04-04 | 1971-07-27 | Roy A Petersen | Catheter with electrical cutting means |
US3669487A (en) | 1970-11-09 | 1972-06-13 | Lonnie D Roberts | Tool |
US3746881A (en) | 1971-02-16 | 1973-07-17 | Maxwell Lab | Marx generator and triggering circuitry therefor |
US3799672A (en) | 1972-09-15 | 1974-03-26 | Us Health Education & Welfare | Oximeter for monitoring oxygen saturation in blood |
US3948251A (en) | 1972-10-25 | 1976-04-06 | Olympus Optical Co., Ltd. | Flexible tube endoscope |
US3854473A (en) | 1973-05-29 | 1974-12-17 | Olympus Optical Co | Stilet for endoscopes |
DE2513868C2 (en) | 1974-04-01 | 1982-11-04 | Olympus Optical Co., Ltd., Tokyo | Bipolar electrodiathermy forceps |
US3946740A (en) | 1974-10-15 | 1976-03-30 | Bassett John W | Suturing device |
US3965890A (en) | 1974-10-18 | 1976-06-29 | William Kohlmann Gauthier | Surgical retractor |
US3961632A (en) | 1974-12-13 | 1976-06-08 | Moossun Mohamed H | Stomach intubation and catheter placement system |
US3994301A (en) | 1975-04-14 | 1976-11-30 | S & S Medical Products Co., Inc. | Submammary dissector |
US4085743A (en) | 1976-03-02 | 1978-04-25 | In Bae Yoon | Multiple occlusion ring applicator and method |
US4012812A (en) | 1976-03-11 | 1977-03-22 | Wade Industries, Inc. | Double lock tufting button |
US4174715A (en) | 1977-03-28 | 1979-11-20 | Hasson Harrith M | Multi-pronged laparoscopy forceps |
US4207873A (en) | 1977-05-16 | 1980-06-17 | American Cystoscope Makers, Inc. | Endoscope deflection control |
US4461281A (en) | 1977-06-15 | 1984-07-24 | Carson Robert W | Arthroscopic surgical apparatus and method |
US5133727A (en) | 1990-05-10 | 1992-07-28 | Symbiosis Corporation | Radial jaw biopsy forceps |
US4178920A (en) | 1977-10-03 | 1979-12-18 | American Hospital Supply Corporation | Urological instrument with deflecting element |
JPS5472489A (en) | 1977-11-18 | 1979-06-09 | Osaka Hiyuuzu Kk | Wire connector |
US4164225A (en) | 1977-12-28 | 1979-08-14 | Johnson & Lorenz, Inc. | Surgical suturing instrument |
US4258716A (en) | 1978-02-06 | 1981-03-31 | The University Of Melbourne | Microsurgical instruments |
US4235238A (en) | 1978-05-11 | 1980-11-25 | Olympus Optical Co., Ltd. | Apparatus for suturing coeliac tissues |
JPS5519124A (en) | 1978-07-27 | 1980-02-09 | Olympus Optical Co | Camera system for medical treatment |
JPS5552748A (en) | 1978-10-12 | 1980-04-17 | Olympus Optical Co | Highhfrequency incising tool |
US4329980A (en) | 1979-03-06 | 1982-05-18 | Olympus Optical Co., Ltd. | Flexible sheath for an endoscope |
JPH0127762Y2 (en) | 1979-06-30 | 1989-08-23 | ||
US4269174A (en) | 1979-08-06 | 1981-05-26 | Medical Dynamics, Inc. | Transcutaneous vasectomy apparatus and method |
US4527564A (en) | 1980-02-06 | 1985-07-09 | Janome Sewing Machine Co. Ltd. | Suturing needle for medical operation |
US4285344A (en) | 1980-02-21 | 1981-08-25 | Marshall Warren S | Surgical scissors |
SU980703A1 (en) | 1980-05-16 | 1982-12-15 | Иркутский Государственный Медицинский Институт | Device for dissection of tissues |
US4396021A (en) | 1980-12-15 | 1983-08-02 | Baumgartner George C | Surgical instrument and process |
US4406656A (en) | 1981-06-01 | 1983-09-27 | Brack Gillium Hattler | Venous catheter having collapsible multi-lumens |
US4452246A (en) | 1981-09-21 | 1984-06-05 | Bader Robert F | Surgical instrument |
US4677982A (en) | 1981-12-31 | 1987-07-07 | New York University | Infrared transcutaneous communicator and method of using same |
AU9143982A (en) | 1982-01-20 | 1983-07-28 | Sorenson Research Co. Inc. | Translating and positioning a catheter |
US4527331A (en) | 1982-01-26 | 1985-07-09 | Lasner Jeffrey I | Suture remover and continuous band scissors |
US4823794A (en) | 1982-07-12 | 1989-04-25 | Pierce William S | Surgical pledget |
US4491132A (en) | 1982-08-06 | 1985-01-01 | Zimmer, Inc. | Sheath and retractable surgical tool combination |
USD281104S (en) | 1982-09-27 | 1985-10-22 | Adler Instrument Company | Serrated surgical scissors |
US4491135A (en) | 1982-11-03 | 1985-01-01 | Klein Harvey A | Surgical needle holder |
GB2130889B (en) | 1982-11-26 | 1986-06-18 | Wolf Gmbh Richard | Rectoscope |
US4655219A (en) | 1983-07-22 | 1987-04-07 | American Hospital Supply Corporation | Multicomponent flexible grasping device |
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US4712545A (en) | 1984-04-05 | 1987-12-15 | Acufex Microsurgical, Inc. | Surgical instrument |
US4569347A (en) | 1984-05-30 | 1986-02-11 | Advanced Cardiovascular Systems, Inc. | Catheter introducing device, assembly and method |
GB2161389B (en) | 1984-07-05 | 1988-06-08 | Wolf Gmbh Richard | Instrument insert for a uretero-renoscope |
US4938214A (en) | 1984-09-10 | 1990-07-03 | Micrins Surgical Instruments, Ltd. | Hand held surgical tool |
US4580551A (en) | 1984-11-02 | 1986-04-08 | Warner-Lambert Technologies, Inc. | Flexible plastic tube for endoscopes and the like |
US4646722A (en) | 1984-12-10 | 1987-03-03 | Opielab, Inc. | Protective endoscope sheath and method of installing same |
US4727600A (en) | 1985-02-15 | 1988-02-23 | Emik Avakian | Infrared data communication system |
US4685447A (en) | 1985-03-25 | 1987-08-11 | Pmt Corporation | Tissue expander system |
US4721116A (en) | 1985-06-04 | 1988-01-26 | Schintgen Jean Marie | Retractable needle biopsy forceps and improved control cable therefor |
US5020535A (en) | 1985-09-26 | 1991-06-04 | Alcon Laboratories, Inc. | Handpiece drive apparatus for powered surgical scissors |
USD295894S (en) | 1985-09-26 | 1988-05-24 | Acme United Corporation | Disposable surgical scissors |
US4669470A (en) | 1985-11-20 | 1987-06-02 | Brandfield Robert T | Surgical forceps/scissors |
US4763669A (en) | 1986-01-09 | 1988-08-16 | Jaeger John C | Surgical instrument with adjustable angle of operation |
FR2595938A1 (en) | 1986-03-18 | 1987-09-25 | Hanna Khalil | MICROSURGICAL INSTRUMENT FOR THE USE OF CLAMPS OR SCISSORS |
US5066295A (en) | 1986-05-13 | 1991-11-19 | Mill-Rose Laboratories, Inc. | Rotatable surgical snare |
US4711240A (en) | 1986-05-15 | 1987-12-08 | Duke University Patents Foundation | Surgical dissector |
US5123914A (en) | 1986-05-19 | 1992-06-23 | Cook Incorporated | Visceral anchor for visceral wall mobilization |
US4867140A (en) | 1986-05-19 | 1989-09-19 | Hovis Donald B | Fluid-actuated medical support |
US5010876A (en) | 1986-06-02 | 1991-04-30 | Smith & Nephew Dyonics, Inc. | Arthroscopic surgical practice |
US4671477A (en) | 1986-06-12 | 1987-06-09 | Cullen Thomas J | Device for handling a workpiece such as a container for chemotherapy drugs or the like |
DE3743920A1 (en) | 1986-12-26 | 1988-07-14 | Olympus Optical Co | ENDOSCOPE DEVICE |
US4733662A (en) | 1987-01-20 | 1988-03-29 | Minnesota Mining And Manufacturing Company | Tissue gripping and cutting assembly for surgical instrument |
US4979950A (en) | 1987-04-08 | 1990-12-25 | Ethicon, Inc. | Surgical hemostatic clips |
GB8708481D0 (en) | 1987-04-09 | 1987-05-13 | Wickham J E A | Tissue disintegrator |
US5065516A (en) | 1987-05-11 | 1991-11-19 | Andrew Tool Company | Disassemblable scissors means |
US4898156A (en) | 1987-05-18 | 1990-02-06 | Mitek Surgical Products, Inc. | Suture anchor |
JPS63309252A (en) | 1987-06-12 | 1988-12-16 | Meidensha Electric Mfg Co Ltd | Hydrated polymer gel actuator |
US4829999A (en) | 1987-07-17 | 1989-05-16 | E. R. Squibb And Sons, Inc. | Side mount guidewire gripping device |
US4950273A (en) | 1987-10-26 | 1990-08-21 | Briggs Jeffrey M | Cable action instrument |
US4815450A (en) | 1988-02-01 | 1989-03-28 | Patel Jayendra I | Endoscope having variable flexibility |
US4926860A (en) | 1988-02-05 | 1990-05-22 | Flexmedics Corporation | ARthroscopic instrumentation and method |
JPH01244732A (en) | 1988-03-28 | 1989-09-29 | Asahi Optical Co Ltd | Endoscope with sheath |
US5052372A (en) | 1988-04-05 | 1991-10-01 | Shapiro Jerome J | Vaginal speculum having a unique single control |
US4869459A (en) | 1988-04-20 | 1989-09-26 | Bourne Douglas A | Valve operators |
US4869238A (en) | 1988-04-22 | 1989-09-26 | Opielab, Inc. | Endoscope for use with a disposable sheath |
US4880015A (en) | 1988-06-03 | 1989-11-14 | Nierman David M | Biopsy forceps |
US6120437A (en) | 1988-07-22 | 2000-09-19 | Inbae Yoon | Methods for creating spaces at obstructed sites endoscopically and methods therefor |
US5843156A (en) | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US4984581A (en) | 1988-10-12 | 1991-01-15 | Flexmedics Corporation | Flexible guide having two-way shape memory alloy |
US4960133A (en) | 1988-11-21 | 1990-10-02 | Brunswick Manufacturing Co., Inc. | Esophageal electrode |
US5222362A (en) | 1989-01-10 | 1993-06-29 | Maus Daryl D | Heat-activated drug delivery system and thermal actuators therefor |
US4911148A (en) | 1989-03-14 | 1990-03-27 | Intramed Laboratories, Inc. | Deflectable-end endoscope with detachable flexible shaft assembly |
US5245460A (en) | 1989-03-30 | 1993-09-14 | Photonics Corporation | Infrared network entry permission method and apparatus |
ATE124232T1 (en) | 1989-04-07 | 1995-07-15 | Univ Melbourne | IMPROVED SURGICAL INSTRUMENT. |
JPH0651018B2 (en) | 1989-05-02 | 1994-07-06 | 株式会社東芝 | Endoscope |
US5033169A (en) | 1989-05-22 | 1991-07-23 | Straight Line Water Sports, Inc. | Rope fastener |
DE3923851C1 (en) | 1989-07-19 | 1990-08-16 | Richard Wolf Gmbh, 7134 Knittlingen, De | |
US5301061A (en) | 1989-07-27 | 1994-04-05 | Olympus Optical Co., Ltd. | Endoscope system |
US4994079A (en) | 1989-07-28 | 1991-02-19 | C. R. Bard, Inc. | Grasping forceps |
US6004330A (en) | 1989-08-16 | 1999-12-21 | Medtronic, Inc. | Device or apparatus for manipulating matter |
JPH03128028A (en) | 1989-10-13 | 1991-05-31 | Machida Seisakusho:Kk | Angle for curving operation device |
EP0422887B1 (en) | 1989-10-13 | 1996-12-11 | Kabushiki Kaisha Machida Seisakusho | Bending device |
US4950285A (en) | 1989-11-27 | 1990-08-21 | Wilk Peter J | Suture device |
US5123913A (en) | 1989-11-27 | 1992-06-23 | Wilk Peter J | Suture device |
US5665100A (en) | 1989-12-05 | 1997-09-09 | Yoon; Inbae | Multifunctional instrument with interchangeable operating units for performing endoscopic procedures |
US5797939A (en) | 1989-12-05 | 1998-08-25 | Yoon; Inbae | Endoscopic scissors with longitudinal operating channel |
US5217473A (en) | 1989-12-05 | 1993-06-08 | Inbae Yoon | Multi-functional instruments and stretchable ligating and occluding devices |
US5984938A (en) | 1989-12-05 | 1999-11-16 | Yoon; Inbae | Surgical instrument with jaws and movable internal scissors and method for use thereof |
US5984939A (en) | 1989-12-05 | 1999-11-16 | Yoon; Inbae | Multifunctional grasping instrument with cutting member and operating channel for use in endoscopic and non-endoscopic procedures |
US5356381A (en) | 1990-03-01 | 1994-10-18 | Ensminger William D | Implantable access devices |
US5345927A (en) | 1990-03-02 | 1994-09-13 | Bonutti Peter M | Arthroscopic retractors |
US6277136B1 (en) | 1990-03-02 | 2001-08-21 | General Surgical Innovations, Inc. | Method for developing an anatomic space |
US5007917A (en) | 1990-03-08 | 1991-04-16 | Stryker Corporation | Single blade cutter for arthroscopic surgery |
US5976131A (en) | 1990-03-13 | 1999-11-02 | The Regents Of The University At California | Detachable endovascular occlusion device activated by alternating electric current |
US5025778A (en) | 1990-03-26 | 1991-06-25 | Opielab, Inc. | Endoscope with potential channels and method of using the same |
US5482054A (en) | 1990-05-10 | 1996-01-09 | Symbiosis Corporation | Edoscopic biopsy forceps devices with selective bipolar cautery |
US5439478A (en) | 1990-05-10 | 1995-08-08 | Symbiosis Corporation | Steerable flexible microsurgical instrument with rotatable clevis |
US5203785A (en) | 1990-05-10 | 1993-04-20 | Symbrosis Corporation | Laparoscopic hook scissors |
US5234453A (en) | 1990-05-10 | 1993-08-10 | Symblosis Corporation | Cobalt base alloy end effectors for laparoscopic surgical scissors |
US5331971A (en) | 1990-05-10 | 1994-07-26 | Symbiosis Corporation | Endoscopic surgical instruments |
US5395386A (en) | 1990-05-10 | 1995-03-07 | Symbiosis Corporation | Endoscopic pericardial scissors |
US5037433A (en) | 1990-05-17 | 1991-08-06 | Wilk Peter J | Endoscopic suturing device and related method and suture |
US5219357A (en) | 1990-05-31 | 1993-06-15 | Tnco, Inc. | Micro-instrument |
US5269785A (en) | 1990-06-28 | 1993-12-14 | Bonutti Peter M | Apparatus and method for tissue removal |
US5224946A (en) | 1990-07-02 | 1993-07-06 | American Cyanamid Company | Bone anchor and method of anchoring a suture to a bone |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
US5843017A (en) | 1990-07-24 | 1998-12-01 | Yoon; Inbae | Multifunctional tissue dissecting instrument |
US5201752A (en) | 1990-09-27 | 1993-04-13 | Pod, Inc. | Cholecystectomy dissector instrument |
US5192300A (en) | 1990-10-01 | 1993-03-09 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
US5108421A (en) | 1990-10-01 | 1992-04-28 | Quinton Instrument Company | Insertion assembly and method of inserting a vessel plug into the body of a patient |
CA2050868C (en) | 1990-10-05 | 2002-01-01 | Ernie Aranyi | Endoscopic surgical instrument |
US5478347A (en) | 1990-10-05 | 1995-12-26 | United States Surgical Corporation | Endoscopic surgical instrument having curved blades |
US5685820A (en) | 1990-11-06 | 1997-11-11 | Partomed Medizintechnik Gmbh | Instrument for the penetration of body tissue |
US5203787A (en) | 1990-11-19 | 1993-04-20 | Biomet, Inc. | Suture retaining arrangement |
US5209747A (en) | 1990-12-13 | 1993-05-11 | Knoepfler Dennis J | Adjustable angle medical forceps |
US5324261A (en) | 1991-01-04 | 1994-06-28 | Medtronic, Inc. | Drug delivery balloon catheter with line of weakness |
US5312416A (en) | 1991-10-18 | 1994-05-17 | Endomedix Corporation | Method and system for enclosing, manipulating, debulking and removing tissue through minimal access incisions |
DE4101472C2 (en) | 1991-01-19 | 1995-07-13 | Winter & Ibe Olympus | Endoscope for transurethral resection |
US5370647A (en) | 1991-01-23 | 1994-12-06 | Surgical Innovations, Inc. | Tissue and organ extractor |
EP0570520A1 (en) | 1991-02-06 | 1993-11-24 | Laparomed Corporation | Electrosurgical device |
US5217453A (en) | 1991-03-18 | 1993-06-08 | Wilk Peter J | Automated surgical system and apparatus |
US5217003A (en) | 1991-03-18 | 1993-06-08 | Wilk Peter J | Automated surgical system and apparatus |
US5174300A (en) | 1991-04-04 | 1992-12-29 | Symbiosis Corporation | Endoscopic surgical instruments having rotatable end effectors |
US5392789A (en) | 1991-04-04 | 1995-02-28 | Symbiosis Corporation | Endoscopic scissors having scissor elements loosely engaged with a clevis |
US5320636A (en) | 1991-04-04 | 1994-06-14 | Symbiosis Corporation | Endoscopic scissors instrument with cammed surface end effectors |
US5383877A (en) | 1991-05-01 | 1995-01-24 | Clarke; Henry C. | Instruments and method for suturing and ligation |
US5330496A (en) | 1991-05-06 | 1994-07-19 | Alferness Clifton A | Vascular catheter assembly for tissue penetration and for cardiac stimulation and methods thereof |
AU666310B2 (en) | 1991-06-06 | 1996-02-08 | Meditech International Pty Ltd. | Speculum |
US5330471A (en) | 1991-06-07 | 1994-07-19 | Hemostatic Surgery Corporation | Bi-polar electrosurgical endoscopic instruments and methods of use |
US5503616A (en) | 1991-06-10 | 1996-04-02 | Endomedical Technologies, Inc. | Collapsible access channel system |
US5386817A (en) | 1991-06-10 | 1995-02-07 | Endomedical Technologies, Inc. | Endoscope sheath and valve system |
US5201908A (en) | 1991-06-10 | 1993-04-13 | Endomedical Technologies, Inc. | Sheath for protecting endoscope from contamination |
ATE150954T1 (en) | 1991-07-29 | 1997-04-15 | Smith & Nephew Richards Inc | TONGS |
US5383888A (en) | 1992-02-12 | 1995-01-24 | United States Surgical Corporation | Articulating endoscopic surgical apparatus |
US5219358A (en) | 1991-08-29 | 1993-06-15 | Ethicon, Inc. | Shape memory effect surgical needles |
US5741429A (en) | 1991-09-05 | 1998-04-21 | Cardia Catheter Company | Flexible tubular device for use in medical applications |
US5222965A (en) | 1991-09-06 | 1993-06-29 | Donald Haughton | Teat knife |
US5275607A (en) | 1991-09-23 | 1994-01-04 | Visionary Medical, Inc. | Intraocular surgical scissors |
CA2075241A1 (en) | 1991-10-03 | 1993-04-04 | Stephen W. Gerry | Handle for manipulating a laparoscopic tool |
US5273524A (en) | 1991-10-09 | 1993-12-28 | Ethicon, Inc. | Electrosurgical device |
US5312023A (en) | 1991-10-18 | 1994-05-17 | United States Surgical Corporation | Self contained gas powered surgical apparatus |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5374273A (en) | 1992-10-05 | 1994-12-20 | Nakao; Naomi L. | Method for retrieval of retained common bile duct stones |
US5190050A (en) | 1991-11-08 | 1993-03-02 | Electro-Catheter Corporation | Tip deflectable steerable catheter |
US5242456A (en) | 1991-11-21 | 1993-09-07 | Kensey Nash Corporation | Apparatus and methods for clamping tissue and reflecting the same |
US5308327A (en) | 1991-11-25 | 1994-05-03 | Advanced Surgical Inc. | Self-deployed inflatable retractor |
US5524633A (en) | 1991-11-25 | 1996-06-11 | Advanced Surgical, Inc. | Self-deploying isolation bag |
US5391174A (en) | 1991-11-29 | 1995-02-21 | Weston; Peter V. | Endoscopic needle holders |
US5197963A (en) | 1991-12-02 | 1993-03-30 | Everest Medical Corporation | Electrosurgical instrument with extendable sheath for irrigation and aspiration |
US5235964A (en) | 1991-12-05 | 1993-08-17 | Analogic Corporation | Flexible probe apparatus |
US5147374A (en) | 1991-12-05 | 1992-09-15 | Alfredo Fernandez | Prosthetic mesh patch for hernia repair |
US5290299A (en) | 1991-12-11 | 1994-03-01 | Ventritex, Inc. | Double jaw apparatus for attaching implanted materials to body tissue |
US5234437A (en) | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
US5190555A (en) | 1991-12-13 | 1993-03-02 | Unisurge, Inc. | Device for collection and removal of body parts during laparoscopic surgery |
US5643283A (en) | 1992-01-03 | 1997-07-01 | Younker; Marlin E. | Surgical pouch |
US6183469B1 (en) | 1997-08-27 | 2001-02-06 | Arthrocare Corporation | Electrosurgical systems and methods for the removal of pacemaker leads |
US5192284A (en) | 1992-01-10 | 1993-03-09 | Pleatman Mark A | Surgical collector and extractor |
US5433721A (en) | 1992-01-17 | 1995-07-18 | Ethicon, Inc. | Endoscopic instrument having a torsionally stiff drive shaft for applying fasteners to tissue |
GB9201214D0 (en) | 1992-01-21 | 1992-03-11 | Mcmahon Michael J | Surgical retractors |
EP0776739B1 (en) | 1992-01-21 | 2003-04-23 | Sri International | Surgical System |
US5284128A (en) | 1992-01-24 | 1994-02-08 | Applied Medical Resources Corporation | Surgical manipulator |
US5514157A (en) | 1992-02-12 | 1996-05-07 | United States Surgical Corporation | Articulating endoscopic surgical apparatus |
US5275614A (en) | 1992-02-21 | 1994-01-04 | Habley Medical Technology Corporation | Axially extendable endoscopic surgical instrument |
US5555883A (en) | 1992-02-24 | 1996-09-17 | Avitall; Boaz | Loop electrode array mapping and ablation catheter for cardiac chambers |
US5352184A (en) | 1992-03-12 | 1994-10-04 | Uresil Corporation | Reservoir for enclosing and retrieving body specimens |
US5297687A (en) | 1992-03-12 | 1994-03-29 | Freed Anna B | Virtual hinge |
US5246424A (en) | 1992-03-13 | 1993-09-21 | Wilk Peter J | Device and method for use in obtaining access to an internal body organ |
US5312333A (en) | 1992-04-03 | 1994-05-17 | United States Surgical Corporation | Endoscopic material delivery device |
US5263958A (en) | 1992-04-08 | 1993-11-23 | Microline Inc. | Microsurgical instrument |
US5470320A (en) | 1992-04-10 | 1995-11-28 | Tiefenbrun; Jonathan | Method and related device for obtaining access to a hollow organ |
US5254130A (en) | 1992-04-13 | 1993-10-19 | Raychem Corporation | Surgical device |
US5318589A (en) | 1992-04-15 | 1994-06-07 | Microsurge, Inc. | Surgical instrument for endoscopic surgery |
EP0680282A1 (en) | 1992-04-16 | 1995-11-08 | MICHALOS, Peter | Surgical cutting instrument |
US5522829A (en) | 1992-04-16 | 1996-06-04 | Arthur D. Little Enterprises, Inc. | Surgical cutting instrument |
US5403328A (en) | 1992-04-22 | 1995-04-04 | United States Surgical Corporation | Surgical apparatus and method for suturing body tissue |
US5417203A (en) | 1992-04-23 | 1995-05-23 | United States Surgical Corporation | Articulating endoscopic surgical apparatus |
US5443463A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Coagulating forceps |
US5484451A (en) | 1992-05-08 | 1996-01-16 | Ethicon, Inc. | Endoscopic surgical instrument and staples for applying purse string sutures |
US5536248A (en) | 1992-05-11 | 1996-07-16 | Arrow Precision Products, Inc. | Method and apparatus for electrosurgically obtaining access to the biliary tree and placing a stent therein |
US5389098A (en) | 1992-05-19 | 1995-02-14 | Olympus Optical Co., Ltd. | Surgical device for stapling and/or fastening body tissues |
DE4217202C2 (en) | 1992-05-23 | 1994-06-23 | Kernforschungsz Karlsruhe | Surgical sewing instrument |
US6540764B1 (en) | 1992-06-02 | 2003-04-01 | General Surgical Innovations, Inc. | Apparatus and method for dissecting tissue layers |
US5540711A (en) | 1992-06-02 | 1996-07-30 | General Surgical Innovations, Inc. | Apparatus and method for developing an anatomic space for laparoscopic procedures with laparoscopic visualization |
US5257999A (en) | 1992-06-04 | 1993-11-02 | Slanetz Jr Charles A | Self-oriented laparoscopic needle holder for curved needles |
US5325845A (en) | 1992-06-08 | 1994-07-05 | Adair Edwin Lloyd | Steerable sheath for use with selected removable optical catheter |
WO1994000059A1 (en) | 1992-06-24 | 1994-01-06 | Microsurge, Inc. | Reusable endoscopic surgical instrument |
US5478351A (en) | 1992-06-24 | 1995-12-26 | Microsurge, Inc. | Endoscopic surgical tool with handle and detachable tool assembly |
CA2098896C (en) | 1992-06-30 | 2005-03-29 | H. Jonathan Tovey | Specimen retrieval pouch and method for use |
US5368606A (en) | 1992-07-02 | 1994-11-29 | Marlow Surgical Technologies, Inc. | Endoscopic instrument system |
US5366466A (en) | 1992-07-09 | 1994-11-22 | Unisurge, Inc. | Surgical scissors |
US5284162A (en) | 1992-07-14 | 1994-02-08 | Wilk Peter J | Method of treating the colon |
US5366467A (en) | 1992-07-15 | 1994-11-22 | Linvatec Corporation | Endoscopic scissors |
US5360428A (en) | 1992-07-22 | 1994-11-01 | Hutchinson Jr William B | Laparoscopic instrument with electrical cutting wires |
US5330486A (en) | 1992-07-29 | 1994-07-19 | Wilk Peter J | Laparoscopic or endoscopic anastomosis technique and associated instruments |
US5511564A (en) | 1992-07-29 | 1996-04-30 | Valleylab Inc. | Laparoscopic stretching instrument and associated method |
US5470308A (en) | 1992-08-12 | 1995-11-28 | Vidamed, Inc. | Medical probe with biopsy stylet |
US5540648A (en) | 1992-08-17 | 1996-07-30 | Yoon; Inbae | Medical instrument stabilizer with anchoring system and methods |
US5297536A (en) | 1992-08-25 | 1994-03-29 | Wilk Peter J | Method for use in intra-abdominal surgery |
US5458131A (en) | 1992-08-25 | 1995-10-17 | Wilk; Peter J. | Method for use in intra-abdominal surgery |
US5630782A (en) | 1992-09-01 | 1997-05-20 | Adair; Edwin L. | Sterilizable endoscope with separable auxiliary assembly |
EP0658090B1 (en) | 1992-09-01 | 1998-11-04 | Edwin L. Adair | Sterilizable endoscope with separable disposable tube assembly |
US5704892A (en) | 1992-09-01 | 1998-01-06 | Adair; Edwin L. | Endoscope with reusable core and disposable sheath with passageways |
US5364408A (en) | 1992-09-04 | 1994-11-15 | Laurus Medical Corporation | Endoscopic suture system |
US6010515A (en) | 1993-09-03 | 2000-01-04 | University College London | Device for use in tying knots |
CA2106128A1 (en) | 1992-09-23 | 1994-03-24 | Ernie Aranyi | Endoscopic surgical instrument |
US5312423A (en) | 1992-10-01 | 1994-05-17 | Advanced Surgical Intervention, Inc. | Apparatus and method for laparaoscopic ligation |
US5374277A (en) | 1992-10-09 | 1994-12-20 | Ethicon, Inc. | Surgical instrument |
US5334198A (en) | 1992-10-09 | 1994-08-02 | Innovasive Devices, Inc. | Surgical instrument |
US5330502A (en) | 1992-10-09 | 1994-07-19 | Ethicon, Inc. | Rotational endoscopic mechanism with jointed drive mechanism |
US5431696A (en) | 1992-10-13 | 1995-07-11 | Atlee, Iii; John L. | Esophageal probe for transeophageal cardiac stimulation |
US5350391A (en) | 1992-10-19 | 1994-09-27 | Benedetto Iacovelli | Laparoscopic instruments |
US5387259A (en) | 1992-10-20 | 1995-02-07 | Sun Microsystems, Inc. | Optical transdermal linking method for transmitting power and a first data stream while receiving a second data stream |
US5259366A (en) | 1992-11-03 | 1993-11-09 | Boris Reydel | Method of using a catheter-sleeve assembly for an endoscope |
US5354302A (en) | 1992-11-06 | 1994-10-11 | Ko Sung Tao | Medical device and method for facilitating intra-tissue visual observation and manipulation of distensible tissues |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US20020095164A1 (en) | 1997-06-26 | 2002-07-18 | Andreas Bernard H. | Device and method for suturing tissue |
US5460168A (en) | 1992-12-25 | 1995-10-24 | Olympus Optical Co., Ltd. | Endoscope cover assembly and cover-system endoscope |
US5653690A (en) | 1992-12-30 | 1997-08-05 | Medtronic, Inc. | Catheter having a balloon with retention enhancement |
DE69427901T2 (en) | 1993-01-07 | 2002-04-04 | Medical Innovations Corp | CATHETER SYSTEM FOR GASTROSTOMY |
US5287852A (en) | 1993-01-13 | 1994-02-22 | Direct Trends International Ltd. | Apparatus and method for maintaining a tracheal stoma |
ATE164992T1 (en) | 1993-01-29 | 1998-05-15 | Smith & Nephew Inc | SWIVELING CURVED INSTRUMENT |
US5312351A (en) | 1993-01-29 | 1994-05-17 | Gerrone Carmen J | Combined pneumo-needle and trocar apparatus |
US6338730B1 (en) | 1993-02-04 | 2002-01-15 | Peter M. Bonutti | Method of using expandable cannula |
US5643294A (en) | 1993-03-01 | 1997-07-01 | United States Surgical Corporation | Surgical apparatus having an increased range of operability |
US5342396A (en) | 1993-03-02 | 1994-08-30 | Cook Melvin S | Staples |
US5431676A (en) | 1993-03-05 | 1995-07-11 | Innerdyne Medical, Inc. | Trocar system having expandable port |
US5344428A (en) | 1993-03-05 | 1994-09-06 | Auburn International, Inc. | Miniature surgical instrument |
US5814058A (en) | 1993-03-05 | 1998-09-29 | Innerdyne, Inc. | Method and apparatus employing conformable sleeve for providing percutaneous access |
US5445638B1 (en) | 1993-03-08 | 1998-05-05 | Everest Medical Corp | Bipolar coagulation and cutting forceps |
US5368605A (en) | 1993-03-09 | 1994-11-29 | Miller, Jr.; Herman A. | Laparoscopic surgical instrument |
US5657755A (en) | 1993-03-11 | 1997-08-19 | Desai; Jawahar M. | Apparatus and method for cardiac ablation |
US5330488A (en) | 1993-03-23 | 1994-07-19 | Goldrath Milton H | Verres needle suturing kit |
US5341815A (en) | 1993-03-25 | 1994-08-30 | Ethicon, Inc. | Endoscopic surgical pouch |
US5374275A (en) | 1993-03-25 | 1994-12-20 | Synvasive Technology, Inc. | Surgical suturing device and method of use |
US5403311A (en) | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
US5496347A (en) | 1993-03-30 | 1996-03-05 | Olympus Optical Co., Ltd. | Surgical instrument |
US5468250A (en) | 1993-04-01 | 1995-11-21 | Ethicon, Inc. | Endoscopic mechanism with friction maintaining handle |
US5613975A (en) | 1993-04-28 | 1997-03-25 | Christy; William J. | Endoscopic suturing device and method |
US5295977A (en) | 1993-05-11 | 1994-03-22 | Symbiosis Corporation | Trocar catheter for drainage |
US5403348A (en) | 1993-05-14 | 1995-04-04 | Bonutti; Peter M. | Suture anchor |
US5456667A (en) | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
US5364410A (en) | 1993-05-28 | 1994-11-15 | Ethicon, Inc. | Percutaneous suture externalizer |
US5334168A (en) | 1993-06-11 | 1994-08-02 | Catheter Research, Inc. | Variable shape guide apparatus |
US5480404A (en) | 1993-06-16 | 1996-01-02 | Ethicon, Inc. | Surgical tissue retrieval instrument |
WO1995001751A1 (en) | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
US5447148A (en) | 1993-07-08 | 1995-09-05 | Vision Sciences, Inc. | Endoscopic contamination protection system to facilitate cleaning of endoscopes |
US5569243A (en) | 1993-07-13 | 1996-10-29 | Symbiosis Corporation | Double acting endoscopic scissors with bipolar cautery capability |
DE4323585A1 (en) | 1993-07-14 | 1995-01-19 | Delma Elektro Med App | Bipolar high-frequency surgical instrument |
US5527321A (en) | 1993-07-14 | 1996-06-18 | United States Surgical Corporation | Instrument for closing trocar puncture wounds |
US5356408A (en) | 1993-07-16 | 1994-10-18 | Everest Medical Corporation | Bipolar electrosurgical scissors having nonlinear blades |
US5582617A (en) | 1993-07-21 | 1996-12-10 | Charles H. Klieman | Surgical instrument for endoscopic and general surgery |
CA2167367A1 (en) | 1993-07-21 | 1995-02-02 | Charles H. Klieman | Surgical instrument for endoscopic and general surgery |
US5827323A (en) | 1993-07-21 | 1998-10-27 | Charles H. Klieman | Surgical instrument for endoscopic and general surgery |
US5792165A (en) | 1993-07-21 | 1998-08-11 | Charles H. Klieman | Endoscopic instrument with detachable end effector |
US5441494A (en) | 1993-07-29 | 1995-08-15 | Ethicon, Inc. | Manipulable hand for laparoscopy |
US5507755A (en) | 1993-08-03 | 1996-04-16 | Origin Medsystems, Inc. | Apparatus and method for closing puncture wounds |
US5462561A (en) | 1993-08-05 | 1995-10-31 | Voda; Jan K. | Suture device |
US5469863A (en) | 1993-08-11 | 1995-11-28 | Polygenex International, Inc. | Polyurethane condom of welded polyurethane film |
US5827299A (en) | 1993-08-25 | 1998-10-27 | Inlet Medical, Inc | Insertable suture passing grasping probe and methodology for using same |
US5902238A (en) | 1993-09-14 | 1999-05-11 | University Of Washington | Medical tube and apparatus for locating the same in the body of a patient |
US5496333A (en) | 1993-10-20 | 1996-03-05 | Applied Medical Resources Corporation | Laparoscopic surgical clamp |
US5690660A (en) | 1993-10-27 | 1997-11-25 | Stryker Corporation | Arthroscopic cutter having curved rotatable drive |
US5405359A (en) | 1994-04-29 | 1995-04-11 | Pierce; Javi | Toggle wedge |
US6569159B1 (en) | 1993-11-08 | 2003-05-27 | Rita Medical Systems, Inc. | Cell necrosis apparatus |
US5405073A (en) | 1993-12-06 | 1995-04-11 | Ethicon, Inc. | Flexible support shaft assembly |
US6530922B2 (en) | 1993-12-15 | 2003-03-11 | Sherwood Services Ag | Cluster ablation electrode system |
US5743456A (en) | 1993-12-16 | 1998-04-28 | Stryker Corporation | Hand actuable surgical handpiece |
CA2138076A1 (en) | 1993-12-17 | 1995-06-18 | Philip E. Eggers | Monopolar electrosurgical instruments |
US5439471A (en) | 1994-01-05 | 1995-08-08 | Kerr; Harry D. | Combined surgical needle holder and scissors |
DZ1761A1 (en) | 1994-01-13 | 2002-02-17 | Haack Karl Warner An | A device for closing wounds. |
IL108352A (en) | 1994-01-17 | 2000-02-29 | Given Imaging Ltd | In vivo video camera system |
US5423821A (en) | 1994-01-18 | 1995-06-13 | Pasque; Michael K. | Sternal closure device |
DE4401237C2 (en) | 1994-01-18 | 1997-06-05 | Ruesch Willy Ag | Trocar device |
US5501692A (en) | 1994-01-28 | 1996-03-26 | Riza; Erol D. | Laparoscopic suture snare |
US5538509A (en) | 1994-01-31 | 1996-07-23 | Richard-Allan Medical Industries, Inc. | Trocar assembly |
US5638827A (en) | 1994-02-01 | 1997-06-17 | Symbiosis Corporation | Super-elastic flexible jaws assembly for an endoscopic multiple sample bioptome |
US5441059A (en) | 1994-02-02 | 1995-08-15 | Dannan; Patrick A. | Method of minimally invasive surgery |
US5645083A (en) | 1994-02-10 | 1997-07-08 | Essig; Mitchell N. | Peritoneal surgical method |
US5501698A (en) | 1994-02-14 | 1996-03-26 | Heartport, Inc. | Endoscopic microsurgical instruments and methods |
US5401248A (en) | 1994-02-22 | 1995-03-28 | Ethicon Endo-Surgery | Seal for trocar assembly |
US5833700A (en) | 1995-03-15 | 1998-11-10 | Ethicon Endo-Surgery, Inc. | Sterile occlusion fasteners and instrument and method for their placement |
US5681330A (en) | 1994-03-02 | 1997-10-28 | Ethicon Endo-Surgery, Inc. | Sterile occlusion fasteners and instrument and method for their placement |
CA2143560C (en) | 1994-03-02 | 2007-01-16 | Mark Fogelberg | Sterile occlusion fasteners and instrument and method for their placement |
US6216043B1 (en) | 1994-03-04 | 2001-04-10 | Ep Technologies, Inc. | Asymmetric multiple electrode support structures |
US5352222A (en) | 1994-03-15 | 1994-10-04 | Everest Medical Corporation | Surgical scissors with bipolar coagulation feature |
GB9405790D0 (en) | 1994-03-23 | 1994-05-11 | Univ London | Sewing device |
US5819736A (en) | 1994-03-24 | 1998-10-13 | Sightline Technologies Ltd. | Viewing method and apparatus particularly useful for viewing the interior of the large intestine |
US5653677A (en) | 1994-04-12 | 1997-08-05 | Fuji Photo Optical Co. Ltd | Electronic endoscope apparatus with imaging unit separable therefrom |
ES2149315T3 (en) | 1994-04-15 | 2000-11-01 | Smith & Nephew Inc | CURVED SURGICAL INSTRUMENT WITH SEGMENTED INTERIOR ELEMENT. |
US5569298A (en) | 1994-05-02 | 1996-10-29 | Schnell; William J. | Resposable scissors |
US5505686A (en) | 1994-05-05 | 1996-04-09 | Imagyn Medical, Inc. | Endoscope with protruding member and method of utilizing the same |
US5807308A (en) | 1996-02-23 | 1998-09-15 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
GB9409625D0 (en) | 1994-05-13 | 1994-07-06 | Univ London | Surgical cutting tool |
US5507731A (en) | 1994-05-17 | 1996-04-16 | Cordis Corporation | Rapid exchange segmented catheter |
US5454827A (en) | 1994-05-24 | 1995-10-03 | Aust; Gilbert M. | Surgical instrument |
US5569183A (en) | 1994-06-01 | 1996-10-29 | Archimedes Surgical, Inc. | Method for performing surgery around a viewing space in the interior of the body |
US5824041A (en) | 1994-06-08 | 1998-10-20 | Medtronic, Inc. | Apparatus and methods for placement and repositioning of intraluminal prostheses |
WO1995035064A1 (en) | 1994-06-20 | 1995-12-28 | Slotman Gus J | Tissue spreading surgical instrument |
JPH0829699A (en) | 1994-07-11 | 1996-02-02 | Kitagawa Ind Co Ltd | Image scope |
US5573540A (en) | 1994-07-18 | 1996-11-12 | Yoon; Inbae | Apparatus and method for suturing an opening in anatomical tissue |
ATE239425T1 (en) | 1994-07-29 | 2003-05-15 | Olympus Optical Co | MEDICAL INSTRUMENT FOR USE IN COMBINATION WITH ENDOSCOPES |
IT1274589B (en) | 1994-08-05 | 1997-07-18 | Nuovo Pignone Spa | IMPROVED SYSTEM OF GRIPPING AND TIGHTENING THE WEFT IN THE TRACTION GRIPPER OF A TEXTILE FRAME |
US5573542A (en) | 1994-08-17 | 1996-11-12 | Tahoe Surgical Instruments-Puerto Rico | Endoscopic suture placement tool |
US5584845A (en) | 1994-08-18 | 1996-12-17 | Innovasive Devices, Inc. | Surgical scissor blade and method for making the same |
JP2802244B2 (en) | 1994-08-29 | 1998-09-24 | オリンパス光学工業株式会社 | Endoscope sheath |
US5456684A (en) | 1994-09-08 | 1995-10-10 | Hutchinson Technology Incorporated | Multifunctional minimally invasive surgical instrument |
DE19501752A1 (en) | 1994-09-20 | 1996-07-25 | Stefan Koscher | Surgical instrument |
US5609601A (en) | 1994-09-23 | 1997-03-11 | United States Surgical Corporation | Endoscopic surgical apparatus with rotation lock |
US5554151A (en) | 1994-09-27 | 1996-09-10 | United States Surgical Corporation | Specimen retrieval container |
JP3614943B2 (en) | 1994-09-29 | 2005-01-26 | オリンパス株式会社 | Endoscopic puncture needle |
US6152920A (en) | 1997-10-10 | 2000-11-28 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body |
US6142994A (en) | 1994-10-07 | 2000-11-07 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body |
US5938668A (en) | 1994-10-07 | 1999-08-17 | United States Surgical | Surgical suturing apparatus |
US5571090A (en) | 1994-10-07 | 1996-11-05 | United States Surgical Corporation | Vascular suturing apparatus |
US5893875A (en) | 1994-10-07 | 1999-04-13 | Tnco, Inc. | Surgical instrument with replaceable jaw assembly |
US5578030A (en) | 1994-11-04 | 1996-11-26 | Levin; John M. | Biopsy needle with cauterization feature |
US5595562A (en) | 1994-11-10 | 1997-01-21 | Research Corporation Technologies, Inc. | Magnetic enteral gastrostomy |
US5549637A (en) | 1994-11-10 | 1996-08-27 | Crainich; Lawrence | Articulated medical instrument |
US5695511A (en) | 1994-11-29 | 1997-12-09 | Metamorphic Surgical Devices | Surgical instruments for minimally invasive procedures |
US7235089B1 (en) | 1994-12-07 | 2007-06-26 | Boston Scientific Corporation | Surgical apparatus and method |
US5533418A (en) | 1994-12-09 | 1996-07-09 | Kung C. Wu | Spherical robotic shoulder joint |
US5976130A (en) | 1994-12-13 | 1999-11-02 | Symbiosis Corporation | Bipolar push rod assembly for a bipolar endoscopic surgical instrument and instruments incorporating the same |
US6447511B1 (en) | 1994-12-13 | 2002-09-10 | Symbiosis Corporation | Bipolar endoscopic surgical scissor blades and instrument incorporating the same |
US5653722A (en) | 1995-01-03 | 1997-08-05 | Kieturakis; Maciej J. | Anterograde/retrograde spiral dissector and method of use in vein grafting |
US5643292A (en) | 1995-01-10 | 1997-07-01 | Applied Medical Resources Corporation | Percutaneous suturing device |
JP3798838B2 (en) | 1995-01-20 | 2006-07-19 | オリンパス株式会社 | Ligation device |
CA2168404C (en) | 1995-02-01 | 2007-07-10 | Dale Schulze | Surgical instrument with expandable cutting element |
US5593420A (en) | 1995-02-17 | 1997-01-14 | Mist, Inc. | Miniature endoscopic surgical instrument assembly and method of use |
US5665096A (en) | 1995-03-07 | 1997-09-09 | Yoon; Inbae | Needle driving apparatus and methods of suturing tissue |
US6391029B1 (en) | 1995-03-07 | 2002-05-21 | Enable Medical Corporation | Bipolar electrosurgical scissors |
US6464701B1 (en) | 1995-03-07 | 2002-10-15 | Enable Medical Corporation | Bipolar electrosurgical scissors |
US6179837B1 (en) | 1995-03-07 | 2001-01-30 | Enable Medical Corporation | Bipolar electrosurgical scissors |
US5695505A (en) | 1995-03-09 | 1997-12-09 | Yoon; Inbae | Multifunctional spring clips and cartridges and applicators therefor |
DE19509116C2 (en) | 1995-03-16 | 2000-01-05 | Deutsch Zentr Luft & Raumfahrt | Flexible structure |
FR2731610B1 (en) | 1995-03-16 | 1997-06-20 | Amp Dev | ANCHOR FOR INSERTION INTO A BONE CAVITY. |
US5868740A (en) | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
DE69632906T2 (en) | 1995-03-31 | 2005-07-28 | Boston Scientific Ltd., St. Michael | BIOPSY SAMPLER |
US5626607A (en) | 1995-04-03 | 1997-05-06 | Heartport, Inc. | Clamp assembly and method of use |
DE19512559A1 (en) | 1995-04-04 | 1996-10-10 | Aesculap Ag | Scissors-shaped tool for a surgical instrument and method for its manufacture |
US5591179A (en) | 1995-04-19 | 1997-01-07 | Applied Medical Resources Corporation | Anastomosis suturing device and method |
US5779701A (en) | 1995-04-27 | 1998-07-14 | Symbiosis Corporation | Bipolar endoscopic surgical scissor blades and instrument incorporating the same |
US6090108A (en) | 1995-04-27 | 2000-07-18 | Symbiosis Corporation | Bipolar endoscopic surgical scissor blades and instrument incorporating the same |
US5626578A (en) | 1995-05-08 | 1997-05-06 | Tihon; Claude | RF valvulotome |
JP3633032B2 (en) | 1995-05-26 | 2005-03-30 | 佐々木 寛 | Puncture device |
US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
DE69622969T2 (en) | 1995-06-07 | 2003-04-24 | Medtronic Inc | WOUND CLOSURE DEVICE |
US5964740A (en) | 1996-07-09 | 1999-10-12 | Asahi Kogaku Kogyo Kabushiki Kaisha | Treatment accessory for an endoscope |
US5702438A (en) | 1995-06-08 | 1997-12-30 | Avitall; Boaz | Expandable recording and ablation catheter system |
US5645565A (en) | 1995-06-13 | 1997-07-08 | Ethicon Endo-Surgery, Inc. | Surgical plug |
US5690656A (en) | 1995-06-27 | 1997-11-25 | Cook Incorporated | Method and apparatus for creating abdominal visceral anastomoses |
US5662621A (en) | 1995-07-06 | 1997-09-02 | Scimed Life Systems, Inc. | Guide catheter with shape memory retention |
US5616117A (en) | 1995-08-03 | 1997-04-01 | Ohio Medical Instrument Company, Inc. | Self locking surgical retractor |
US5562693A (en) | 1995-08-11 | 1996-10-08 | Alcon Laboratories, Inc. | Cutting blade assembly for a surgical scissors |
US5716326A (en) | 1995-08-14 | 1998-02-10 | Dannan; Patrick A. | Method for lifting tissue and apparatus for performing same |
US5951547A (en) | 1995-08-15 | 1999-09-14 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
US6090105A (en) | 1995-08-15 | 2000-07-18 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus and method |
US6053937A (en) | 1995-08-15 | 2000-04-25 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus and method with cooling element |
US6562052B2 (en) | 1995-08-24 | 2003-05-13 | Sutura, Inc. | Suturing device and method |
US6117144A (en) | 1995-08-24 | 2000-09-12 | Sutura, Inc. | Suturing device and method for sealing an opening in a blood vessel or other biological structure |
US6001120A (en) | 1995-09-07 | 1999-12-14 | Levin; John M. | Universal dissector |
US5797959A (en) | 1995-09-21 | 1998-08-25 | United States Surgical Corporation | Surgical apparatus with articulating jaw structure |
US5860995A (en) | 1995-09-22 | 1999-01-19 | Misener Medical Co. Inc. | Laparoscopic endoscopic surgical instrument |
US5624399A (en) | 1995-09-29 | 1997-04-29 | Ackrad Laboratories, Inc. | Catheter having an intracervical/intrauterine balloon made from polyurethane |
US5810715A (en) | 1995-09-29 | 1998-09-22 | Olympus Optical Co., Ltd. | Endoscope provided with function of being locked to flexibility of insertion part which is set by flexibility modifying operation member |
US5810876A (en) | 1995-10-03 | 1998-09-22 | Akos Biomedical, Inc. | Flexible forceps device |
WO1997012557A1 (en) | 1995-10-06 | 1997-04-10 | Kelleher Brian S | Steerable, flexible forceps device |
US5779716A (en) | 1995-10-06 | 1998-07-14 | Metamorphic Surgical Devices, Inc. | Device for removing solid objects from body canals, cavities and organs |
US5853374A (en) | 1995-10-11 | 1998-12-29 | Applied Medical Resources Corporation | Tissue collection and retrieval bag |
ATE275880T1 (en) | 1995-10-13 | 2004-10-15 | Transvascular Inc | DEVICE FOR BYPASSING ARTERIAL Narrowings AND/OR FOR PERFORMING OTHER TRANSVASCULAR PROCEDURES |
US5882344A (en) | 1995-10-18 | 1999-03-16 | Stouder, Jr.; Albert E. | Adjustable length cannula and trocar |
US5730740A (en) | 1995-11-09 | 1998-03-24 | Ethicon Endo-Surgery, Inc. | Latch mechanism for surgical instruments |
IT1277690B1 (en) | 1995-12-22 | 1997-11-11 | Bieffe Medital Spa | VERTEBRAL SUPPORT AND IMPLEMENTATION SYSTEM IN PARTICULAR FOR SURGICAL AND DIAGNOSTIC INSTRUMENTS |
US5817107A (en) | 1995-12-28 | 1998-10-06 | Schaller; Guenter | Grasping instrument with a guided-on, attachable modified knot pusher |
US5711921A (en) | 1996-01-02 | 1998-01-27 | Kew Import/Export Inc. | Medical cleaning and sterilizing apparatus |
US5827281A (en) | 1996-01-05 | 1998-10-27 | Levin; John M. | Insulated surgical scissors |
US6109852A (en) | 1996-01-18 | 2000-08-29 | University Of New Mexico | Soft actuators and artificial muscles |
US5628732A (en) | 1996-01-19 | 1997-05-13 | Ethicon Endo-Surgery, Inc. | Trocar with improved universal seal |
US5791022A (en) | 1996-01-29 | 1998-08-11 | Bohman; Lars | Cord locking mechanism |
JP2001508318A (en) | 1996-02-02 | 2001-06-26 | トランスバスキュラー インコーポレイテッド | Apparatus, systems and methods for interstitial transvascular intervention |
US5749889A (en) | 1996-02-13 | 1998-05-12 | Imagyn Medical, Inc. | Method and apparatus for performing biopsy |
US5957953A (en) | 1996-02-16 | 1999-09-28 | Smith & Nephew, Inc. | Expandable suture anchor |
US6436107B1 (en) | 1996-02-20 | 2002-08-20 | Computer Motion, Inc. | Method and apparatus for performing minimally invasive surgical procedures |
US5855546A (en) | 1996-02-29 | 1999-01-05 | Sci-Med Life Systems | Perfusion balloon and radioactive wire delivery system |
US5702390A (en) | 1996-03-12 | 1997-12-30 | Ethicon Endo-Surgery, Inc. | Bioplar cutting and coagulation instrument |
US5833603A (en) | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
US5649372A (en) | 1996-03-14 | 1997-07-22 | American Dryer Corporation | Drying cycle controller for controlling drying as a function of humidity and temperature |
US6016452A (en) | 1996-03-19 | 2000-01-18 | Kasevich; Raymond S. | Dynamic heating method and radio frequency thermal treatment |
US5725523A (en) | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
US5813976A (en) | 1996-04-02 | 1998-09-29 | Filipi; Charles J. | Stabilizing instrumentation for the performing of endoscopic surgical procedures |
JPH1024049A (en) | 1996-04-04 | 1998-01-27 | Valleylab Inc | Device for electric surgical operation |
US5669875A (en) | 1996-04-16 | 1997-09-23 | United States Surgical Corporation | Endoscopic surgical apparatus with longitudinal actuation |
EP0893970B1 (en) | 1996-04-19 | 2006-06-21 | Applied Medical Resources Corporation | Grasping clip applier |
US5700275A (en) | 1996-04-25 | 1997-12-23 | United States Surgical Corporation | Articulating endoscopic surgical instrument |
US6036640A (en) | 1996-04-29 | 2000-03-14 | Medtronic, Inc. | Device and method for repositioning the heart during surgery |
EP0848598B1 (en) | 1996-05-10 | 2005-02-23 | Emmanuil Giannadakis | System of laparoscopic-endoscopic surgery |
US5893846A (en) | 1996-05-15 | 1999-04-13 | Symbiosis Corp. | Ceramic coated endoscopic scissor blades and a method of making the same |
US5860913A (en) | 1996-05-16 | 1999-01-19 | Olympus Optical Co., Ltd. | Endoscope whose distal cover can be freely detachably attached to main distal part thereof with high positioning precision |
US5792135A (en) | 1996-05-20 | 1998-08-11 | Intuitive Surgical, Inc. | Articulated surgical instrument for performing minimally invasive surgery with enhanced dexterity and sensitivity |
US6090129A (en) | 1996-06-11 | 2000-07-18 | Asahi Kogaku Kogyo Kabushiki Kaisha | Treatment accessory for endoscope |
US5993474A (en) | 1996-06-11 | 1999-11-30 | Asahi Kogaku Kogyo Kabushiki Kaisha | Treatment accessory for endoscope |
US5855585A (en) | 1996-06-11 | 1999-01-05 | X-Site, L.L.C. | Device and method for suturing blood vessels and the like |
US6206872B1 (en) | 1996-06-24 | 2001-03-27 | Karl Storz Gmbh & Co. Kg | Endoscopic instrument which can be bent |
US5925052A (en) | 1996-06-26 | 1999-07-20 | Simmons; Paul L. | Umbilical surgical scissors |
US5752951A (en) | 1996-07-02 | 1998-05-19 | Yanik; Gary W. | Shielded monopolar electrosurgical apparatus |
US5728133A (en) | 1996-07-09 | 1998-03-17 | Cardiologics, L.L.C. | Anchoring device and method for sealing percutaneous punctures in vessels |
US5782748A (en) | 1996-07-10 | 1998-07-21 | Symbiosis Corporation | Endoscopic surgical instruments having detachable proximal and distal portions |
US5741234A (en) | 1996-07-16 | 1998-04-21 | Aboul-Hosn; Walid Nagib | Anatomical cavity access sealing condit |
US5902254A (en) | 1996-07-29 | 1999-05-11 | The Nemours Foundation | Cathether guidewire |
US6106521A (en) | 1996-08-16 | 2000-08-22 | United States Surgical Corporation | Apparatus for thermal treatment of tissue |
US5993447A (en) | 1996-08-16 | 1999-11-30 | United States Surgical | Apparatus for thermal treatment of tissue |
US5718717A (en) | 1996-08-19 | 1998-02-17 | Bonutti; Peter M. | Suture anchor |
US6123712A (en) | 1996-08-23 | 2000-09-26 | Scimed Life Systems, Inc. | Balloon catheter with stent securement means |
US5810806A (en) | 1996-08-29 | 1998-09-22 | Ethicon Endo-Surgery | Methods and devices for collection of soft tissue |
US6072154A (en) | 1996-09-05 | 2000-06-06 | Medtronic, Inc. | Selectively activated shape memory device |
CA2265752A1 (en) | 1996-09-16 | 1998-03-19 | Philip S. Green | System and method for endosurgery employing conjoint operation of an endoscope and endosurgical instrument |
US5655548A (en) | 1996-09-16 | 1997-08-12 | Circulation, Inc. | Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion |
US6152936A (en) | 1996-09-23 | 2000-11-28 | Esd Medical, Llc | Surgical loop delivery device |
JP2957134B2 (en) | 1996-10-08 | 1999-10-04 | 株式会社八光電機製作所 | Valve and valved trocar mantle |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US5954720A (en) | 1996-10-28 | 1999-09-21 | Endoscopic Concepts, Inc. | Bipolar electrosurgical end effectors |
US6371956B1 (en) | 1996-10-28 | 2002-04-16 | Endoscopic Concepts, Inc. | Monopolar electrosurgical end effectors |
IL129518A (en) | 1996-11-06 | 2004-03-28 | S T S Biopolymer Inc | Echogenic coating containing gaseous spaces for ultrasonography |
US6106473A (en) | 1996-11-06 | 2000-08-22 | Sts Biopolymers, Inc. | Echogenic coatings |
US5749826A (en) | 1996-11-06 | 1998-05-12 | Faulkner; James W. | Urinary incontinence control device |
US5976178A (en) | 1996-11-07 | 1999-11-02 | Vascular Science Inc. | Medical grafting methods |
US5735849A (en) | 1996-11-07 | 1998-04-07 | Everest Medical Corporation | Endoscopic forceps with thumb-slide lock release mechanism |
US6091995A (en) | 1996-11-08 | 2000-07-18 | Surx, Inc. | Devices, methods, and systems for shrinking tissues |
EP1230902A1 (en) | 1996-11-15 | 2002-08-14 | Advanced Bio Surfaces, Inc. | Biomaterial system for in situ tissue repair |
DE69735501T2 (en) | 1996-11-18 | 2006-12-14 | The University Of Massachusetts, Boston | SYSTEMS AND INSTRUMENTS FOR MINIMALLY INVASIVE SURGERY |
US6165184A (en) | 1996-11-18 | 2000-12-26 | Smith & Nephew, Inc. | Systems methods and instruments for minimally invasive surgery |
US6102926A (en) | 1996-12-02 | 2000-08-15 | Angiotrax, Inc. | Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use |
US5792113A (en) | 1996-12-12 | 1998-08-11 | Ethicon Endo-Surgerym Inc. | Universal seal for a trocar |
US6071279A (en) | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Branched structures for supporting multiple electrode elements |
US5951549A (en) | 1996-12-20 | 1999-09-14 | Enable Medical Corporation | Bipolar electrosurgical scissors |
US6030634A (en) | 1996-12-20 | 2000-02-29 | The Chinese University Of Hong Kong | Polymer gel composition and uses therefor |
US5782861A (en) | 1996-12-23 | 1998-07-21 | Sub Q Inc. | Percutaneous hemostasis device |
US6708066B2 (en) | 1999-12-10 | 2004-03-16 | Ewa Herbst | Electrochemical treatment of tissues, especially tumors |
US5709708A (en) | 1997-01-31 | 1998-01-20 | Thal; Raymond | Captured-loop knotless suture anchor assembly |
US5916213A (en) | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
US5893874A (en) | 1997-02-07 | 1999-04-13 | Smith & Nephew, Inc. | Surgical instrument |
US5779727A (en) | 1997-02-18 | 1998-07-14 | Orejola; Wilmo C. | Hydraulically operated surgical scissors |
US5911737A (en) | 1997-02-28 | 1999-06-15 | The Regents Of The University Of California | Microfabricated therapeutic actuators |
US6152944A (en) | 1997-03-05 | 2000-11-28 | Scimed Life Systems, Inc. | Catheter with removable balloon protector and stent delivery system with removable stent protector |
US5957943A (en) | 1997-03-05 | 1999-09-28 | Ethicon Endo-Surgery, Inc. | Method and devices for increasing ultrasonic effects |
US5876411A (en) | 1997-03-11 | 1999-03-02 | X-Site L.L.C. | Device and method for locating and sealing a blood vessel |
US5830231A (en) | 1997-03-19 | 1998-11-03 | Geiges, Jr.; John J. | Handle and actuating mechanism for surgical instruments |
US5782866A (en) | 1997-03-25 | 1998-07-21 | Ethicon, Inc. | System for anchoring tissue to bone |
US5936536A (en) | 1997-04-08 | 1999-08-10 | Medicor Corporation | Electrical insulation testing device and method for electrosurgical instruments |
US6033399A (en) | 1997-04-09 | 2000-03-07 | Valleylab, Inc. | Electrosurgical generator with adaptive power control |
US5897487A (en) | 1997-04-15 | 1999-04-27 | Asahi Kogaku Kogyo Kabushiki Kaisha | Front end hood for endoscope |
US5921993A (en) | 1997-05-01 | 1999-07-13 | Yoon; Inbae | Methods of endoscopic tubal ligation |
US5957936A (en) | 1997-05-01 | 1999-09-28 | Inbae Yoon | Instrument assemblies for performing anatomical tissue ligation |
US5908429A (en) | 1997-05-01 | 1999-06-01 | Yoon; Inbae | Methods of anatomical tissue ligation |
US6017358A (en) | 1997-05-01 | 2000-01-25 | Inbae Yoon | Surgical instrument with multiple rotatably mounted offset end effectors |
US5817061A (en) | 1997-05-16 | 1998-10-06 | Ethicon Endo-Surgery, Inc. | Trocar assembly |
US5810849A (en) | 1997-06-09 | 1998-09-22 | Cardiologics, L.L.C. | Device and method for suturing blood vessels and the like |
US6183420B1 (en) | 1997-06-20 | 2001-02-06 | Medtronic Ave, Inc. | Variable stiffness angioplasty guide wire |
WO1999000060A1 (en) | 1997-06-26 | 1999-01-07 | Advanced Coronary Intervention | Electrosurgical catheter for resolving obstructions by radio frequency ablation |
US6322578B1 (en) | 1997-07-14 | 2001-11-27 | Heartport, Inc. | Endoscopic microsurgical instruments |
WO1999004710A1 (en) | 1997-07-25 | 1999-02-04 | Cosman Eric R | Cluster ablation electrode system |
US5954731A (en) | 1997-07-29 | 1999-09-21 | Yoon; Inbae | Surgical instrument with multiple rotatably mounted spreadable end effectors |
US6293952B1 (en) | 1997-07-31 | 2001-09-25 | Circon Corporation | Medical instrument system for piercing through tissue |
US5904702A (en) | 1997-08-14 | 1999-05-18 | University Of Massachusetts | Instrument for thoracic surgical procedures |
US5803903A (en) | 1997-08-15 | 1998-09-08 | Mist, Inc. | Surgical retractor and method of use with balloon dissection |
US6102909A (en) | 1997-08-26 | 2000-08-15 | Ethicon, Inc. | Scissorlike electrosurgical cutting instrument |
US6024744A (en) | 1997-08-27 | 2000-02-15 | Ethicon, Inc. | Combined bipolar scissor and grasper |
US5922008A (en) | 1997-08-28 | 1999-07-13 | Gimpelson; Richard J. | Surgical forceps |
WO1999011177A2 (en) | 1997-09-05 | 1999-03-11 | Deslauriers Richard J | Self-retaining anchor track and method of making and using same |
US6149662A (en) | 1997-09-08 | 2000-11-21 | Miltex Technology Corporation | Medical scissor sharpener |
US6267761B1 (en) | 1997-09-09 | 2001-07-31 | Sherwood Services Ag | Apparatus and method for sealing and cutting tissue |
US6179832B1 (en) | 1997-09-11 | 2001-01-30 | Vnus Medical Technologies, Inc. | Expandable catheter having two sets of electrodes |
US5964782A (en) | 1997-09-18 | 1999-10-12 | Scimed Life Systems, Inc. | Closure device and method |
US6017356A (en) | 1997-09-19 | 2000-01-25 | Ethicon Endo-Surgery Inc. | Method for using a trocar for penetration and skin incision |
US5916147A (en) | 1997-09-22 | 1999-06-29 | Boury; Harb N. | Selectively manipulable catheter |
US5868762A (en) | 1997-09-25 | 1999-02-09 | Sub-Q, Inc. | Percutaneous hemostatic suturing device and method |
US5995875A (en) | 1997-10-01 | 1999-11-30 | United States Surgical | Apparatus for thermal treatment of tissue |
WO1999017661A1 (en) | 1997-10-02 | 1999-04-15 | Board Of Regents, The University Of Texas System | Subcutaneous endoscopic dissector |
US5908420A (en) | 1997-10-03 | 1999-06-01 | Everest Medical Corporation | Surgical scissors with bipolar distal electrodes |
US6283963B1 (en) | 1997-10-08 | 2001-09-04 | Ethicon, Inc. | Bipolar electrosurgical scissors for fine or delicate surgical dissection |
US6171316B1 (en) | 1997-10-10 | 2001-01-09 | Origin Medsystems, Inc. | Endoscopic surgical instrument for rotational manipulation |
DE19745157A1 (en) | 1997-10-14 | 1999-06-10 | Storz Karl Gmbh & Co | Instrument or forceps for medical and especially endoscopic applications |
JP3342021B2 (en) | 1997-10-17 | 2002-11-05 | サーコン コーポレーション | Medical device system that penetrates tissue |
US20020055717A1 (en) | 1997-10-20 | 2002-05-09 | Philippe Poncet | Fluid-based agent delivery device with self-expanding delivery element |
JP4121615B2 (en) | 1997-10-31 | 2008-07-23 | オリンパス株式会社 | Endoscope |
US6019770A (en) | 1997-12-04 | 2000-02-01 | Christoudias; George C. | Versatile endoscopic retrieval bag |
US6168570B1 (en) | 1997-12-05 | 2001-01-02 | Micrus Corporation | Micro-strand cable with enhanced radiopacity |
US5976075A (en) | 1997-12-15 | 1999-11-02 | University Of Massachusetts | Endoscope deployment apparatus |
AU1726999A (en) | 1997-12-17 | 1999-07-05 | Surgical Insight, Inc. | Low profile endoscopic surgical instruments |
US5989182A (en) | 1997-12-19 | 1999-11-23 | Vista Medical Technologies, Inc. | Device-steering shaft assembly and endoscope |
DE19757056B4 (en) | 1997-12-20 | 2008-08-28 | Aesculap Ag & Co. Kg | Surgical instrument |
US6626919B1 (en) | 1997-12-29 | 2003-09-30 | Lee L. Swanstrom | Method and apparatus for attaching or locking an implant to an anatomic vessel or hollow organ wall |
DE19800917A1 (en) | 1998-01-14 | 1999-07-15 | Storz Karl Gmbh & Co | Instrument for insertion during endoscopic operations |
US6068648A (en) | 1998-01-26 | 2000-05-30 | Orthodyne, Inc. | Tissue anchoring system and method |
US6165175A (en) | 1999-02-02 | 2000-12-26 | Ethicon Endo-Surgery, Inc. | RF bipolar mesentery takedown device including improved bipolar end effector |
US6440127B2 (en) | 1998-02-11 | 2002-08-27 | Cosman Company, Inc. | Method for performing intraurethral radio-frequency urethral enlargement |
US6352543B1 (en) | 2000-04-29 | 2002-03-05 | Ventrica, Inc. | Methods for forming anastomoses using magnetic force |
JP4157183B2 (en) | 1998-02-17 | 2008-09-24 | オリンパス株式会社 | Endoscopic treatment tool |
US7090683B2 (en) | 1998-02-24 | 2006-08-15 | Hansen Medical, Inc. | Flexible instrument |
US6949106B2 (en) | 1998-02-24 | 2005-09-27 | Endovia Medical, Inc. | Surgical instrument |
US6454727B1 (en) | 1998-03-03 | 2002-09-24 | Senorx, Inc. | Tissue acquisition system and method of use |
US6141037A (en) | 1998-03-18 | 2000-10-31 | Linvatec Corporation | Video camera system and related method |
US7674259B2 (en) | 2000-12-09 | 2010-03-09 | Tsunami Medtech | Medical instruments and techniques for thermally-mediated therapies |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6139562A (en) | 1998-03-30 | 2000-10-31 | Agilent Technologies, Inc. | Apparatus and method for incising |
US5971995A (en) | 1998-03-30 | 1999-10-26 | Ethicon, Inc. | Surgical pouch instrument |
JPH11285502A (en) | 1998-04-03 | 1999-10-19 | Asahi Optical Co Ltd | High frequency treatment tool for endoscope |
US6296630B1 (en) | 1998-04-08 | 2001-10-02 | Biocardia, Inc. | Device and method to slow or stop the heart temporarily |
US6383195B1 (en) | 1998-04-13 | 2002-05-07 | Endoline, Inc. | Laparoscopic specimen removal apparatus |
US6030384A (en) | 1998-05-01 | 2000-02-29 | Nezhat; Camran | Bipolar surgical instruments having focused electrical fields |
US6315753B1 (en) | 1998-05-01 | 2001-11-13 | Sub-Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
US5997555A (en) | 1998-05-01 | 1999-12-07 | X-Site, L.L.C. | Device and method for suturing blood vessels |
US5980539A (en) | 1998-05-06 | 1999-11-09 | X-Site L.L.C. | Device and method for suturing blood vessels and the like |
JP2000037388A (en) | 1998-05-20 | 2000-02-08 | Osamu Yoshida | Organ housing bag and organ housing bag inserter |
US6740082B2 (en) | 1998-12-29 | 2004-05-25 | John H. Shadduck | Surgical instruments for treating gastro-esophageal reflux |
CA2333121C (en) | 1998-05-21 | 2006-07-25 | Christopher J. Walshe | A tissue anchor system |
US5972002A (en) | 1998-06-02 | 1999-10-26 | Cabot Technology Corporation | Apparatus and method for surgical ligation |
US6027522A (en) | 1998-06-02 | 2000-02-22 | Boston Scientific Corporation | Surgical instrument with a rotatable distal end |
US6030365A (en) | 1998-06-10 | 2000-02-29 | Laufer; Michael D. | Minimally invasive sterile surgical access device and method |
JP3331172B2 (en) | 1998-06-12 | 2002-10-07 | 旭光学工業株式会社 | Endoscope foreign matter collection tool |
US6679882B1 (en) | 1998-06-22 | 2004-01-20 | Lina Medical Aps | Electrosurgical device for coagulating and for making incisions, a method of severing blood vessels and a method of coagulating and for making incisions in or severing tissue |
US5970581A (en) | 1998-06-22 | 1999-10-26 | Bic Corporation | Controllable fluid gripping devices |
US6096046A (en) | 1998-06-24 | 2000-08-01 | Weiss; Sol | Surgical instrument |
US6537248B2 (en) | 1998-07-07 | 2003-03-25 | Medtronic, Inc. | Helical needle apparatus for creating a virtual electrode used for the ablation of tissue |
US6148222A (en) | 1998-07-10 | 2000-11-14 | Cardiocommand, Inc. | Esophageal catheters and method of use |
US6352503B1 (en) | 1998-07-17 | 2002-03-05 | Olympus Optical Co., Ltd. | Endoscopic surgery apparatus |
DE19833600A1 (en) | 1998-07-25 | 2000-03-02 | Storz Karl Gmbh & Co Kg | Medical forceps with two independently movable jaw parts |
US6889089B2 (en) | 1998-07-28 | 2005-05-03 | Scimed Life Systems, Inc. | Apparatus and method for treating tumors near the surface of an organ |
US6212433B1 (en) | 1998-07-28 | 2001-04-03 | Radiotherapeutics Corporation | Method for treating tumors near the surface of an organ |
TW455482B (en) | 1998-07-30 | 2001-09-21 | David Lubowski | Sigmoidoscope |
IT1301986B1 (en) | 1998-07-31 | 2000-07-20 | Valerio Cigaina | LAPAROSCOPIC FORCEPS FOR SUTURE. |
US5916145A (en) | 1998-08-07 | 1999-06-29 | Scimed Life Systems, Inc. | Device and method of using a surgical assembly with mesh sheath |
US7335220B2 (en) | 2004-11-05 | 2008-02-26 | Access Closure, Inc. | Apparatus and methods for sealing a vascular puncture |
US6786913B1 (en) | 1999-02-01 | 2004-09-07 | Onux Medical, Inc. | Surgical suturing instrument and method of use |
JP4225624B2 (en) | 1998-08-27 | 2009-02-18 | オリンパス株式会社 | High frequency treatment device |
US6454783B1 (en) | 1998-09-15 | 2002-09-24 | Gregory Piskun | Laparoscopic instruments and trocar systems for trans-umbilical laproscopic surgery |
US6731875B1 (en) | 1998-09-22 | 2004-05-04 | Lucent Technologies Inc. | Wavelength bus architecture for ultra-high speed dense wavelength division multiplexed systems |
US6402689B1 (en) | 1998-09-30 | 2002-06-11 | Sicel Technologies, Inc. | Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors |
US6074408A (en) | 1998-10-13 | 2000-06-13 | Freeman; Kenneth V. | Modular medical instrument and method of using same |
US6053927A (en) | 1998-10-15 | 2000-04-25 | Rsh-Gs Trust | Apparatus and method for implant removal |
US6190383B1 (en) | 1998-10-21 | 2001-02-20 | Sherwood Services Ag | Rotatable electrode device |
US7267677B2 (en) | 1998-10-23 | 2007-09-11 | Sherwood Services Ag | Vessel sealing instrument |
US7137980B2 (en) | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
US6086530A (en) | 1998-10-30 | 2000-07-11 | Mack; Michael | Adjustable sleeve for endoscopes |
DE69924750T2 (en) | 1998-11-16 | 2006-03-02 | United States Surgical Corp., Norwalk | DEVICE FOR THE THERMAL TREATMENT OF TISSUE |
US6066160A (en) | 1998-11-23 | 2000-05-23 | Quickie Llc | Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing |
US6234958B1 (en) | 1998-11-30 | 2001-05-22 | Medical Access Systems, Llc | Medical device introduction system including medical introducer having a plurality of access ports and methods of performing medical procedures with same |
EP1602333B1 (en) | 1998-12-01 | 2008-06-04 | Atropos Limited | A wound retractor device |
DE19855812C2 (en) | 1998-12-03 | 2001-05-03 | Aesculap Ag & Co Kg | Surgical bipolar scissors |
AU736964B2 (en) | 1998-12-09 | 2001-08-09 | Cook Medical Technologies Llc | Hollow, curved, superelastic medical needle |
JP4096325B2 (en) | 1998-12-14 | 2008-06-04 | 正喜 江刺 | Active capillary and method for manufacturing the same |
US6346092B1 (en) | 1998-12-14 | 2002-02-12 | Datascope Investment Corp. | Intra-aortic balloon catheter and insertion sheath |
US6110183A (en) | 1998-12-22 | 2000-08-29 | Cook Incorporated | Suture anchor device |
US6306159B1 (en) | 1998-12-23 | 2001-10-23 | Depuy Orthopaedics, Inc. | Meniscal repair device |
US7172714B2 (en) | 1999-01-11 | 2007-02-06 | 2Phase Technologies, Inc. | Use of state-change materials in reformable shapes, templates or tooling |
US6780352B2 (en) | 1999-01-11 | 2004-08-24 | 2Phase Technologies, Inc. | Use of state-change materials in reformable shapes, templates or tooling |
US6170130B1 (en) | 1999-01-15 | 2001-01-09 | Illinois Tool Works Inc. | Lashing system |
US20030171747A1 (en) | 1999-01-25 | 2003-09-11 | Olympus Optical Co., Ltd. | Medical treatment instrument |
US6896683B1 (en) | 1999-01-25 | 2005-05-24 | Applied Material Resources Corporation | Surgical instrument with improved handle assembly |
US6113593A (en) | 1999-02-01 | 2000-09-05 | Tu; Lily Chen | Ablation apparatus having temperature and force sensing capabilities |
GB9902647D0 (en) | 1999-02-05 | 1999-03-31 | Minop Ltd | Actuating and locking mechanism for a surgical tool |
EP1150734B1 (en) | 1999-02-12 | 2004-10-20 | Karl Storz GmbH & Co. | Device for introducing an intubation tube into the trachea |
DE19906191A1 (en) | 1999-02-15 | 2000-08-17 | Ingo F Herrmann | Mouldable endoscope for transmitting light and images with supplementary device has non-round cross section along longitudinal section for inserting in human or animal body opening |
US6427089B1 (en) | 1999-02-19 | 2002-07-30 | Edward W. Knowlton | Stomach treatment apparatus and method |
ATE552771T1 (en) | 1999-02-25 | 2012-04-15 | Medtronic Minimed Inc | TEST PLUG AND CABLE FOR GLUCOSE MONITORING DEVICE |
US8636648B2 (en) | 1999-03-01 | 2014-01-28 | West View Research, Llc | Endoscopic smart probe |
JP2000245683A (en) | 1999-03-02 | 2000-09-12 | Toshiba Corp | Endoscope system cart |
US6179776B1 (en) | 1999-03-12 | 2001-01-30 | Scimed Life Systems, Inc. | Controllable endoscopic sheath apparatus and related method of use |
US6149535A (en) | 1999-03-12 | 2000-11-21 | Acushnet Company | Golf ball with spun elastic threads |
US6328730B1 (en) | 1999-03-26 | 2001-12-11 | William W. Harkrider, Jr. | Endoluminal multi-luminal surgical sheath and method |
US6228096B1 (en) | 1999-03-31 | 2001-05-08 | Sam R. Marchand | Instrument and method for manipulating an operating member coupled to suture material while maintaining tension on the suture material |
CA2366760A1 (en) | 1999-04-07 | 2000-10-12 | John T. Kilcoyne | Implantable monitoring probe |
US6491626B1 (en) | 1999-04-16 | 2002-12-10 | Nuvasive | Articulation systems for positioning minimally invasive surgical tools |
US6210409B1 (en) | 1999-05-03 | 2001-04-03 | Alan G. Ellman | Electrosurgical handpiece for treating tissue |
US6331158B1 (en) | 1999-05-04 | 2001-12-18 | Cardiothoracic Systems, Inc. | Surgical retractor apparatus for operating on the heart through an incision |
WO2000066017A1 (en) | 1999-05-04 | 2000-11-09 | Curon Medical, Inc. | Electrodes for creating lesions in tissue regions at or near a sphincter |
US6167297A (en) | 1999-05-05 | 2000-12-26 | Benaron; David A. | Detecting, localizing, and targeting internal sites in vivo using optical contrast agents |
DE60002059T2 (en) | 1999-05-07 | 2004-02-19 | Emmet Joseph Howard Peter Andrews | SURGICAL PLIERS |
US6673088B1 (en) | 1999-05-18 | 2004-01-06 | Cardica, Inc. | Tissue punch |
JP2000325301A (en) | 1999-05-18 | 2000-11-28 | Asahi Optical Co Ltd | Auxiliary tool for inserting endoscope in large intestine |
US6692462B2 (en) | 1999-05-19 | 2004-02-17 | Mackenzie Andrew J. | System and method for establishing vascular access |
US6214007B1 (en) | 1999-06-01 | 2001-04-10 | David G. Anderson | Surgical fastener for fixation of a soft tissue graft to a bone tunnel |
US6699256B1 (en) | 1999-06-04 | 2004-03-02 | St. Jude Medical Atg, Inc. | Medical grafting apparatus and methods |
CA2377430A1 (en) | 1999-06-15 | 2000-12-21 | Cryocath Technologies Inc. | Deflection structure |
US7813789B2 (en) | 1999-06-15 | 2010-10-12 | Given Imaging Ltd. | In-vivo imaging device, optical system and method |
US6890329B2 (en) | 1999-06-15 | 2005-05-10 | Cryocath Technologies Inc. | Defined deflection structure |
SE519023C2 (en) | 1999-06-21 | 2002-12-23 | Micromuscle Ab | Catheter-borne microsurgical tool kit |
US7637905B2 (en) | 2003-01-15 | 2009-12-29 | Usgi Medical, Inc. | Endoluminal tool deployment system |
US7416554B2 (en) | 2002-12-11 | 2008-08-26 | Usgi Medical Inc | Apparatus and methods for forming and securing gastrointestinal tissue folds |
FR2795301B1 (en) | 1999-06-25 | 2001-08-31 | Prec | ENDOSCOPIC SURGERY INSTRUMENT |
US8574243B2 (en) | 1999-06-25 | 2013-11-05 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6364867B2 (en) | 1999-07-01 | 2002-04-02 | Catheter Innovations, Inc. | Anti-clotting methods and apparatus for indwelling catheter tubes |
NL1012527C2 (en) | 1999-07-06 | 2001-01-09 | Cordis Europ | Balloon catheter with tear line. |
US6117158A (en) | 1999-07-07 | 2000-09-12 | Ethicon Endo-Surgery, Inc. | Ratchet release mechanism for hand held instruments |
US6168605B1 (en) | 1999-07-08 | 2001-01-02 | Ethicon Endo-Surgery, Inc. | Curved laparoscopic scissor having arcs of curvature |
US6387671B1 (en) | 1999-07-21 | 2002-05-14 | The Regents Of The University Of California | Electrical impedance tomography to control electroporation |
US6692445B2 (en) | 1999-07-27 | 2004-02-17 | Scimed Life Systems, Inc. | Biopsy sampler |
US6326177B1 (en) | 1999-08-04 | 2001-12-04 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Method and apparatus for intracellular electro-manipulation |
US6419639B2 (en) | 1999-08-05 | 2002-07-16 | National Institute Of Health | Laparoscopic SAC holder assembly |
US6235026B1 (en) | 1999-08-06 | 2001-05-22 | Scimed Life Systems, Inc. | Polypectomy snare instrument |
US6325534B1 (en) | 1999-08-12 | 2001-12-04 | Tarwa L. Hawley | Medication reminder |
US6246914B1 (en) | 1999-08-12 | 2001-06-12 | Irvine Biomedical, Inc. | High torque catheter and methods thereof |
US6491627B1 (en) | 1999-08-18 | 2002-12-10 | Fuji Photo Optical Co., Ltd. | Manipulation mechanism for an angle section of an endoscope |
JP3901421B2 (en) | 1999-08-19 | 2007-04-04 | 有限会社 パックス オプティカ ジャパン | Organ anastomosis device |
US6685724B1 (en) | 1999-08-24 | 2004-02-03 | The Penn State Research Foundation | Laparoscopic surgical instrument and method |
EP1235522B1 (en) | 1999-09-09 | 2007-05-30 | Tuebingen Scientific Medical GmbH | Surgical instrument for minimally invasive surgical interventions |
GB2354170A (en) | 1999-09-16 | 2001-03-21 | Minop Ltd | A tool and an effector, e.g. surgical forceps, scissors or spreader |
US6368328B1 (en) | 1999-09-16 | 2002-04-09 | Scimed Life Systems, Inc. | Laser-resistant medical retrieval device |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6258064B1 (en) | 1999-10-04 | 2001-07-10 | Syntheon, Llc | Helically advanceable endoscopic needle device |
US6491691B1 (en) | 1999-10-08 | 2002-12-10 | Intuitive Surgical, Inc. | Minimally invasive surgical hook apparatus and method for using same |
AU8015300A (en) | 1999-10-12 | 2001-04-23 | Ohio State University, The | Reactive polymeric valve, dispensing devices and methods using same |
US6409727B1 (en) | 1999-10-15 | 2002-06-25 | Scimed Life Systems, Inc. | Multifilar flexible rotary shaft and medical instruments incorporating the same |
US6749560B1 (en) | 1999-10-26 | 2004-06-15 | Circon Corporation | Endoscope shaft with slotted tube |
US6780151B2 (en) | 1999-10-26 | 2004-08-24 | Acmi Corporation | Flexible ureteropyeloscope |
US20030093104A1 (en) | 1999-10-29 | 2003-05-15 | Bonner Matthew D. | Methods and apparatus for providing intra-pericardial access |
US6402735B1 (en) | 1999-11-19 | 2002-06-11 | University Of Florida | Medical tube collar |
US6551304B1 (en) | 1999-12-01 | 2003-04-22 | Abbeymoor Medical, Inc. | Magnetic retrieval device and method of use |
US7887551B2 (en) | 1999-12-02 | 2011-02-15 | Smith & Nephew, Inc. | Soft tissue attachment and repair |
AU4512801A (en) | 1999-12-02 | 2001-06-18 | Scott Resnick | Speculum |
DK200001852A (en) | 1999-12-14 | 2001-06-15 | Asahi Optical Co Ltd | Manipulation section for an endoscopic treatment instrument |
US6428487B1 (en) | 1999-12-17 | 2002-08-06 | Ethicon Endo-Surgery, Inc. | Surgical biopsy system with remote control for selecting an operational mode |
US7842068B2 (en) | 2000-12-07 | 2010-11-30 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
CA2397147A1 (en) | 2000-01-10 | 2001-07-19 | Medivas, Llc | Flexible stabilizer arm for forcibly holding an object against a surface |
US6989028B2 (en) | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
US6458076B1 (en) | 2000-02-01 | 2002-10-01 | 5 Star Medical | Multi-lumen medical device |
SE0000372D0 (en) | 2000-02-07 | 2000-02-07 | Pacesetter Ab | Medical system |
WO2001058360A2 (en) | 2000-02-08 | 2001-08-16 | Medsource Technologies, Llc | Endoscopic tool restraint |
US6493590B1 (en) | 2000-02-09 | 2002-12-10 | Micronet Medical, Inc. | Flexible band electrodes for medical leads |
US6610074B2 (en) | 2000-02-10 | 2003-08-26 | Albert N. Santilli | Aorta cross clamp assembly |
DE10007919C2 (en) | 2000-02-21 | 2003-07-17 | Wolf Gmbh Richard | Forceps for free preparation of tissue in a body cavity |
MXPA00001922A (en) | 2000-02-24 | 2002-03-08 | De Hayos Garza Andres | Percutaneous intra-gastric balloon catheter for obesity treatment. |
US7993368B2 (en) | 2003-03-13 | 2011-08-09 | C.R. Bard, Inc. | Suture clips, delivery devices and methods |
US6613068B2 (en) | 2000-03-07 | 2003-09-02 | Pentax Corporation | Endoscopic treatment instrument |
KR100800040B1 (en) | 2000-03-08 | 2008-01-31 | 기븐 이미징 리미티드 | A capsule for in vivo imaging |
US6264664B1 (en) | 2000-03-10 | 2001-07-24 | General Science And Technology Corp. | Surgical basket devices |
JP4222706B2 (en) | 2000-03-22 | 2009-02-12 | オリンパス株式会社 | Medical instrument holding device |
AU2001249308A1 (en) | 2000-03-24 | 2001-10-15 | Johns Hopkins University | Peritoneal cavity device and method |
DE10015421C2 (en) | 2000-03-28 | 2002-07-04 | Implex Ag Hearing Technology I | Partially or fully implantable hearing system |
EP1662972A4 (en) | 2000-04-03 | 2010-08-25 | Intuitive Surgical Inc | Activated polymer articulated instruments and methods of insertion |
US6984203B2 (en) | 2000-04-03 | 2006-01-10 | Neoguide Systems, Inc. | Endoscope with adjacently positioned guiding apparatus |
US6800056B2 (en) | 2000-04-03 | 2004-10-05 | Neoguide Systems, Inc. | Endoscope with guiding apparatus |
US6837846B2 (en) | 2000-04-03 | 2005-01-04 | Neo Guide Systems, Inc. | Endoscope having a guide tube |
US6974411B2 (en) | 2000-04-03 | 2005-12-13 | Neoguide Systems, Inc. | Endoscope with single step guiding apparatus |
JP2001292107A (en) | 2000-04-06 | 2001-10-19 | Sony Corp | Reception device, transmission device and communication system |
US6485411B1 (en) | 2000-04-12 | 2002-11-26 | Circon Corporation | Endoscope shaft with superelastic alloy spiral frame and braid |
US20020107514A1 (en) | 2000-04-27 | 2002-08-08 | Hooven Michael D. | Transmural ablation device with parallel jaws |
US8518062B2 (en) | 2000-04-29 | 2013-08-27 | Medtronic, Inc. | Devices and methods for forming magnetic anastomoses between vessels |
US6569091B2 (en) | 2000-05-04 | 2003-05-27 | Ananias Diokno | Disconnectable vaginal speculum with removeable blades |
DE10023534A1 (en) | 2000-05-13 | 2001-11-22 | Aesculap Ag & Co Kg | Scissors-shaped or forceps-shaped surgical instrument |
US6869395B2 (en) | 2000-05-15 | 2005-03-22 | C. R. Bard, Inc. | Endoscopic accessory attachment mechanism |
US6709387B1 (en) | 2000-05-15 | 2004-03-23 | Given Imaging Ltd. | System and method for controlling in vivo camera capture and display rate |
US6485503B2 (en) | 2000-05-19 | 2002-11-26 | Coapt Systems, Inc. | Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device |
WO2001089596A2 (en) | 2000-05-23 | 2001-11-29 | Given Imaging Ltd. | Device for positioning object in a body lumen |
US6743239B1 (en) | 2000-05-25 | 2004-06-01 | St. Jude Medical, Inc. | Devices with a bendable tip for medical procedures |
JP4038960B2 (en) | 2000-05-31 | 2008-01-30 | 松下電工株式会社 | lighting equipment |
DE10026847A1 (en) | 2000-05-31 | 2002-01-10 | Engelbert Gmeilbauer | Tool for tensioning or releasing / opening spring clamping elements |
US6602262B2 (en) | 2000-06-02 | 2003-08-05 | Scimed Life Systems, Inc. | Medical device having linear to rotation control |
US20020023353A1 (en) | 2000-06-06 | 2002-02-28 | Wu. Ting-Kung | Surgical scissors |
US6527782B2 (en) | 2000-06-07 | 2003-03-04 | Sterotaxis, Inc. | Guide for medical devices |
AU2001268230A1 (en) | 2000-06-09 | 2001-12-24 | Fiberliner Networks | Method and apparatus for lining a conduit |
US6394979B1 (en) | 2000-06-09 | 2002-05-28 | Inviro Medical Devices Ltd. | Cannula for use with a medical syringe |
US6840246B2 (en) | 2000-06-20 | 2005-01-11 | University Of Maryland, Baltimore | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US6477426B1 (en) | 2000-06-20 | 2002-11-05 | Celsion Corporation | System and method for heating the prostate gland to treat and prevent the growth and spread of prostate tumors |
US7727242B2 (en) | 2000-06-29 | 2010-06-01 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
WO2002005865A2 (en) | 2000-07-14 | 2002-01-24 | Sub-Q, Inc. | Sheath-mounted arterial plug delivery device |
US6340344B1 (en) | 2000-07-18 | 2002-01-22 | Evergreen Medical Incorporated | Endoscope with a removable suction tube |
US6652551B1 (en) | 2000-07-21 | 2003-11-25 | Frederick W. Heiss | Biliary sphincter scissors |
AU2002224519A1 (en) | 2000-07-21 | 2002-02-05 | Atropos Limited | A surgical instrument |
US6921361B2 (en) | 2000-07-24 | 2005-07-26 | Olympus Corporation | Endoscopic instrument for forming an artificial valve |
CA2416581A1 (en) | 2000-07-25 | 2002-04-25 | Rita Medical Systems, Inc. | Apparatus for detecting and treating tumors using localized impedance measurement |
US6795728B2 (en) | 2001-08-17 | 2004-09-21 | Minnesota Medical Physics, Llc | Apparatus and method for reducing subcutaneous fat deposits by electroporation |
US6572629B2 (en) | 2000-08-17 | 2003-06-03 | Johns Hopkins University | Gastric reduction endoscopy |
GB0020263D0 (en) | 2000-08-18 | 2000-10-04 | Femcare Cyprus Ltd | Improvements in or relating to applicators |
US6551270B1 (en) | 2000-08-30 | 2003-04-22 | Snowden Pencer, Inc. | Dual lumen access port |
JP4249479B2 (en) | 2000-09-27 | 2009-04-02 | ギブン イメージング リミテッド | Immobilizable in vivo detection device |
US6638275B1 (en) | 2000-10-05 | 2003-10-28 | Medironic, Inc. | Bipolar ablation apparatus and method |
JP2002112946A (en) | 2000-10-11 | 2002-04-16 | Olympus Optical Co Ltd | Hood for endoscope |
US6554823B2 (en) | 2000-10-11 | 2003-04-29 | Medcania, Inc. | System for performing port off-pump beating heart coronary artery bypass surgery |
WO2002034122A2 (en) | 2000-10-20 | 2002-05-02 | Onux Medical, Inc. | Surgical suturing instrument and method of use |
US6500176B1 (en) | 2000-10-23 | 2002-12-31 | Csaba Truckai | Electrosurgical systems and techniques for sealing tissue |
US6645225B1 (en) | 2000-11-01 | 2003-11-11 | Alvan W. Atkinson | Method and apparatus for plugging a patent foramen ovale formed in the heart |
US6679889B1 (en) | 2000-11-13 | 2004-01-20 | Hs West Investments, Llc | Apparatus and methods for independently conditioning and pretensioning a plurality of ligament grafts during joint repair surgery |
JP2004529676A (en) | 2000-11-13 | 2004-09-30 | ダブリュ アイ ティー アイ ピー コーポレーション | Treatment catheter with insulated area |
US6638286B1 (en) | 2000-11-16 | 2003-10-28 | Vascular Control Systems, Inc. | Doppler directed suture ligation device and method |
US6419641B1 (en) | 2000-11-28 | 2002-07-16 | Promex, Llc | Flexible tip medical instrument |
US6431500B1 (en) | 2000-11-28 | 2002-08-13 | Gregory J. Jacobs | Flexible tube or cord anchoring apparatus |
US7727246B2 (en) | 2000-12-06 | 2010-06-01 | Ethicon Endo-Surgery, Inc. | Methods for endoluminal treatment |
US6716226B2 (en) | 2001-06-25 | 2004-04-06 | Inscope Development, Llc | Surgical clip |
US20020138086A1 (en) | 2000-12-06 | 2002-09-26 | Robert Sixto | Surgical clips particularly useful in the endoluminal treatment of gastroesophageal reflux disease (GERD) |
US6569085B2 (en) | 2001-08-16 | 2003-05-27 | Syntheon, Llc | Methods and apparatus for delivering a medical instrument over an endoscope while the endoscope is in a body lumen |
US7232445B2 (en) | 2000-12-06 | 2007-06-19 | Id, Llc | Apparatus for the endoluminal treatment of gastroesophageal reflux disease (GERD) |
US20020068945A1 (en) | 2000-12-06 | 2002-06-06 | Robert Sixto | Surgical clips particularly useful in the endoluminal treatment of gastroesophageal reflux disease (GERD) |
US6890343B2 (en) | 2000-12-14 | 2005-05-10 | Ensure Medical, Inc. | Plug with detachable guidewire element and methods for use |
US6896692B2 (en) | 2000-12-14 | 2005-05-24 | Ensure Medical, Inc. | Plug with collet and apparatus and method for delivering such plugs |
US6846319B2 (en) | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
US6623509B2 (en) | 2000-12-14 | 2003-09-23 | Core Medical, Inc. | Apparatus and methods for sealing vascular punctures |
US6592603B2 (en) | 2000-12-15 | 2003-07-15 | Michael Lasner | Manually adjustable scissors or forceps |
US6673087B1 (en) | 2000-12-15 | 2004-01-06 | Origin Medsystems | Elongated surgical scissors |
US6350267B1 (en) | 2000-12-21 | 2002-02-26 | Ethicon Endo-Surgery, Inc. | Method of use of an improved specimen retrieval bag |
US6406440B1 (en) | 2000-12-21 | 2002-06-18 | Ethicon Endo-Surgery, Inc. | Specimen retrieval bag |
US6840938B1 (en) | 2000-12-29 | 2005-01-11 | Intuitive Surgical, Inc. | Bipolar cauterizing instrument |
EP1363700A4 (en) | 2001-01-11 | 2005-11-09 | Rita Medical Systems Inc | Bone-treatment instrument and method |
US6837848B2 (en) | 2003-01-15 | 2005-01-04 | Medtronic, Inc. | Methods and apparatus for accessing and stabilizing an area of the heart |
US20060025781A1 (en) | 2001-01-17 | 2006-02-02 | Young Wayne P | Laparoscopic instruments and methods utilizing suction |
US7131980B1 (en) | 2001-01-18 | 2006-11-07 | Dvl Acquisitions Sub, Inc. | Surgical suturing instrument and method of use |
US6652521B2 (en) | 2001-01-24 | 2003-11-25 | Ethicon, Inc. | Surgical instrument with a bi-directional cutting element |
US6464702B2 (en) | 2001-01-24 | 2002-10-15 | Ethicon, Inc. | Electrosurgical instrument with closing tube for conducting RF energy and moving jaws |
US6443970B1 (en) | 2001-01-24 | 2002-09-03 | Ethicon, Inc. | Surgical instrument with a dissecting tip |
US6554829B2 (en) | 2001-01-24 | 2003-04-29 | Ethicon, Inc. | Electrosurgical instrument with minimally invasive jaws |
US7105005B2 (en) | 2001-01-29 | 2006-09-12 | Scanlan International, Inc. | Arteriotomy scissors for minimally invasive surgical procedures |
JP4624572B2 (en) | 2001-01-30 | 2011-02-02 | オリンパス株式会社 | Endoscope |
US6997931B2 (en) | 2001-02-02 | 2006-02-14 | Lsi Solutions, Inc. | System for endoscopic suturing |
US8313496B2 (en) | 2001-02-02 | 2012-11-20 | Lsi Solutions, Inc. | System for endoscopic suturing |
JP2002224124A (en) | 2001-02-06 | 2002-08-13 | Olympus Optical Co Ltd | Ligating device |
JP3939158B2 (en) | 2001-02-06 | 2007-07-04 | オリンパス株式会社 | Endoscope device |
US6743226B2 (en) | 2001-02-09 | 2004-06-01 | Cosman Company, Inc. | Adjustable trans-urethral radio-frequency ablation |
US7699835B2 (en) | 2001-02-15 | 2010-04-20 | Hansen Medical, Inc. | Robotically controlled surgical instruments |
US20030135204A1 (en) | 2001-02-15 | 2003-07-17 | Endo Via Medical, Inc. | Robotically controlled medical instrument with a flexible section |
US7842050B2 (en) | 2001-02-26 | 2010-11-30 | Diduch David R | Suture passing devices |
JP3905320B2 (en) | 2001-02-28 | 2007-04-18 | オリンパス株式会社 | Endoscopic high-temperature high-pressure steam sterilization container and endoscope cleaning and sterilization system |
US20020133115A1 (en) | 2001-03-13 | 2002-09-19 | Pharmaspec Corporation | Apparatus and methods for capture of medical agents |
US6623448B2 (en) | 2001-03-30 | 2003-09-23 | Advanced Cardiovascular Systems, Inc. | Steerable drug delivery device |
US20030181900A1 (en) | 2002-03-25 | 2003-09-25 | Long Gary L. | Endoscopic ablation system with a plurality of electrodes |
EP1418845A4 (en) | 2001-04-04 | 2006-06-07 | Given Imaging Ltd | Induction powered in vivo imaging device |
EP1248177B1 (en) | 2001-04-05 | 2007-12-05 | Alps Electric Co., Ltd. | Fitting structure for knobs |
WO2002082154A1 (en) | 2001-04-05 | 2002-10-17 | Scalar Corporation | Camera and unit for camera |
US7118587B2 (en) | 2001-04-06 | 2006-10-10 | Sherwood Services Ag | Vessel sealer and divider |
US7101371B2 (en) | 2001-04-06 | 2006-09-05 | Dycus Sean T | Vessel sealer and divider |
US7101373B2 (en) | 2001-04-06 | 2006-09-05 | Sherwood Services Ag | Vessel sealer and divider |
US7090673B2 (en) | 2001-04-06 | 2006-08-15 | Sherwood Services Ag | Vessel sealer and divider |
US7083618B2 (en) | 2001-04-06 | 2006-08-01 | Sherwood Services Ag | Vessel sealer and divider |
US7101372B2 (en) | 2001-04-06 | 2006-09-05 | Sherwood Sevices Ag | Vessel sealer and divider |
US6562035B1 (en) | 2001-04-19 | 2003-05-13 | Levin John M | Insulated surgical scissors including cauterizing tip |
US6994708B2 (en) | 2001-04-19 | 2006-02-07 | Intuitive Surgical | Robotic tool with monopolar electro-surgical scissors |
US20060069429A1 (en) | 2001-04-24 | 2006-03-30 | Spence Paul A | Tissue fastening systems and methods utilizing magnetic guidance |
US7422579B2 (en) | 2001-05-01 | 2008-09-09 | St. Jude Medical Cardiology Divison, Inc. | Emboli protection devices and related methods of use |
US7020531B1 (en) | 2001-05-01 | 2006-03-28 | Intrapace, Inc. | Gastric device and suction assisted method for implanting a device on a stomach wall |
US20080065169A1 (en) | 2001-05-01 | 2008-03-13 | Intrapace, Inc. | Endoscopic Instrument for Engaging a Device |
US6535764B2 (en) | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
US6685715B2 (en) | 2001-05-02 | 2004-02-03 | Novare Surgical Systems | Clamp having bendable shaft |
CN100518685C (en) | 2001-05-10 | 2009-07-29 | 脉管动力股份有限公司 | RF tissue ablation apparatus and method |
US6575988B2 (en) | 2001-05-15 | 2003-06-10 | Ethicon, Inc. | Deployment apparatus for supple surgical materials |
US6814739B2 (en) | 2001-05-18 | 2004-11-09 | U.S. Endoscopy Group, Inc. | Retrieval device |
US6808491B2 (en) | 2001-05-21 | 2004-10-26 | Syntheon, Llc | Methods and apparatus for on-endoscope instruments having end effectors and combinations of on-endoscope and through-endoscope instruments |
US7083629B2 (en) | 2001-05-30 | 2006-08-01 | Satiety, Inc. | Overtube apparatus for insertion into a body |
US7560006B2 (en) | 2001-06-11 | 2009-07-14 | Boston Scientific Scimed, Inc. | Pressure lamination method for forming composite ePTFE/textile and ePTFE/stent/textile prostheses |
JP2002369791A (en) | 2001-06-14 | 2002-12-24 | Pentax Corp | Endoscopic system and insertion assist instrument for endoscope |
US6673058B2 (en) | 2001-06-20 | 2004-01-06 | Scimed Life Systems, Inc. | Temporary dilating tip for gastro-intestinal tubes |
US7090685B2 (en) | 2001-06-25 | 2006-08-15 | Ethicon Endo-Surgery, Inc. | Surgical tool having a distal ratchet mechanism |
US7727248B2 (en) | 2001-06-25 | 2010-06-01 | Ethicon Endo-Surgery, Inc. | Surgical clip |
US8241309B2 (en) | 2001-06-29 | 2012-08-14 | World Heart Corporation | Cannulation apparatus and method |
US6409733B1 (en) | 2001-06-29 | 2002-06-25 | Ethicon Endo-Surgery, Inc. | Specimen retrieval bag |
US6817974B2 (en) | 2001-06-29 | 2004-11-16 | Intuitive Surgical, Inc. | Surgical tool having positively positionable tendon-actuated multi-disk wrist joint |
US6383197B1 (en) | 2001-06-29 | 2002-05-07 | Ethicon Endo-Surgery, Inc. | Self disengaging anti-backup mechanism for specimen retrieval bag deployment |
JP4744026B2 (en) | 2001-07-30 | 2011-08-10 | オリンパス株式会社 | Capsule endoscope and capsule endoscope system |
US6951536B2 (en) | 2001-07-30 | 2005-10-04 | Olympus Corporation | Capsule-type medical device and medical system |
EP1281356A3 (en) | 2001-08-03 | 2003-08-13 | Terumo Kabushiki Kaisha | Blood vessel connecting instrument |
AT411144B (en) | 2001-08-03 | 2003-10-27 | Ami Gmbh | MEDICAL INSTRUMENT FOR INTRODUCING SURGICAL IMPLANTS |
DE10138356A1 (en) | 2001-08-04 | 2003-02-27 | Aesculap Ag & Co Kg | Scissors, in particular for surgical purposes |
WO2003013374A1 (en) | 2001-08-06 | 2003-02-20 | Penn State Research Foundation | Multifunctional tool and method for minimally invasive surgery |
US7112208B2 (en) | 2001-08-06 | 2006-09-26 | Morris John K | Compact suture punch with malleable needle |
US20040249394A1 (en) | 2001-08-06 | 2004-12-09 | Arthrex, Inc. | Compact suture punch with malleable needle |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US7130697B2 (en) | 2002-08-13 | 2006-10-31 | Minnesota Medical Physics Llc | Apparatus and method for the treatment of benign prostatic hyperplasia |
US20040249443A1 (en) | 2001-08-20 | 2004-12-09 | Shanley John F. | Expandable medical device for treating cardiac arrhythmias |
US6719764B1 (en) | 2001-08-24 | 2004-04-13 | Scimed Life Systems, Inc. | Forward deploying suturing device and methods of use |
US6945472B2 (en) | 2001-09-04 | 2005-09-20 | Boehringer Ingelheim International Gmbh | Locking-stressing mechanism for a miniaturised high pressuriser |
US6761718B2 (en) | 2001-09-06 | 2004-07-13 | Children's Medical Center Corp. | Direction-oriented and spatially controlled bipolar coagulator for in-situ cauterization of adherent cranial tissue occluding a ventricular catheter previously implanted in-vivo |
US20030050603A1 (en) | 2001-09-12 | 2003-03-13 | Todd Erik F. | Cannula that provides bi-directional fluid flow that is regulated by a single valve |
US6743228B2 (en) | 2001-09-12 | 2004-06-01 | Manoa Medical, Inc. | Devices and methods for tissue severing and removal |
US6489745B1 (en) | 2001-09-13 | 2002-12-03 | The Boeing Company | Contactless power supply |
ATE398969T1 (en) | 2001-09-17 | 2008-07-15 | Hydrocision Inc | SURGICAL ROTATING ABRASION DEVICE |
US6773434B2 (en) | 2001-09-18 | 2004-08-10 | Ethicon, Inc. | Combination bipolar forceps and scissors instrument |
JP2003088494A (en) | 2001-09-19 | 2003-03-25 | Pentax Corp | Flexibility varying device for flexible tube part of endoscope |
US6587750B2 (en) | 2001-09-25 | 2003-07-01 | Intuitive Surgical, Inc. | Removable infinite roll master grip handle and touch sensor for robotic surgery |
JP5073895B2 (en) | 2001-09-25 | 2012-11-14 | オリンパス株式会社 | Endoscopic treatment tool |
DE10147145C2 (en) | 2001-09-25 | 2003-12-18 | Kunz Reiner | Multi-function instrument for micro-invasive surgery |
JP2003116772A (en) | 2001-10-18 | 2003-04-22 | Olympus Optical Co Ltd | Endoscope instrument and hood member for endoscope |
US6652518B2 (en) | 2001-09-28 | 2003-11-25 | Ethicon, Inc. | Transmural ablation tool and method |
US6776787B2 (en) | 2001-10-05 | 2004-08-17 | Trinh D. Phung | Surgical punch device |
US6866669B2 (en) | 2001-10-12 | 2005-03-15 | Cordis Corporation | Locking handle deployment mechanism for medical device and method |
US20030078471A1 (en) | 2001-10-18 | 2003-04-24 | Foley Frederick J. | Manipulation of an organ |
US20030124009A1 (en) | 2001-10-23 | 2003-07-03 | Ravi Vilupanur A. | Hydrophilic polymer actuators |
US6592594B2 (en) | 2001-10-25 | 2003-07-15 | Spiration, Inc. | Bronchial obstruction device deployment system and method |
WO2003051286A2 (en) | 2001-11-01 | 2003-06-26 | Regents Of The University Of Minnesota | Hydrogel compositions, devices, and microscale components |
GB2369797B (en) | 2001-11-20 | 2002-11-06 | Tayside Flow Technologies Ltd | Helical formations in tubes |
CA2363473C (en) | 2001-11-20 | 2010-10-19 | Marc G. Morin | Anoscope |
US6830578B2 (en) | 2001-11-26 | 2004-12-14 | Neosurg Technologies, Inc. | Trocar |
AU2002360540A1 (en) | 2001-12-04 | 2003-06-17 | University Of Southern California | Method for intracellular modifications within living cells using pulsed electric fields |
US6706018B2 (en) | 2001-12-04 | 2004-03-16 | Cardiac Pacemakers, Inc. | Adjustable length catheter assembly |
US7542807B2 (en) | 2001-12-04 | 2009-06-02 | Endoscopic Technologies, Inc. | Conduction block verification probe and method of use |
US7367939B2 (en) | 2004-06-14 | 2008-05-06 | Ethicon Endo-Surgery, Inc. | Rotational, translational and torqueing control members for an endoscopic instrument |
US20040193186A1 (en) | 2003-03-25 | 2004-09-30 | Kortenbach Juergen A. | Flexible housing element for a surgical tool |
US7131978B2 (en) | 2001-12-11 | 2006-11-07 | Dvl Acquisition Sub, Inc. | Surgical suturing instrument and method of use |
US20030114731A1 (en) | 2001-12-14 | 2003-06-19 | Cadeddu Jeffrey A. | Magnetic positioning system for trocarless laparoscopic instruments |
US7029450B2 (en) | 2001-12-14 | 2006-04-18 | Boston Scientific Scimed, Inc. | Dilation catheter assembly and related methods |
US20030114732A1 (en) | 2001-12-18 | 2003-06-19 | Advanced Cardiovascular Systems, Inc. | Sheath for guiding imaging instruments |
US6908476B2 (en) | 2001-12-21 | 2005-06-21 | Alcon Grieshaber Ag | Micro surgical cutting instrument configured as scissors |
US6814743B2 (en) | 2001-12-26 | 2004-11-09 | Origin Medsystems, Inc. | Temporary seal and method for facilitating anastomosis |
IL147324A0 (en) | 2001-12-26 | 2002-08-14 | Sergey Popov | Minimally invasive device |
US6961602B2 (en) | 2001-12-31 | 2005-11-01 | Biosense Webster, Inc. | Catheter having multiple spines each having electrical mapping and location sensing capabilities |
US6695791B2 (en) | 2002-01-04 | 2004-02-24 | Spiration, Inc. | System and method for capturing body tissue samples |
US6740030B2 (en) | 2002-01-04 | 2004-05-25 | Vision Sciences, Inc. | Endoscope assemblies having working channels with reduced bending and stretching resistance |
US7150750B2 (en) | 2002-01-10 | 2006-12-19 | Boston Scientific Scimed, Inc. | Method and device for endoscopic suturing |
US6878110B2 (en) | 2002-01-14 | 2005-04-12 | Seung Choul Yang | Surgical instruments and method for creating anatomic working space in minilaparotomy procedure |
US20030139646A1 (en) | 2002-01-23 | 2003-07-24 | Sharrow James S. | Devices and methods for manipulation of organ tissue |
US6752822B2 (en) | 2002-01-23 | 2004-06-22 | Chris A. Jespersen | Body tissue retrievel bag arrangement |
US6749609B1 (en) | 2002-02-05 | 2004-06-15 | Origin Medsystems, Inc. | Electrocautery scissors |
JP3826045B2 (en) | 2002-02-07 | 2006-09-27 | オリンパス株式会社 | Endoscope hood |
AU2003215263A1 (en) | 2002-02-13 | 2003-09-04 | Arthrocare Corporation | Electrosurgical apparatus and methods for treating joint tissue |
US7494499B2 (en) | 2002-02-15 | 2009-02-24 | Olympus Corporation | Surgical therapeutic instrument |
JP3893065B2 (en) | 2002-02-15 | 2007-03-14 | 有限会社 パックス オプティカ ジャパン | Organ anastomosis device |
US6736822B2 (en) | 2002-02-20 | 2004-05-18 | Mcclellan Scott B. | Device and method for internal ligation of tubular structures |
US20030158521A1 (en) | 2002-02-21 | 2003-08-21 | Ameri Darius M. | Trocar placement guide needle |
US20050215858A1 (en) | 2002-03-07 | 2005-09-29 | Vail William B Iii | Tubular personal pelvic viewers |
US8723936B2 (en) | 2002-03-12 | 2014-05-13 | Karl Storz Imaging, Inc. | Wireless camera coupling with rotatable coupling |
US6921408B2 (en) | 2002-03-12 | 2005-07-26 | Lsi Solutions, Inc. | Apparatus for sewing tissue and method of use |
US7060025B2 (en) | 2002-03-15 | 2006-06-13 | Ethicon Endo-Surgery, Inc. | Method for controlling position of medical instruments |
GB0206208D0 (en) | 2002-03-15 | 2002-05-01 | Gyrus Medical Ltd | A surgical instrument |
US7060024B2 (en) | 2002-03-15 | 2006-06-13 | Ethicon Endo-Surgery, Inc. | Apparatus for guiding an instrument used with an endoscope |
US7261728B2 (en) | 2002-03-15 | 2007-08-28 | Ethicon Endo-Surgery, Inc. | Biopsy forceps device and method |
US6988987B2 (en) | 2002-03-18 | 2006-01-24 | Olympus Corporation | Guide tube |
JP4351458B2 (en) | 2002-03-18 | 2009-10-28 | オリンパス株式会社 | Endoscope insertion system |
AU2003224714A1 (en) | 2002-03-21 | 2003-10-08 | The Regents Of The University Of California | Conducting polymer activators based on microporous asymmetric membranes |
JP3869291B2 (en) | 2002-03-25 | 2007-01-17 | オリンパス株式会社 | Capsule medical device |
US7137981B2 (en) | 2002-03-25 | 2006-11-21 | Ethicon Endo-Surgery, Inc. | Endoscopic ablation system with a distally mounted image sensor |
US7588585B2 (en) | 2002-03-26 | 2009-09-15 | Novare Surgical Systems, Inc. | Handleless clamping device |
WO2003082122A1 (en) | 2002-03-27 | 2003-10-09 | Tyco Healthcare Group Lp | Minimally invasive removal device with breakaway sheath |
US6926725B2 (en) | 2002-04-04 | 2005-08-09 | Rex Medical, L.P. | Thrombectomy device with multi-layered rotational wire |
US6858014B2 (en) | 2002-04-05 | 2005-02-22 | Scimed Life Systems, Inc. | Multiple biopsy device |
US6699263B2 (en) | 2002-04-05 | 2004-03-02 | Cook Incorporated | Sliding suture anchor |
US8131371B2 (en) * | 2002-04-08 | 2012-03-06 | Ardian, Inc. | Methods and apparatus for monopolar renal neuromodulation |
US7146984B2 (en) | 2002-04-08 | 2006-12-12 | Synecor, Llc | Method and apparatus for modifying the exit orifice of a satiation pouch |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8774913B2 (en) | 2002-04-08 | 2014-07-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravasculary-induced neuromodulation |
JP4131011B2 (en) | 2002-04-09 | 2008-08-13 | Hoya株式会社 | Endoscopic sputum treatment device |
JP3930757B2 (en) | 2002-04-10 | 2007-06-13 | 有限会社 パックス オプティカ ジャパン | Organ anastomosis device |
US6866628B2 (en) | 2002-04-11 | 2005-03-15 | Medtronic, Inc. | Apparatus for temporarily engaging body tissue |
US7648515B2 (en) | 2002-04-16 | 2010-01-19 | Tyco Healthcare Group Lp | Method and apparatus for anastomosis including an expandable anchor |
US6887255B2 (en) | 2002-04-19 | 2005-05-03 | Peter Shimm | Laparoscopic specimen extraction port |
US7485093B2 (en) | 2002-04-25 | 2009-02-03 | Given Imaging Ltd. | Device and method for in-vivo sensing |
US6939327B2 (en) | 2002-05-07 | 2005-09-06 | Cardiac Pacemakers, Inc. | Peel-away sheath |
US7632250B2 (en) | 2002-05-10 | 2009-12-15 | Tyco Healthcare Group Lp | Introducer seal assembly |
US6830545B2 (en) | 2002-05-13 | 2004-12-14 | Everest Vit | Tube gripper integral with controller for endoscope of borescope |
US6685628B2 (en) | 2002-05-15 | 2004-02-03 | Dinh Q. Vu | Endoscopic balloon for spill-proof laparoscopic ovarian cystectomy |
JP3831683B2 (en) | 2002-05-16 | 2006-10-11 | ペンタックス株式会社 | Bending prevention of flexible tube insertion part of endoscope with outer sheath |
JP2005525866A (en) | 2002-05-17 | 2005-09-02 | オーナックス・メディカル・インコーポレーテッド | Surgical suture instrument and method of use thereof |
US6852078B2 (en) | 2002-05-22 | 2005-02-08 | Pentax Corporation | Outer sheathed endoscope |
US7250027B2 (en) | 2002-05-30 | 2007-07-31 | Karl Storz Endovision, Inc. | Articulating vertebrae with asymmetrical and variable radius of curvature |
US6543456B1 (en) | 2002-05-31 | 2003-04-08 | Ethicon Endo-Surgery, Inc. | Method for minimally invasive surgery in the digestive system |
JP2004000336A (en) | 2002-05-31 | 2004-01-08 | Olympus Corp | Ultrasonic treatment apparatus |
JP4808961B2 (en) | 2002-06-04 | 2011-11-02 | オフィス オブ テクノロジー ライセンシング スタンフォード ユニバーシティ | Device for rapidly aspirating and collecting body tissue from an encapsulated body space |
US20030229269A1 (en) | 2002-06-05 | 2003-12-11 | Humphrey Robert N. | Scope sleeve |
ES2317360T3 (en) | 2002-06-06 | 2009-04-16 | Covidien Ag | BIPOLAR LAPAROSCOPIC ELECTRO-SURGICAL INSTRUMENT. |
US20030229273A1 (en) | 2002-06-06 | 2003-12-11 | Mulac Anthony J. | Universal scissors joint apparatus |
US20030229371A1 (en) | 2002-06-10 | 2003-12-11 | Whitworth Warren A. | Offset surgical scissors |
US6837847B2 (en) | 2002-06-13 | 2005-01-04 | Usgi Medical, Inc. | Shape lockable apparatus and method for advancing an instrument through unsupported anatomy |
US20050137455A1 (en) | 2002-06-13 | 2005-06-23 | Usgi Medical Corp. | Shape lockable apparatus and method for advancing an instrument through unsupported anatomy |
US7041052B2 (en) | 2002-06-13 | 2006-05-09 | Usgi Medical Inc. | Shape lockable apparatus and method for advancing an instrument through unsupported anatomy |
US20060058582A1 (en) | 2002-06-13 | 2006-03-16 | Usgi Medical Inc. | Disposable shapelocking system |
CA2489401C (en) | 2002-06-18 | 2011-01-25 | Andrew J. Bilsbury | Tissue removal device |
DE60333012D1 (en) | 2002-06-20 | 2010-07-29 | Tyco Healthcare | DEVICE FOR ANASTOMOSIS WITH AN ANCHORING SLEEVE |
US20040002683A1 (en) | 2002-06-26 | 2004-01-01 | Nicholson Thomas J. | Percutaneous medical insertion device |
US7288075B2 (en) | 2002-06-27 | 2007-10-30 | Ethicon, Inc. | Methods and devices utilizing rheological materials |
US6932834B2 (en) | 2002-06-27 | 2005-08-23 | Ethicon, Inc. | Suture anchor |
US6881213B2 (en) | 2002-06-28 | 2005-04-19 | Ethicon, Inc. | Device and method to expand treatment array |
US20050228406A1 (en) | 2002-07-03 | 2005-10-13 | Bose Ganendra C | Formation of knots |
JP2004033525A (en) | 2002-07-04 | 2004-02-05 | Fuji Photo Optical Co Ltd | Hardness variable treatment instrument |
JP4373146B2 (en) | 2002-07-11 | 2009-11-25 | オリンパス株式会社 | Endoscopic suturing device |
AU2003249036A1 (en) | 2002-07-12 | 2004-02-02 | Cook Urological, Inc. | Flexible cannula shaft |
US6976992B2 (en) | 2002-07-16 | 2005-12-20 | Suturecut, Llc | Dual-function medical instrument |
US7294139B1 (en) | 2002-07-26 | 2007-11-13 | C.M. Wright, Inc. | Controlled - motion endoscopic grasping instrument |
US20040210245A1 (en) | 2002-07-26 | 2004-10-21 | John Erickson | Bendable needle with removable stylet |
CN1678239A (en) | 2002-08-01 | 2005-10-05 | 约翰霍普金斯大学 | Techniques for identifying molecular structures and treating cell types lining a body lumen using fluorescence |
JP4172966B2 (en) | 2002-08-08 | 2008-10-29 | Hoya株式会社 | Endoscope hardness variable sheath adapter |
NL1021295C2 (en) | 2002-08-19 | 2004-02-20 | Monti Ind B V | Container, especially for foodstuffs, can be torn along line of weakness using tab to separate it into different parts |
EP1542577B1 (en) | 2002-09-06 | 2016-05-25 | C.R. Bard, Inc. | Endoscopic accessory mounting adaptor |
US7188627B2 (en) | 2002-09-06 | 2007-03-13 | Apneon, Inc. | Magnetic force devices, systems, and methods for resisting tissue collapse within the pharyngeal conduit |
US8298161B2 (en) | 2002-09-12 | 2012-10-30 | Intuitive Surgical Operations, Inc. | Shape-transferring cannula system and method of use |
US7947000B2 (en) | 2003-09-12 | 2011-05-24 | Intuitive Surgical Operations, Inc. | Cannula system for free-space navigation and method of use |
WO2004026105A2 (en) | 2002-09-18 | 2004-04-01 | The Board Of Trustees Of The Leland Stanford Junior University | Tubular compliant mechanisms for ultrasonic imaging systems |
US6966919B2 (en) | 2002-09-20 | 2005-11-22 | Id, Llc | Instrument for applying a surgical fastener particularly for the transoral treatment of gastroesophageal reflux disease (GERD) |
US7118531B2 (en) | 2002-09-24 | 2006-10-10 | The Johns Hopkins University | Ingestible medical payload carrying capsule with wireless communication |
US6944490B1 (en) | 2002-09-25 | 2005-09-13 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for positioning and delivering a therapeutic tool to the inside of a heart |
ATE353235T1 (en) | 2002-09-27 | 2007-02-15 | Nucletron Bv | DEVICE FOR RADIATION TREATMENT OF PROLIFERATIVE TISSUE BOUNDARY TO A BODY CAVITY |
ES2337248T3 (en) | 2002-10-04 | 2010-04-22 | Tyco Healthcare Group Lp | TOOL ASSEMBLY FOR A SURGICAL STAPLING DEVICE. |
JP3791916B2 (en) | 2002-10-11 | 2006-06-28 | オリンパス株式会社 | End hood member for endoscope |
US6958035B2 (en) | 2002-10-15 | 2005-10-25 | Dusa Pharmaceuticals, Inc | Medical device sheath apparatus and method of making and using same |
US20040092970A1 (en) | 2002-10-18 | 2004-05-13 | Xavier Alfredo F. | Prosthetic mesh anchor device |
US6960209B2 (en) | 2002-10-23 | 2005-11-01 | Medtronic, Inc. | Electrosurgical methods and apparatus for making precise incisions in body vessels |
WO2004037149A1 (en) | 2002-10-23 | 2004-05-06 | Tcam Technologies, Inc. | Smart decubitus mat |
US6861250B1 (en) | 2002-10-25 | 2005-03-01 | Pmt Corporation | Tissue dissecting board assembly |
US6936003B2 (en) | 2002-10-29 | 2005-08-30 | Given Imaging Ltd | In-vivo extendable element device and system, and method of use |
US7083620B2 (en) | 2002-10-30 | 2006-08-01 | Medtronic, Inc. | Electrosurgical hemostat |
US6656194B1 (en) | 2002-11-05 | 2003-12-02 | Satiety, Inc. | Magnetic anchoring devices |
JP4187508B2 (en) | 2002-11-12 | 2008-11-26 | フジノン株式会社 | Electronic endoscope device |
US20050004515A1 (en) | 2002-11-15 | 2005-01-06 | Hart Charles C. | Steerable kink resistant sheath |
US7211092B2 (en) | 2002-11-19 | 2007-05-01 | Pilling Weck Incorporated | Automated-feed surgical clip applier and related methods |
JP2004173850A (en) | 2002-11-26 | 2004-06-24 | Olympus Corp | Transporter for steam sterilization |
JP4098613B2 (en) | 2002-12-11 | 2008-06-11 | 朝日インテック株式会社 | Hollow stranded wire coil body, medical instrument using the same, and manufacturing method thereof |
US7037290B2 (en) | 2002-12-16 | 2006-05-02 | Medtronic, Inc. | Multi-lumen steerable catheter |
US20040115164A1 (en) | 2002-12-17 | 2004-06-17 | Pierce Ryan K. | Soft filament occlusive device delivery system |
US6969381B2 (en) | 2002-12-18 | 2005-11-29 | Medical Components, Inc. | Multi-lumen catheter with detachable locking hub |
TW589170B (en) | 2002-12-25 | 2004-06-01 | De-Yang Tian | Endoscopic device |
US6908427B2 (en) | 2002-12-30 | 2005-06-21 | PARÉ Surgical, Inc. | Flexible endoscope capsule |
US6869398B2 (en) | 2003-01-06 | 2005-03-22 | Theodore G. Obenchain | Four-blade surgical speculum |
US20040186350A1 (en) | 2003-01-13 | 2004-09-23 | Usgi Medical Corp. | Apparatus and methods for guiding an endoscope via a rigidizable wire guide |
US20040136779A1 (en) | 2003-01-13 | 2004-07-15 | Vishal Bhaskar | Connector |
US20040249367A1 (en) | 2003-01-15 | 2004-12-09 | Usgi Medical Corp. | Endoluminal tool deployment system |
US20040138587A1 (en) | 2003-01-15 | 2004-07-15 | Lyons William Lawrence | Specimen collection instrument with inflatable bag |
JP2004219329A (en) | 2003-01-16 | 2004-08-05 | Ntt Docomo Inc | Method, system and instrument for measuring position, and in-vivo wireless device |
US20040225186A1 (en) | 2003-01-29 | 2004-11-11 | Horne Guy E. | Composite flexible endoscope insertion shaft with tubular substructure |
JP4197965B2 (en) | 2003-01-31 | 2008-12-17 | オリンパス株式会社 | High frequency snare and medical equipment |
US7476237B2 (en) | 2003-02-27 | 2009-01-13 | Olympus Corporation | Surgical instrument |
US20040176699A1 (en) | 2003-03-03 | 2004-09-09 | Volcano Therapeutics, Inc. | Thermography catheter with improved wall contact |
JP4414662B2 (en) | 2003-03-03 | 2010-02-10 | オリンパス株式会社 | Closely wound coil and medical treatment tool using the closely wound coil |
EP3222218A1 (en) | 2003-03-17 | 2017-09-27 | Covidien LP | Endoscopic tissue removal apparatus and method |
US9486241B2 (en) | 2003-03-21 | 2016-11-08 | Ethicon Endo-Surgery, Llc | Trocar seal assembly |
US20040193189A1 (en) | 2003-03-25 | 2004-09-30 | Kortenbach Juergen A. | Passive surgical clip |
US20060041188A1 (en) | 2003-03-25 | 2006-02-23 | Dirusso Carlo A | Flexible endoscope |
US7105000B2 (en) | 2003-03-25 | 2006-09-12 | Ethicon Endo-Surgery, Inc. | Surgical jaw assembly with increased mechanical advantage |
US20040193188A1 (en) | 2003-03-25 | 2004-09-30 | Inscope Development, Llc | Laminated surgical clip |
US7972330B2 (en) | 2003-03-27 | 2011-07-05 | Terumo Kabushiki Kaisha | Methods and apparatus for closing a layered tissue defect |
US7001369B2 (en) | 2003-03-27 | 2006-02-21 | Scimed Life Systems, Inc. | Medical device |
US7922739B2 (en) | 2003-03-28 | 2011-04-12 | Downey Earl C | Surgical instrument with trigger control |
DE10324844A1 (en) | 2003-04-01 | 2004-12-23 | Tuebingen Scientific Surgical Products Gmbh | Surgical instrument with instrument handle and zero point adjustment |
US20040199052A1 (en) | 2003-04-01 | 2004-10-07 | Scimed Life Systems, Inc. | Endoscopic imaging system |
US7591783B2 (en) | 2003-04-01 | 2009-09-22 | Boston Scientific Scimed, Inc. | Articulation joint for video endoscope |
US7008375B2 (en) | 2003-04-03 | 2006-03-07 | Surgical Solutions Llc | Articulating shaft |
GB0307826D0 (en) | 2003-04-04 | 2003-05-07 | Univ London | A device for transfixing and joining tissue |
US20040199192A1 (en) | 2003-04-04 | 2004-10-07 | Takayuki Akahoshi | Phacoemulsification needle |
US20040206859A1 (en) | 2003-04-17 | 2004-10-21 | Chong Ian M. | Apparatuses, systems, and methods for positioning a powered tool |
CA2522865C (en) | 2003-04-22 | 2015-11-24 | Jorge A. Campos | System, apparatus, and method for viewing a visually obscured portion of a cavity |
US20040254572A1 (en) | 2003-04-25 | 2004-12-16 | Mcintyre Jon T. | Self anchoring radio frequency ablation array |
JP2004350938A (en) | 2003-05-29 | 2004-12-16 | Olympus Corp | Forceps for endoscope |
US20050143690A1 (en) | 2003-05-01 | 2005-06-30 | High Kenneth A. | Cystotomy catheter capture device and methods of using same |
JP4391762B2 (en) | 2003-05-08 | 2009-12-24 | オリンパス株式会社 | Surgical instrument |
JP4610563B2 (en) | 2003-05-08 | 2011-01-12 | タイコ ヘルスケア グループ リミテッド パートナーシップ | Balloon dissection instrument with balloon tip cannula |
US7615005B2 (en) | 2003-05-16 | 2009-11-10 | Ethicon Endo-Surgery, Inc. | Medical apparatus for use with an endoscope |
JP4565218B2 (en) | 2003-05-16 | 2010-10-20 | シー・アール・バード・インク | Single intubation multiple-time suture endoscopic suture system |
US7815565B2 (en) | 2003-05-16 | 2010-10-19 | Ethicon Endo-Surgery, Inc. | Endcap for use with an endoscope |
US7615003B2 (en) | 2005-05-13 | 2009-11-10 | Ethicon Endo-Surgery, Inc. | Track for medical devices |
US6978921B2 (en) | 2003-05-20 | 2005-12-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument incorporating an E-beam firing mechanism |
US7410483B2 (en) | 2003-05-23 | 2008-08-12 | Novare Surgical Systems, Inc. | Hand-actuated device for remote manipulation of a grasping tool |
US7413563B2 (en) | 2003-05-27 | 2008-08-19 | Cardia, Inc. | Flexible medical device |
JP3854946B2 (en) | 2003-05-30 | 2006-12-06 | オリンパス株式会社 | Endoscope |
DE10325225B4 (en) | 2003-06-04 | 2006-11-16 | Leica Microsystems Semiconductor Gmbh | system Cabinets |
US6967462B1 (en) | 2003-06-05 | 2005-11-22 | Nasa Glenn Research Center | Charging of devices by microwave power beaming |
JP4145200B2 (en) | 2003-06-06 | 2008-09-03 | オリンパス株式会社 | Suture device |
EP1643906A2 (en) | 2003-06-12 | 2006-04-12 | University of Utah Research Foundation | Apparatus, systems and methods for diagnosing carpal tunnel syndrome |
US7150097B2 (en) | 2003-06-13 | 2006-12-19 | Sherwood Services Ag | Method of manufacturing jaw assembly for vessel sealer and divider |
US7561916B2 (en) | 2005-06-24 | 2009-07-14 | Ethicon Endo-Surgery, Inc. | Implantable medical device with indicator |
US7850660B2 (en) | 2003-12-19 | 2010-12-14 | Ethicon Endo-Surgery, Inc. | Implantable medical device with simultaneous attachment mechanism and method |
US7862546B2 (en) | 2003-06-16 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Subcutaneous self attaching injection port with integral moveable retention members |
US20040260337A1 (en) | 2003-06-18 | 2004-12-23 | Scimed Life Systems, Inc. | Endoscopic instruments and methods of manufacture |
US8469993B2 (en) | 2003-06-18 | 2013-06-25 | Boston Scientific Scimed, Inc. | Endoscopic instruments |
US6918871B2 (en) | 2003-06-19 | 2005-07-19 | Ethicon Endo-Surgery, Inc. | Method for accessing cavity |
DE10328512A1 (en) | 2003-06-20 | 2005-01-13 | Aesculap Ag & Co. Kg | Surgical instrument |
JP4398184B2 (en) | 2003-06-24 | 2010-01-13 | オリンパス株式会社 | Endoscope |
GB0315479D0 (en) | 2003-07-02 | 2003-08-06 | Paz Adrian | Virtual ports devices |
JP4266738B2 (en) | 2003-07-02 | 2009-05-20 | オリンパス株式会社 | Ligation device |
US6786382B1 (en) | 2003-07-09 | 2004-09-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument incorporating an articulation joint for a firing bar track |
US7066879B2 (en) | 2003-07-15 | 2006-06-27 | The Trustees Of Columbia University In The City Of New York | Insertable device and system for minimal access procedure |
US8684967B2 (en) | 2003-07-15 | 2014-04-01 | Medtronic, Inc. | Kink resistant cannula having buckle resistant apertures |
US8308682B2 (en) | 2003-07-18 | 2012-11-13 | Broncus Medical Inc. | Devices for maintaining patency of surgically created channels in tissue |
US7291127B2 (en) | 2003-07-28 | 2007-11-06 | Boston Scientific Scimed, Inc. | Variable manipulative strength catheter |
US8753262B2 (en) | 2003-07-29 | 2014-06-17 | Hoya Corporation | Internal treatment apparatus having circumferential side holes |
JP4547184B2 (en) | 2003-07-29 | 2010-09-22 | オリンパス株式会社 | Endoscope adapter and endoscope |
US7623904B2 (en) | 2003-08-06 | 2009-11-24 | Olympus Corporation | Medical apparatus, medical apparatus guide system, capsule type medical apparatus, and capsule type medical apparatus guide apparatus |
US8216252B2 (en) | 2004-05-07 | 2012-07-10 | Usgi Medical, Inc. | Tissue manipulation and securement system |
US7001341B2 (en) | 2003-08-13 | 2006-02-21 | Scimed Life Systems, Inc. | Marking biopsy sites |
GB0319504D0 (en) | 2003-08-20 | 2003-09-17 | Promedics Ltd | Suturing device |
US7763012B2 (en) | 2003-09-02 | 2010-07-27 | St. Jude Medical, Cardiology Division, Inc. | Devices and methods for crossing a chronic total occlusion |
US7154378B1 (en) | 2003-09-11 | 2006-12-26 | Stryker Corporation | Apparatus and method for using RFID to track use of a component within a device |
US20050059963A1 (en) | 2003-09-12 | 2005-03-17 | Scimed Life Systems, Inc. | Systems and method for creating transmural lesions |
US20050059964A1 (en) | 2003-09-12 | 2005-03-17 | Fitz William R. | Enhancing the effectiveness of medial branch nerve root RF neurotomy |
AU2004281641B2 (en) | 2003-09-15 | 2010-06-17 | Apollo Endosurgery, Inc. | Implantable device fastening system and methods of use |
DE10342759A1 (en) | 2003-09-16 | 2005-04-14 | Campus Gmbh & Co. Kg | Stent with improved durability |
US20060200005A1 (en) | 2003-09-17 | 2006-09-07 | Levahn Intellectual Property Holding Company, Llc | Low profile, handle-in-between surgical scissors clamp |
US20050065509A1 (en) | 2003-09-22 | 2005-03-24 | Scimed Life Systems, Inc. | Flat electrode arrays for generating flat lesions |
JP4533695B2 (en) | 2003-09-23 | 2010-09-01 | オリンパス株式会社 | Treatment endoscope |
US7035680B2 (en) | 2003-09-23 | 2006-04-25 | Cardiac Pacemakers, Inc. | Catheter lead placement system and method |
US7588557B2 (en) | 2003-09-24 | 2009-09-15 | Granit-Medical Innovations, Llc | Medical instrument for fluid injection and related method |
US7955355B2 (en) | 2003-09-24 | 2011-06-07 | Stryker Spine | Methods and devices for improving percutaneous access in minimally invasive surgeries |
US7169115B2 (en) | 2003-09-29 | 2007-01-30 | Ethicon Endo-Surgery, Inc. | Endoscopic mucosal resection device with overtube and method of use |
US6994705B2 (en) | 2003-09-29 | 2006-02-07 | Ethicon-Endo Surgery, Inc. | Endoscopic mucosal resection device with conductive tissue stop |
US7789825B2 (en) | 2003-09-29 | 2010-09-07 | Ethicon Endo-Surgery, Inc. | Handle for endoscopic device |
US7708756B2 (en) | 2003-09-29 | 2010-05-04 | Ethicon Endo-Surgery, Inc. | Actuation mechanism for flexible endoscopic device |
EP3443915B2 (en) | 2003-09-30 | 2024-01-31 | Boston Scientific Scimed, Inc. | Apparatus for deployment of a hemostatic clip |
US7549990B2 (en) | 2003-10-07 | 2009-06-23 | Jerome Canady | Surgical scissors with argon plasma coagulation capability |
CA2542368A1 (en) | 2003-10-15 | 2005-04-28 | Kabushikikaisha Igaki Iryo Sekkei | Device for delivery of stent for vessel |
US7029435B2 (en) | 2003-10-16 | 2006-04-18 | Granit Medical Innovation, Llc | Endoscope having multiple working segments |
US7270663B2 (en) | 2003-10-16 | 2007-09-18 | Granit Medical Innovations, Llc | Medical snare loop with indentations for changing effective size of loop and associated method |
US7762949B2 (en) | 2003-10-16 | 2010-07-27 | Granit Medical Innovation, Llc | Endoscope with open channels |
US7150713B2 (en) | 2003-10-16 | 2006-12-19 | Smith & Nephew, Inc. | Endoscopic device |
JP2005121947A (en) | 2003-10-17 | 2005-05-12 | Olympus Corp | Object lens insertion fixture, microscope and microscope system |
US20050143774A1 (en) | 2003-10-21 | 2005-06-30 | Polo Oscar R. | Laparoscopic needle manipulator |
US7329383B2 (en) | 2003-10-22 | 2008-02-12 | Boston Scientific Scimed, Inc. | Alloy compositions and devices including the compositions |
US20050096502A1 (en) | 2003-10-29 | 2005-05-05 | Khalili Theodore M. | Robotic surgical device |
US7842028B2 (en) | 2005-04-14 | 2010-11-30 | Cambridge Endoscopic Devices, Inc. | Surgical instrument guide device |
US7338513B2 (en) | 2003-10-30 | 2008-03-04 | Cambridge Endoscopic Devices, Inc. | Surgical instrument |
US7147650B2 (en) | 2003-10-30 | 2006-12-12 | Woojin Lee | Surgical instrument |
US7686826B2 (en) | 2003-10-30 | 2010-03-30 | Cambridge Endoscopic Devices, Inc. | Surgical instrument |
CA2543792A1 (en) | 2003-11-05 | 2005-07-14 | Applied Medical Resources Corporation | Multiple-angle scissor blade |
US7666203B2 (en) | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
EP1684641B1 (en) | 2003-11-07 | 2012-02-15 | Scimed Life Systems, Inc. | Endoscopic hemoscopic clipping apparatus |
US20050101838A1 (en) | 2003-11-12 | 2005-05-12 | Camillocci Philip L. | Endoscope cover |
EP1689302A4 (en) | 2003-11-12 | 2010-07-07 | Lue Stephen J Van | Magnetic devices and apparatus for medical/surgical procedures and methods for using same |
US7115124B1 (en) | 2003-11-12 | 2006-10-03 | Jia Hua Xiao | Device and method for tissue ablation using bipolar radio-frequency current |
US7524281B2 (en) | 2003-11-17 | 2009-04-28 | Boston Scientific Scimed, Inc. | Systems and methods relating to associating a medical implant with a delivery device |
WO2005053517A1 (en) | 2003-12-01 | 2005-06-16 | Olympus Corporation | Endoscope system |
US7052489B2 (en) | 2003-12-05 | 2006-05-30 | Scimed Life Systems, Inc. | Medical device with deflecting shaft and related methods of manufacture and use |
US20050131457A1 (en) | 2003-12-15 | 2005-06-16 | Ethicon, Inc. | Variable stiffness shaft |
US7524302B2 (en) | 2003-12-17 | 2009-04-28 | Numed, Inc. | Prenatal balloon catheter |
US20050149096A1 (en) | 2003-12-23 | 2005-07-07 | Hilal Said S. | Catheter with conduit traversing tip |
ES2543832T3 (en) | 2003-12-24 | 2015-08-24 | The Regents Of The University Of California | Tissue ablation with irreversible electroporation |
US20050143803A1 (en) | 2003-12-24 | 2005-06-30 | Medtronic Vascular, Inc. | Protective sheath for drug coated stent |
JP4286127B2 (en) | 2003-12-25 | 2009-06-24 | オリンパス株式会社 | In-subject position detection system |
US7320695B2 (en) | 2003-12-31 | 2008-01-22 | Biosense Webster, Inc. | Safe septal needle and method for its use |
US7951073B2 (en) | 2004-01-21 | 2011-05-31 | Boston Scientific Limited | Endoscopic device having spray mechanism and related methods of use |
US20050165429A1 (en) | 2004-01-23 | 2005-07-28 | Peter Douglas | Surgical clamp possessing a combined parallel and scissor style clamp head |
CA2553940A1 (en) | 2004-01-30 | 2005-08-18 | Nmt Medical, Inc. | Devices, systems, and methods for closure of cardiac openings |
DE102004005709A1 (en) | 2004-02-05 | 2005-08-25 | Polydiagnost Gmbh | Endoscope with a flexible probe |
US7798960B2 (en) | 2004-02-09 | 2010-09-21 | John C. Jaeger | Speculum |
US7637903B2 (en) | 2004-02-09 | 2009-12-29 | Cryocor, Inc. | Catheter articulation segment with alternating cuts |
ITPI20040008A1 (en) | 2004-02-17 | 2004-05-17 | Dino Accoto | ROBOTIC CAPSULE FOR INTRA-BODY BIOMEDICAL APPLICATIONS |
US7435229B2 (en) | 2004-02-25 | 2008-10-14 | Wolf Erich W | System for transcutaneous monitoring of intracranial pressure (ICP) using near infrared (NIR) telemetry |
JP4436698B2 (en) | 2004-02-25 | 2010-03-24 | オリンパス株式会社 | High frequency treatment tool |
US20050192478A1 (en) | 2004-02-27 | 2005-09-01 | Williams James P. | System and method for endoscopic optical constrast imaging using an endo-robot |
WO2005082226A1 (en) | 2004-02-27 | 2005-09-09 | Olympus Corporation | Endoscope |
DE602005012482D1 (en) | 2004-02-27 | 2009-03-12 | Applied Med Resources | SYSTEM FOR ACTUATING A LAPAROSCOPY INSTRUMENT |
US6932824B1 (en) | 2004-03-02 | 2005-08-23 | St. Jude Medical Puerto Rico B.V. | Three-needle closure device |
US7179254B2 (en) | 2004-03-09 | 2007-02-20 | Ethicon, Inc. | High intensity ablation device |
EP1723913A1 (en) | 2004-03-10 | 2006-11-22 | Olympus Corporation | Treatment tool for surgery |
JP2005261514A (en) | 2004-03-17 | 2005-09-29 | Pentax Corp | Beak-like high frequency hemostatic forceps for endoscope |
US7699864B2 (en) | 2004-03-18 | 2010-04-20 | Onset Medical Corporation | Expandable medical access device |
US20050209624A1 (en) | 2004-03-22 | 2005-09-22 | Venkataramana Vijay | Scissors for piercing and cutting anatomical vessels |
US7255675B2 (en) | 2004-03-23 | 2007-08-14 | Michael Gertner | Devices and methods to treat a patient |
US20060142790A1 (en) | 2004-03-23 | 2006-06-29 | Michael Gertner | Methods and devices to facilitate connections between body lumens |
ES2409160T3 (en) | 2004-03-23 | 2013-06-25 | Boston Scientific Limited | Live View System |
US7402162B2 (en) | 2004-03-24 | 2008-07-22 | Hoya Corporation | High frequency treatment instrument for endoscope |
US7323006B2 (en) | 2004-03-30 | 2008-01-29 | Xtent, Inc. | Rapid exchange interventional devices and methods |
JP4652713B2 (en) | 2004-04-02 | 2011-03-16 | オリンパス株式会社 | Endoscopic treatment device |
EP1732623B1 (en) | 2004-04-05 | 2014-07-16 | Covidien LP | Surgical hand access apparatus |
AU2005231485B2 (en) | 2004-04-05 | 2010-08-05 | Covidien Lp | Surgical hand access apparatus |
JP2005296412A (en) | 2004-04-13 | 2005-10-27 | Olympus Corp | Endoscopic treatment apparatus |
US20050272977A1 (en) | 2004-04-14 | 2005-12-08 | Usgi Medical Inc. | Methods and apparatus for performing endoluminal procedures |
US8277373B2 (en) | 2004-04-14 | 2012-10-02 | Usgi Medical, Inc. | Methods and apparaus for off-axis visualization |
WO2006033671A2 (en) | 2004-04-15 | 2006-03-30 | Wilson-Cook Medical Inc. | Endoscopic surgical access devices and methods of articulating an external accessory channel |
US8517921B2 (en) | 2004-04-16 | 2013-08-27 | Gyrus Acmi, Inc. | Endoscopic instrument having reduced diameter flexible shaft |
US8092549B2 (en) | 2004-09-24 | 2012-01-10 | The Invention Science Fund I, Llc | Ciliated stent-like-system |
US20070167682A1 (en) | 2004-04-21 | 2007-07-19 | Acclarent, Inc. | Endoscopic methods and devices for transnasal procedures |
US7534228B2 (en) | 2004-04-27 | 2009-05-19 | Applied Medical Technology, Inc. | Bridle catheter with umbilical tape |
US7301250B2 (en) | 2004-05-04 | 2007-11-27 | Stangenes Industries, Inc. | High voltage pulsed power supply using solid state switches |
ES2407684T3 (en) | 2004-05-05 | 2013-06-13 | Direct Flow Medical, Inc. | Heart valve without stent with support structure formed on site |
US7918869B2 (en) | 2004-05-07 | 2011-04-05 | Usgi Medical, Inc. | Methods and apparatus for performing endoluminal gastroplasty |
US20060135971A1 (en) | 2004-05-07 | 2006-06-22 | Usgi Medical Inc. | System for treating gastroesophageal reflux disease |
US20050251176A1 (en) | 2004-05-07 | 2005-11-10 | Usgi Medical Inc. | System for treating gastroesophageal reflux disease |
US7736374B2 (en) | 2004-05-07 | 2010-06-15 | Usgi Medical, Inc. | Tissue manipulation and securement system |
EP1750595A4 (en) | 2004-05-07 | 2008-10-22 | Valentx Inc | Devices and methods for attaching an endolumenal gastrointestinal implant |
US7837615B2 (en) | 2004-05-10 | 2010-11-23 | Usgi Medical, Inc. | Shape lockable apparatus and method for advancing an instrument through unsupported anatomy |
US20050267492A1 (en) | 2004-05-12 | 2005-12-01 | Philippe Poncet | Surgical instrument for specimen retrieval |
US20050256524A1 (en) | 2004-05-14 | 2005-11-17 | Long Gary L | RF ablation device and method of use |
US20060004409A1 (en) | 2004-05-14 | 2006-01-05 | Nobis Rudolph H | Devices for locking and/or cutting a suture |
US7658738B2 (en) | 2004-05-14 | 2010-02-09 | Ethicon Endo-Surgery, Inc. | Medical devices for use with endoscope |
WO2005112784A2 (en) | 2004-05-14 | 2005-12-01 | Ethicon Endo-Surgery, Inc. | Devices and methods for locking and cutting a suture in a medical procedure |
US7846171B2 (en) | 2004-05-27 | 2010-12-07 | C.R. Bard, Inc. | Method and apparatus for delivering a prosthetic fabric into a patient |
WO2005120376A2 (en) | 2004-06-02 | 2005-12-22 | Medtronic, Inc. | Ablation device with jaws |
US7803195B2 (en) | 2004-06-03 | 2010-09-28 | Mayo Foundation For Medical Education And Research | Obesity treatment and device |
US7828808B2 (en) | 2004-06-07 | 2010-11-09 | Novare Surgical Systems, Inc. | Link systems and articulation mechanisms for remote manipulation of surgical or diagnostic tools |
US7066936B2 (en) | 2004-06-07 | 2006-06-27 | Ethicon, Inc. | Surgical cutting and tissue vaporizing instrument |
US8216255B2 (en) | 2004-06-14 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Endoscopic clip applier actuator |
US7931661B2 (en) | 2004-06-14 | 2011-04-26 | Usgi Medical, Inc. | Apparatus and methods for performing transluminal gastrointestinal procedures |
US20050274935A1 (en) | 2004-06-14 | 2005-12-15 | Nelson Mark S | Post puller |
US7241290B2 (en) | 2004-06-16 | 2007-07-10 | Kinetic Surgical, Llc | Surgical tool kit |
JP4954874B2 (en) | 2004-06-16 | 2012-06-20 | スミス アンド ネフュー インコーポレーテッド | Suture threader |
KR100615881B1 (en) | 2004-06-21 | 2006-08-25 | 한국과학기술연구원 | Capsule Type Endoscope Control System |
US20060074413A1 (en) | 2004-06-28 | 2006-04-06 | Kamran Behzadian | Method and apparatus for substantial and uniform ablation about a linear bipolar array of electrodes |
US20050288555A1 (en) | 2004-06-28 | 2005-12-29 | Binmoeller Kenneth E | Methods and devices for illuminating, vievwing and monitoring a body cavity |
WO2006005061A2 (en) | 2004-06-30 | 2006-01-12 | Sitzmann James V | Medical devices for minimally invasive surgeries and other internal procedures |
JP2006014960A (en) | 2004-07-01 | 2006-01-19 | Olympus Corp | Endoscope |
US20060004406A1 (en) | 2004-07-05 | 2006-01-05 | Helmut Wehrstein | Surgical instrument |
US7497867B2 (en) | 2004-07-12 | 2009-03-03 | Jeffrey Lasner | Handles and shafts for manually adjustable scissors and forceps |
US20060015131A1 (en) | 2004-07-15 | 2006-01-19 | Kierce Paul C | Cannula for in utero surgery |
WO2006012630A2 (en) | 2004-07-23 | 2006-02-02 | Calypso Medical Technologies, Inc. | Apparatuses and methods for percutaneously implanting objects in patients |
WO2006014881A2 (en) | 2004-07-26 | 2006-02-09 | Van Lue Stephen J | Surgical stapler with magnetically secured components |
US7857183B2 (en) | 2004-07-28 | 2010-12-28 | Ethicon Endo-Surgery, Inc. | Surgical instrument incorporating an electrically actuated articulation mechanism |
US20060025812A1 (en) | 2004-07-28 | 2006-02-02 | Ethicon Endo-Surgery, Inc. | Surgical instrument incorporating an electrically actuated pivoting articulation mechanism |
US20060036267A1 (en) | 2004-08-11 | 2006-02-16 | Usgi Medical Inc. | Methods and apparatus for performing malabsorptive bypass procedures within a patient's gastro-intestinal lumen |
US7261725B2 (en) | 2005-01-13 | 2007-08-28 | Binmoeller Kenneth F | Endoscopic device with independently actuated legs |
US20060135962A1 (en) | 2004-09-09 | 2006-06-22 | Kick George F | Expandable trans-septal sheath |
US7195631B2 (en) | 2004-09-09 | 2007-03-27 | Sherwood Services Ag | Forceps with spring loaded end effector assembly |
DE102004044119B4 (en) | 2004-09-11 | 2016-11-03 | Olympus Winter & Ibe Gmbh | Video endoscope with rotatable video camera |
US20060064083A1 (en) | 2004-09-17 | 2006-03-23 | Steve Khalaj | Multi-tip probe used for an ocular procedure |
EP1791476B1 (en) | 2004-09-20 | 2015-12-23 | Endoevolution, Llc | Apparatus for minimally invasive suturing |
US7540872B2 (en) | 2004-09-21 | 2009-06-02 | Covidien Ag | Articulating bipolar electrosurgical instrument |
US20060095031A1 (en) | 2004-09-22 | 2006-05-04 | Arthrocare Corporation | Selectively controlled active electrodes for electrosurgical probe |
US7559916B2 (en) | 2004-09-24 | 2009-07-14 | Syntheon, Llc | Catheter with controllable stiffness and method for operating a selective stiffening catheter |
DE602005020738D1 (en) | 2004-09-24 | 2010-06-02 | Toshiba Kk | ULTRASOUND PROBE |
JP4302602B2 (en) | 2004-09-24 | 2009-07-29 | オリンパス株式会社 | Endoscopic treatment tool, endoscopic treatment system, and support adapter |
US20060069424A1 (en) | 2004-09-27 | 2006-03-30 | Xtent, Inc. | Self-constrained segmented stents and methods for their deployment |
US7909809B2 (en) | 2004-09-27 | 2011-03-22 | Boston Scientific Scimed, Inc. | Devices and methods for agent-assisted medical procedures |
EP1799123B1 (en) | 2004-09-28 | 2015-05-06 | Surgical Solutions, LLC | Suture anchor |
JP4756258B2 (en) | 2004-10-07 | 2011-08-24 | 学校法人慶應義塾 | Capillary tube that bends over by light |
WO2006042047A1 (en) | 2004-10-07 | 2006-04-20 | Flea Street Translational, Llc | Methods, systems and devices for establishing communication between hollow organs and tissue lumens |
US7628792B2 (en) | 2004-10-08 | 2009-12-08 | Covidien Ag | Bilateral foot jaws |
EP1814500B1 (en) | 2004-10-11 | 2008-06-11 | SMM Medical AB | Electro active compression bandage |
US7229438B2 (en) | 2004-10-14 | 2007-06-12 | Boston Scientific Scimed, Inc. | Ablation probe with distal inverted electrode array |
CN101044284B (en) | 2004-10-19 | 2010-12-01 | 东京制纲株式会社 | Cable composed of high strength fiber composite material |
DE102004052515B4 (en) | 2004-10-22 | 2019-01-03 | Aesculap Ag | Surgical scissors and method for making a surgical scissors |
EP1656963B1 (en) | 2004-11-10 | 2007-11-21 | Creganna Technologies Limited | Stent delivery catheter assembly |
US20060217665A1 (en) | 2004-11-18 | 2006-09-28 | Laparoscopic Partners Llc | Surgical instrument seal assembly and triple lead thread |
US20060111704A1 (en) | 2004-11-22 | 2006-05-25 | Rox Medical, Inc. | Devices, systems, and methods for energy assisted arterio-venous fistula creation |
CA2587857C (en) | 2004-11-23 | 2017-10-10 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
US9700334B2 (en) | 2004-11-23 | 2017-07-11 | Intuitive Surgical Operations, Inc. | Articulating mechanisms and link systems with torque transmission in remote manipulation of instruments and tools |
US20080215070A1 (en) | 2004-12-01 | 2008-09-04 | Philip L Gildenberg | System and Method for Tensioning a Suture |
US7655014B2 (en) | 2004-12-06 | 2010-02-02 | Cameron Health, Inc. | Apparatus and method for subcutaneous electrode insertion |
US7559887B2 (en) | 2004-12-08 | 2009-07-14 | Patrick Dannan | Tool insertion device for use in minimally invasive surgery |
GB0427506D0 (en) | 2004-12-15 | 2005-01-19 | George Samuel | Improvements in or relating to specula |
WO2006066114A1 (en) | 2004-12-15 | 2006-06-22 | Cook Urological Incorporated | Radiopaque manipulation devices |
US7163525B2 (en) | 2004-12-17 | 2007-01-16 | Ethicon Endo-Surgery, Inc. | Duckbill seal protector |
US20060142798A1 (en) | 2004-12-27 | 2006-06-29 | Holman Thomas J | Device and method for closing an opening in a body cavity or lumen |
US20060142652A1 (en) | 2004-12-28 | 2006-06-29 | Erick Keenan | Concepts using the improved "composite flexible and conductive catheter electrode bands" and their method of construction |
US20060149132A1 (en) | 2004-12-30 | 2006-07-06 | Given Imaging Ltd. | Device and method for in vivo illumination |
US20060149131A1 (en) | 2005-01-05 | 2006-07-06 | Sightline Technologies Ltd. | Surgical tool for endoscope |
EP1838228A1 (en) | 2005-01-19 | 2007-10-03 | Applied Medical Resources Corporation | Disposable laparoscopic instrument |
GB2423269A (en) | 2005-02-16 | 2006-08-23 | Samuel George | Scissors with laterally restrained blades |
US20060184161A1 (en) | 2005-02-16 | 2006-08-17 | Usgi Medical Inc. | Flexible shaft system having interchangeable end effectors |
US7559450B2 (en) | 2005-02-18 | 2009-07-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument incorporating a fluid transfer controlled articulation mechanism |
US7559452B2 (en) | 2005-02-18 | 2009-07-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument having fluid actuated opposing jaws |
US7654431B2 (en) | 2005-02-18 | 2010-02-02 | Ethicon Endo-Surgery, Inc. | Surgical instrument with guided laterally moving articulation member |
US9089323B2 (en) | 2005-02-22 | 2015-07-28 | P Tech, Llc | Device and method for securing body tissue |
US20060200121A1 (en) | 2005-03-03 | 2006-09-07 | Mowery Thomas M | Navigable, multi-positional and variable tissue ablation apparatus and methods |
US20060200169A1 (en) | 2005-03-07 | 2006-09-07 | Kevin Sniffin | Specimen retrieval apparatus and method of use |
US20060200170A1 (en) | 2005-03-07 | 2006-09-07 | Ernest Aranyi | Specimen retrieval apparatus and method of use |
GB0504988D0 (en) | 2005-03-10 | 2005-04-20 | Emcision Ltd | Device and method for the treatment of diseased tissue such as tumors |
US7784663B2 (en) | 2005-03-17 | 2010-08-31 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having load sensing control circuitry |
US7670336B2 (en) | 2005-03-25 | 2010-03-02 | Boston Scientific Scimed, Inc. | Ablation probe with heat sink |
US7918848B2 (en) | 2005-03-25 | 2011-04-05 | Maquet Cardiovascular, Llc | Tissue welding and cutting apparatus and method |
US20060217742A1 (en) | 2005-03-28 | 2006-09-28 | Messerly Jeffrey D | Mechanical coupling method |
US7621927B2 (en) | 2005-03-28 | 2009-11-24 | Ethicon Endo-Surgery, Inc. | Medical instrument with a mechanical coupling |
US7670346B2 (en) | 2005-03-29 | 2010-03-02 | Tyco Healthcare Group Lp | Specimen retrieval apparatus |
US7547310B2 (en) | 2005-03-29 | 2009-06-16 | Tyco Healthcare Group Lp | Specimen retrieval apparatus |
US7195612B2 (en) | 2005-03-31 | 2007-03-27 | Gordis Corporation | Esophageal balloon catheter with visual marker |
US7931624B2 (en) | 2005-04-05 | 2011-04-26 | Tyco Healthcare Group Lp | Introducer seal assembly with low profile gimbal seal |
IL174531A0 (en) | 2005-04-06 | 2006-08-20 | Given Imaging Ltd | System and method for performing capsule endoscopy diagnosis in remote sites |
US20060270911A1 (en) | 2005-04-08 | 2006-11-30 | Voegele James W | Tissue retraction device |
JP2006297005A (en) | 2005-04-15 | 2006-11-02 | Yoshimoto Ando | Artificial muscle with double layer structure |
US8333777B2 (en) | 2005-04-22 | 2012-12-18 | Benvenue Medical, Inc. | Catheter-based tissue remodeling devices and methods |
US20060241570A1 (en) | 2005-04-22 | 2006-10-26 | Wilk Patent, Llc | Intra-abdominal medical method |
US8663236B2 (en) | 2005-04-26 | 2014-03-04 | Usgi Medical Inc. | Transgastric abdominal access |
US20060237023A1 (en) | 2005-04-26 | 2006-10-26 | Usgi Medical Inc. | Transgastric tubal ligation |
ATE410960T1 (en) | 2005-04-26 | 2008-10-15 | Niti On Co Ltd | ENDOSCOPIC SURGICAL INSTRUMENT |
US20060264752A1 (en) | 2005-04-27 | 2006-11-23 | The Regents Of The University Of California | Electroporation controlled with real time imaging |
US20060247663A1 (en) | 2005-04-27 | 2006-11-02 | Southern Illinois University Office Of Research, Development And Administration | Laser resistant calculus retrieval device and method of using |
US7645288B2 (en) | 2005-05-05 | 2010-01-12 | Ethicon Endo-Surgery, Inc. | Anastomotic ring applier with inflatable members |
US20060264904A1 (en) | 2005-05-09 | 2006-11-23 | Kerby Walter L | Medical device |
US7846107B2 (en) | 2005-05-13 | 2010-12-07 | Boston Scientific Scimed, Inc. | Endoscopic apparatus with integrated multiple biopsy device |
US7813590B2 (en) | 2005-05-13 | 2010-10-12 | Given Imaging Ltd. | System and method for displaying an in-vivo image stream |
US20060259010A1 (en) | 2005-05-13 | 2006-11-16 | David Stefanchik | Feeding tube |
US7762960B2 (en) | 2005-05-13 | 2010-07-27 | Boston Scientific Scimed, Inc. | Biopsy forceps assemblies |
US7905830B2 (en) | 2005-05-13 | 2011-03-15 | Ethicon Endo-Surgery, Inc. | Sheath for use with an endoscope |
US7648457B2 (en) | 2005-05-13 | 2010-01-19 | Ethicon Endo-Surgery, Inc. | Method of positioning a device on an endoscope |
JP2006314703A (en) | 2005-05-16 | 2006-11-24 | Fujinon Corp | Apparatus for supporting laparoscope |
US7666180B2 (en) | 2005-05-20 | 2010-02-23 | Tyco Healthcare Group Lp | Gastric restrictor assembly and method of use |
DE102006023696B4 (en) | 2005-05-20 | 2019-10-17 | Kaneka Corporation | High-frequency incision instrument for an endoscope |
US20080208213A1 (en) | 2005-05-25 | 2008-08-28 | Elad Benjamin | Devices and methods for the controlled formation and closure of vascular openings |
AU2006251051B2 (en) | 2005-05-25 | 2009-07-16 | Gyrus Medical, Inc. | A surgical instrument |
US20060271042A1 (en) | 2005-05-26 | 2006-11-30 | Gyrus Medical, Inc. | Cutting and coagulating electrosurgical forceps having cam controlled jaw closure |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US7553278B2 (en) | 2005-06-01 | 2009-06-30 | Cannuflow, Inc. | Protective cap for arthroscopic instruments |
JP2006343510A (en) | 2005-06-08 | 2006-12-21 | Eastman Kodak Co | Lens adapter |
US8641728B2 (en) | 2005-06-13 | 2014-02-04 | Ethicon Endo-Surgery, Inc. | Attachment apparatus for coupling with an endoscope |
EP1892009B1 (en) | 2005-06-14 | 2011-12-21 | Olympus Medical Systems Corp. | Endoscope treatment instrument |
US20060287666A1 (en) | 2005-06-15 | 2006-12-21 | Usgi Medical Inc. | Apparatus and methods for endoluminal advancement |
US7618413B2 (en) | 2005-06-22 | 2009-11-17 | Boston Scientific Scimed, Inc. | Medical device control system |
JP2007000463A (en) | 2005-06-24 | 2007-01-11 | Terumo Corp | Catheter assembly |
US7918844B2 (en) | 2005-06-24 | 2011-04-05 | Ethicon Endo-Surgery, Inc. | Applier for implantable medical device |
US7651483B2 (en) | 2005-06-24 | 2010-01-26 | Ethicon Endo-Surgery, Inc. | Injection port |
CN101217908B (en) | 2005-07-08 | 2012-10-24 | 奥林巴斯医疗株式会社 | Apparatus for placing capsule type medical device, apparatus for placing capsule endoscope in the body |
AU2006268238A1 (en) | 2005-07-11 | 2007-01-18 | Medtronic Ablation Frontiers Llc | Low power tissue ablation system |
US20070015965A1 (en) | 2005-07-13 | 2007-01-18 | Usgi Medical Inc. | Methods and apparatus for colonic cleaning |
US7618437B2 (en) | 2005-07-15 | 2009-11-17 | Granit Medical Innovation, Llc | Endoscope retrieval instrument assembly |
DE202006021213U1 (en) | 2005-07-21 | 2013-11-08 | Covidien Lp | Apparatus for treating a hollow anatomical structure |
CN101511305B (en) | 2005-07-26 | 2012-05-30 | 梅纳赫姆·P·韦斯 | Extending intrabody capsule |
US7548040B2 (en) | 2005-07-28 | 2009-06-16 | Zerog Wireless, Inc. | Wireless battery charging of electronic devices such as wireless headsets/headphones |
JP2007054125A (en) | 2005-08-22 | 2007-03-08 | Olympus Medical Systems Corp | Endoscope |
US8052597B2 (en) | 2005-08-30 | 2011-11-08 | Boston Scientific Scimed, Inc. | Method for forming an endoscope articulation joint |
US7998132B2 (en) | 2005-09-02 | 2011-08-16 | Boston Scientific Scimed, Inc. | Adjustable stiffness catheter |
US20070051375A1 (en) | 2005-09-06 | 2007-03-08 | Milliman Keith L | Instrument introducer |
WO2007033379A2 (en) | 2005-09-14 | 2007-03-22 | Neoguide Systems, Inc. | Methods and apparatus for performing transluminal and other procedures |
US20070066869A1 (en) | 2005-09-21 | 2007-03-22 | David Hoffman | Endoscopic assembly including cap and sheath |
US8114113B2 (en) | 2005-09-23 | 2012-02-14 | Acclarent, Inc. | Multi-conduit balloon catheter |
US20070073102A1 (en) | 2005-09-27 | 2007-03-29 | Kiyotaka Matsuno | Endoscope apparatus |
US7875041B2 (en) | 2005-09-28 | 2011-01-25 | Olympus Medical Systems Corp. | Suturing method for penetrating hole |
US8702753B2 (en) | 2005-09-28 | 2014-04-22 | Olympus Medical Systems Corp. | Method for suturing perforation and suture instrument |
CA2561034C (en) | 2005-09-30 | 2014-12-09 | Sherwood Services Ag | Flexible endoscopic catheter with an end effector for coagulating and transfecting tissue |
US7520950B2 (en) | 2005-10-06 | 2009-04-21 | Usgi Medical Inc. | Flexible tubular liner coating system |
US8096459B2 (en) | 2005-10-11 | 2012-01-17 | Ethicon Endo-Surgery, Inc. | Surgical stapler with an end effector support |
US8721658B2 (en) | 2005-10-14 | 2014-05-13 | Applied Medical Resources Corporation | Tissue retrieval system |
US20070123840A1 (en) | 2005-10-18 | 2007-05-31 | Usgi Medical, Inc. | Instrument assisted abdominal access |
US20070173870A2 (en) | 2005-10-18 | 2007-07-26 | Jaime Zacharias | Precision Surgical System |
US8221310B2 (en) | 2005-10-25 | 2012-07-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US20070106219A1 (en) | 2005-10-31 | 2007-05-10 | Andreas Grabinsky | Cleveland round tip (CRT) needle |
CN101355901B (en) | 2005-11-08 | 2011-10-05 | 纽约市哥伦比亚大学理事会 | Apparatuses and methods for delivering one or more deliverables into a body |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
JP5329810B2 (en) | 2005-11-14 | 2013-10-30 | オリンパスメディカルシステムズ株式会社 | Medical device |
US7815659B2 (en) | 2005-11-15 | 2010-10-19 | Ethicon Endo-Surgery, Inc. | Suture anchor applicator |
US8876772B2 (en) | 2005-11-16 | 2014-11-04 | Boston Scientific Scimed, Inc. | Variable stiffness shaft |
US20070167901A1 (en) | 2005-11-17 | 2007-07-19 | Herrig Judson A | Self-sealing residual compressive stress graft for dialysis |
US20070118115A1 (en) | 2005-11-22 | 2007-05-24 | Sherwood Services Ag | Bipolar electrosurgical sealing instrument having an improved tissue gripping device |
SG132553A1 (en) | 2005-11-28 | 2007-06-28 | Pang Ah San | A device for laparoscopic or thoracoscopic surgery |
US20080312502A1 (en) | 2005-12-02 | 2008-12-18 | Christopher Paul Swain | System and Device for in Vivo Procedures |
US7751869B2 (en) | 2005-12-09 | 2010-07-06 | Boston Scientific Scimed, Inc. | Radiation ablation tracking system and method |
JP2007167302A (en) | 2005-12-21 | 2007-07-05 | Olympus Medical Systems Corp | Overtube for endoscope and endoscopic system |
US7744591B2 (en) | 2005-12-29 | 2010-06-29 | Boston Scientific Scimed, Inc. | Foam electrode and method of use thereof during tissue resection |
US7678043B2 (en) | 2005-12-29 | 2010-03-16 | Given Imaging, Ltd. | Device, system and method for in-vivo sensing of a body lumen |
US20070156028A1 (en) | 2005-12-29 | 2007-07-05 | Van Lue Stephen J | Magnetic surgical/oral retractor |
US20070161855A1 (en) | 2006-01-06 | 2007-07-12 | Olympus Medical Systems Corp. | Medical procedure through natural body orifice |
US8518052B2 (en) | 2006-01-06 | 2013-08-27 | Cordis Corporation | Medical delivery system for delivery of a medically useful payload |
TW200744518A (en) | 2006-01-06 | 2007-12-16 | Olympus Medical Systems Corp | Medical system conducted percutaneous or using naturally ocurring body orifice |
US9308049B2 (en) | 2006-01-13 | 2016-04-12 | Olympus Corporation | Medical treatment endoscope |
US20070173872A1 (en) | 2006-01-23 | 2007-07-26 | Ethicon Endo-Surgery, Inc. | Surgical instrument for cutting and coagulating patient tissue |
AU2007210010A1 (en) | 2006-01-27 | 2007-08-09 | Medtronic, Inc. | Ablation device and system for guiding said ablation device into a patient's body |
US7575144B2 (en) | 2006-01-31 | 2009-08-18 | Ethicon Endo-Surgery, Inc. | Surgical fastener and cutter with single cable actuator |
US7628797B2 (en) | 2006-01-31 | 2009-12-08 | Edwards Lifesciences Corporation | System, apparatus, and method for fastening tissue |
JP2007208781A (en) | 2006-02-03 | 2007-08-16 | Olympus Corp | Imaging apparatus |
US7953326B2 (en) | 2006-02-06 | 2011-05-31 | Woods Hole Oceanographic Institution | Systems and methods for underwater optical communication |
US20070191904A1 (en) * | 2006-02-14 | 2007-08-16 | Imad Libbus | Expandable stimulation electrode with integrated pressure sensor and methods related thereto |
JP5131951B2 (en) | 2006-02-21 | 2013-01-30 | 富士フイルム株式会社 | Body cavity observation device |
US20070198057A1 (en) | 2006-02-21 | 2007-08-23 | Daniel Gelbart | Method and device for closing holes in tissue |
US20080015413A1 (en) | 2006-02-22 | 2008-01-17 | Olympus Medical Systems Corporation | Capsule endoscope system and medical procedure |
ATE551010T1 (en) | 2006-02-24 | 2012-04-15 | Terumo Corp | PFO CLOSURE DEVICE |
JP4425227B2 (en) | 2006-02-28 | 2010-03-03 | Hoya株式会社 | Endoscopic high-frequency treatment instrument |
US8092374B2 (en) | 2006-03-02 | 2012-01-10 | Kevin Smith | Variably flexible insertion device and method for variably flexing an insertion device |
US20070213754A1 (en) | 2006-03-08 | 2007-09-13 | Olympus Medical Systems Corp. | Incision instrument, incision apparatus, and organ incision method |
US8715281B2 (en) | 2006-03-09 | 2014-05-06 | Olympus Medical Systems Corp. | Treatment device for endoscope |
ITMI20060443A1 (en) | 2006-03-13 | 2007-09-14 | Ethicon Endo Surgery Inc | DEVICE FOR THE MANIPULATION OF BODY TEXTILE |
EP2001383A4 (en) | 2006-03-17 | 2011-01-19 | Microcube Llc | Devices and methods for creating continuous lesions |
US7815652B2 (en) | 2006-03-21 | 2010-10-19 | Ethicon Endo-Surgery, Inc. | Surgical fastener and instrument |
US7918783B2 (en) | 2006-03-22 | 2011-04-05 | Boston Scientific Scimed, Inc. | Endoscope working channel with multiple functionality |
US7771396B2 (en) | 2006-03-22 | 2010-08-10 | Ethicon Endo-Surgery, Inc. | Intubation device for enteral feeding |
US7850686B2 (en) | 2006-03-30 | 2010-12-14 | Ethicon Endo-Surgery, Inc. | Protective needle knife |
US20070233040A1 (en) | 2006-03-31 | 2007-10-04 | Boston Scientific Scimed, Inc. | Flexible endoscope with variable stiffness shaft |
US7579550B2 (en) | 2006-03-31 | 2009-08-25 | Boston Scientific Scimed, Inc. | Flexible device shaft with angled spiral wrap |
US8430811B2 (en) | 2008-09-30 | 2013-04-30 | Ethicon Endo-Surgery, Inc. | Multiple port surgical access device |
DE102006027873B4 (en) | 2006-06-16 | 2009-10-15 | Erbe Elektromedizin Gmbh | Endoscopic multifunction surgery device |
US8034046B2 (en) | 2006-04-13 | 2011-10-11 | Boston Scientific Scimed, Inc. | Medical devices including shape memory materials |
US8202265B2 (en) | 2006-04-20 | 2012-06-19 | Boston Scientific Scimed, Inc. | Multiple lumen assembly for use in endoscopes or other medical devices |
US7520876B2 (en) | 2006-04-21 | 2009-04-21 | Entellus Medical, Inc. | Device and method for treatment of sinusitis |
JP5091229B2 (en) | 2006-04-24 | 2012-12-05 | シネコー・エルエルシー | Transluminal surgical system |
US8518024B2 (en) | 2006-04-24 | 2013-08-27 | Transenterix, Inc. | System and method for multi-instrument surgical access using a single access port |
EP2012697A4 (en) | 2006-04-29 | 2010-07-21 | Univ Texas | Devices for use in transluminal and endoluminal surgery |
US20070255303A1 (en) | 2006-05-01 | 2007-11-01 | Ethicon Endo-Surgery, Inc. | Integrated Guidewire Needle Knife Device |
US8328836B2 (en) | 2006-05-01 | 2012-12-11 | Ethicon Endo-Surgery, Inc. | Flexible endoscopic safety needle |
US7846087B2 (en) | 2006-05-01 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Endoscopic rotation |
US7862582B2 (en) | 2006-05-02 | 2011-01-04 | Ethicon Endo-Surgery, Inc. | Suture management |
AU2007247948B2 (en) | 2006-05-03 | 2013-05-16 | Indiana University Research & Technology Corporation | Methods and apparatuses for reshaping the esophagus and other body lumens |
US7963912B2 (en) | 2006-05-08 | 2011-06-21 | Ethicon Endo-Surgery, Inc. | Endoscopic translumenal surgical methods using a sheath |
US20070260273A1 (en) | 2006-05-08 | 2007-11-08 | Ethicon Endo-Surgery, Inc. | Endoscopic Translumenal Surgical Systems |
US20070260121A1 (en) | 2006-05-08 | 2007-11-08 | Ethicon Endo-Surgery, Inc. | Endoscopic Translumenal Surgical Systems |
US7959642B2 (en) | 2006-05-16 | 2011-06-14 | Ethicon Endo-Surgery, Inc. | Medical instrument having a needle knife |
US7927271B2 (en) | 2006-05-17 | 2011-04-19 | C.R. Bard, Inc. | Endoscope tool coupling |
US20070270907A1 (en) | 2006-05-19 | 2007-11-22 | Stokes Michael J | Suture locking device |
US20070270629A1 (en) | 2006-05-19 | 2007-11-22 | Charles Filipi J | System and techniques for magnetic manipulation of internal organs during minimally invasive surgery |
US7758598B2 (en) | 2006-05-19 | 2010-07-20 | Ethicon Endo-Surgery, Inc. | Combination knotting element and suture anchor applicator |
KR20090019794A (en) | 2006-05-22 | 2009-02-25 | 코닌클리케 필립스 일렉트로닉스 엔.브이. | Catheter insertion sheath with adjustable flexibility |
US7635373B2 (en) | 2006-05-25 | 2009-12-22 | Ethicon Endo-Surgery, Inc. | Absorbable gastric restriction devices and methods |
US20070282165A1 (en) | 2006-05-31 | 2007-12-06 | Karl Storz Endovision | Optically coupled endoscope with microchip |
US9596994B2 (en) | 2006-06-02 | 2017-03-21 | J. William J. Futrell | System and methods for illuminating materials |
US7615067B2 (en) | 2006-06-05 | 2009-11-10 | Cambridge Endoscopic Devices, Inc. | Surgical instrument |
BRPI0602735A (en) | 2006-06-06 | 2008-01-29 | Luiz Gonzaga Granja Jr | anastomosis prosthesis |
BRPI0602379A (en) | 2006-06-06 | 2008-01-22 | Luiz Gonzaga Granja Jr | anastomosis prosthesis |
EP2032057B1 (en) | 2006-06-12 | 2009-12-09 | Region Hovedstaden v/Herlev Hospital | Electrode introducer device |
WO2008108863A2 (en) | 2006-06-23 | 2008-09-12 | Cornerstone Research Group, Inc. | Locking device using shape memory materials |
EP2089096A4 (en) | 2006-06-23 | 2010-09-29 | Amir Belson | Transesophageal implantation of cardiac electrodes and delivery of cardiac therapies |
ATE545374T1 (en) | 2006-06-30 | 2012-03-15 | Bovie Medical Corp | SURGICAL INSTRUMENT WITH REMOVABLE TOOL ARRANGEMENT |
JP4546424B2 (en) | 2006-07-04 | 2010-09-15 | オリンパスメディカルシステムズ株式会社 | Endoscopic treatment tool |
CA2657435A1 (en) | 2006-07-10 | 2008-07-03 | Medipacs, Inc. | Super elastic epoxy hydrogel |
WO2008007355A1 (en) | 2006-07-13 | 2008-01-17 | Stark Med Gmbh | Trans-douglas endoscopical surgical device (ted) |
US7744615B2 (en) | 2006-07-18 | 2010-06-29 | Covidien Ag | Apparatus and method for transecting tissue on a bipolar vessel sealing instrument |
US8202295B2 (en) | 2006-07-20 | 2012-06-19 | Kaplan Lee D | Surgical instruments |
US20080022927A1 (en) | 2006-07-28 | 2008-01-31 | Sean Xiao-An Zhang | Microfluidic device for controlled movement of material |
DE102006000382A1 (en) | 2006-08-01 | 2008-02-07 | Novineon Healthcare Technology Partners Gmbh | Medical instrument |
US8840655B2 (en) | 2006-08-09 | 2014-09-23 | Coherex Medical, Inc. | Systems and devices for reducing the size of an internal tissue opening |
US7789827B2 (en) | 2006-08-21 | 2010-09-07 | Karl Storz Endovision, Inc. | Variable shaft flexibility in endoscope |
US20080058586A1 (en) | 2006-09-05 | 2008-03-06 | Wilson-Cook Medical Inc. | Hood member for use with an endoscope |
CA2662602C (en) | 2006-09-11 | 2011-12-06 | Karl Storz Endovision, Inc. | System and method for an hysteroscope with integrated instruments |
US7648519B2 (en) | 2006-09-13 | 2010-01-19 | Cambridge Endoscopic Devices, Inc. | Surgical instrument |
US7680543B2 (en) | 2006-09-14 | 2010-03-16 | Lazure Technologies, Llc | Tissue ablation and removal |
US7965180B2 (en) | 2006-09-28 | 2011-06-21 | Semiconductor Energy Laboratory Co., Ltd. | Wireless sensor device |
US8220690B2 (en) | 2006-09-29 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Connected surgical staples and stapling instruments for deploying the same |
WO2008041225A2 (en) | 2006-10-03 | 2008-04-10 | Virtual Ports Ltd | Lens cleaning device, system and method for surgical procdures |
US8603138B2 (en) | 2006-10-04 | 2013-12-10 | Ethicon Endo-Surgery, Inc. | Use of an adhesive to treat intraluminal bleeding |
US7892220B2 (en) | 2006-10-04 | 2011-02-22 | Ethicon Endo-Surgery, Inc. | Use of an adhesive as an intestinal barrier for bariatrics |
EP2081481B1 (en) | 2006-10-05 | 2015-03-11 | Covidien LP | Flexible endoscopic stitching devices |
US7674275B2 (en) | 2006-10-05 | 2010-03-09 | Ethicon Endo-Surgery, Inc. | Suture anchor |
US20080161841A1 (en) | 2006-10-16 | 2008-07-03 | Clague Cynthia T | Cutting device and method of vessel harvesting |
IL178801A (en) | 2006-10-22 | 2013-11-28 | Jonathan Agmon | Episiotomy aid device |
GB2456681B (en) | 2006-10-26 | 2009-11-11 | Starbridge Systems Ltd | Pump |
US20080103527A1 (en) | 2006-10-27 | 2008-05-01 | Martin David T | Flexible endoscopic suture anchor applier |
AU2007319364B2 (en) | 2006-11-10 | 2013-02-21 | Cook Medical Technologies Llc | Ring magnets for surgical procedures |
US7935130B2 (en) | 2006-11-16 | 2011-05-03 | Intuitive Surgical Operations, Inc. | Two-piece end-effectors for robotic surgical tools |
US20100286791A1 (en) | 2006-11-21 | 2010-11-11 | Goldsmith David S | Integrated system for the ballistic and nonballistic infixion and retrieval of implants |
KR100876647B1 (en) | 2006-11-22 | 2009-01-08 | 주식회사 코렌 | Capsule type image photographing apparatus and endoscopy using the same |
WO2008066920A2 (en) | 2006-11-28 | 2008-06-05 | Stryker Development Llc | Gastrotomy closure device |
US7749161B2 (en) | 2006-12-01 | 2010-07-06 | Ethicon Endo-Surgery, Inc. | Hand assisted laparoscopic device |
US9345462B2 (en) | 2006-12-01 | 2016-05-24 | Boston Scientific Scimed, Inc. | Direct drive endoscopy systems and methods |
US7758577B2 (en) | 2006-12-05 | 2010-07-20 | Ethicon Endo-Surgery, Inc. | Monopolar resection device and method of use |
US20080140113A1 (en) | 2006-12-07 | 2008-06-12 | Cierra, Inc. | Method for sealing a pfo using an energy delivery device |
US20080140069A1 (en) | 2006-12-07 | 2008-06-12 | Cierra, Inc. | Multi-electrode apparatus for tissue welding and ablation |
JP2008142410A (en) | 2006-12-12 | 2008-06-26 | Olympus Corp | Device introduced inside subject |
US7879004B2 (en) | 2006-12-13 | 2011-02-01 | University Of Washington | Catheter tip displacement mechanism |
US8062306B2 (en) | 2006-12-14 | 2011-11-22 | Ethicon Endo-Surgery, Inc. | Manually articulating devices |
AU2007334417A1 (en) | 2006-12-15 | 2008-06-26 | Tyco Healthcare Group Lp | Trocar assembly with obturator and retractable stylet |
US20080171907A1 (en) | 2007-01-12 | 2008-07-17 | Ethicon Endo-Surgery, Inc. | Magnetic Tissue Grasping |
JP4847354B2 (en) | 2007-01-22 | 2011-12-28 | オリンパスメディカルシステムズ株式会社 | Endoscopic treatment tool |
US20080188710A1 (en) | 2007-02-02 | 2008-08-07 | Olympus Medical Systems Corporation | Capsule medical apparatus and body-cavity observation method |
US20080200755A1 (en) | 2007-02-15 | 2008-08-21 | Bakos Gregory J | Method and device for retrieving suture tags |
US20080200911A1 (en) | 2007-02-15 | 2008-08-21 | Long Gary L | Electrical ablation apparatus, system, and method |
US20080200934A1 (en) | 2007-02-15 | 2008-08-21 | Fox William D | Surgical devices and methods using magnetic force to form an anastomosis |
WO2008101228A2 (en) | 2007-02-15 | 2008-08-21 | Hansen Medical, Inc. | Robotic medical instrument system |
US20080200933A1 (en) | 2007-02-15 | 2008-08-21 | Bakos Gregory J | Surgical devices and methods for forming an anastomosis between organs by gaining access thereto through a natural orifice in the body |
US20080200762A1 (en) | 2007-02-16 | 2008-08-21 | Stokes Michael J | Flexible endoscope shapelock |
GB0703417D0 (en) | 2007-02-22 | 2007-04-04 | Eschmann Holdings Ltd | Electro-surgical systems |
US7815662B2 (en) | 2007-03-08 | 2010-10-19 | Ethicon Endo-Surgery, Inc. | Surgical suture anchors and deployment device |
US20080221587A1 (en) | 2007-03-09 | 2008-09-11 | Jeremy Schwartz | Two-stage snare-basket medical device |
US20080228213A1 (en) | 2007-03-15 | 2008-09-18 | Terumo Cardiovascular Systems Corporation And Olympus Medical Systems Corporation | Variable size trocar |
US7780691B2 (en) | 2007-03-21 | 2010-08-24 | Ethicon Endo-Surgery, Inc. | Endoscopic tissue resection device |
US8075567B2 (en) | 2007-03-22 | 2011-12-13 | Anchor Products Company | Surgical tissue retrieval instrument |
US20080230972A1 (en) | 2007-03-23 | 2008-09-25 | Ganley Robert F | Pipe holding or manipulating tool |
US8377044B2 (en) | 2007-03-30 | 2013-02-19 | Ethicon Endo-Surgery, Inc. | Detachable end effectors |
US20080262524A1 (en) | 2007-04-19 | 2008-10-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and methods for closing of fascia |
WO2008147603A2 (en) | 2007-04-19 | 2008-12-04 | S.D.M.H.Pty. Ltd. | Devices and methods for thermal ablation of biological tissue using geometric ablation patterns |
US20080262540A1 (en) | 2007-04-19 | 2008-10-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and methods for approximating surfaces |
US9596980B2 (en) | 2007-04-25 | 2017-03-21 | Karl Storz Endovision, Inc. | Endoscope system with pivotable arms |
US8075572B2 (en) | 2007-04-26 | 2011-12-13 | Ethicon Endo-Surgery, Inc. | Surgical suturing apparatus |
CA2684079C (en) | 2007-04-27 | 2016-08-23 | Cvdevices, Llc | Devices, systems, and methods for accessing the epicardial surface of the heart |
US8100922B2 (en) | 2007-04-27 | 2012-01-24 | Ethicon Endo-Surgery, Inc. | Curved needle suturing tool |
US7875042B2 (en) | 2007-05-04 | 2011-01-25 | Ethicon Endo-Surgery, Inc. | Suture anchor loader |
US8821520B2 (en) | 2007-05-04 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Loader for knotting element |
WO2008144522A2 (en) | 2007-05-17 | 2008-11-27 | Boston Scientific Scimed, Inc. | Tissue securing and sealing apparatus and related methods of use |
US7945332B2 (en) | 2007-05-22 | 2011-05-17 | Vitrumed, Inc. | Apparatus for attachment and reinforcement of tissue, apparatus for reinforcement of tissue, methods of attaching and reinforcing tissue, and methods of reinforcing tissue |
JP2009006128A (en) | 2007-05-25 | 2009-01-15 | Kazuya Akaboshi | High-frequency treatment instrument |
US7798386B2 (en) | 2007-05-30 | 2010-09-21 | Ethicon Endo-Surgery, Inc. | Surgical instrument articulation joint cover |
US7549564B2 (en) | 2007-06-22 | 2009-06-23 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with an articulating end effector |
US20080300461A1 (en) | 2007-05-31 | 2008-12-04 | Ethicon Endo-Surgery, Inc. | Endoscopic Device |
US7967842B2 (en) | 2007-06-01 | 2011-06-28 | Ethicon Endo-Surgery, Inc. | Integrated securement and closure apparatus |
WO2008151237A1 (en) | 2007-06-04 | 2008-12-11 | Terumo Kabushiki Kaisha | Multi-electrode apparatus for tissue welding and ablation |
US8348827B2 (en) | 2007-06-12 | 2013-01-08 | Ethicon Endo-Surgery, Inc. | Specimen removal pouch |
US7771416B2 (en) | 2007-06-14 | 2010-08-10 | Ethicon Endo-Surgery, Inc. | Control mechanism for flexible endoscopic device and method of use |
JP4472728B2 (en) | 2007-06-14 | 2010-06-02 | オリンパスメディカルシステムズ株式会社 | Endoscope system |
JP4472727B2 (en) | 2007-06-14 | 2010-06-02 | オリンパスメディカルシステムズ株式会社 | Endoscope device |
JP2008307226A (en) | 2007-06-14 | 2008-12-25 | Olympus Medical Systems Corp | Endoscope system |
US7731072B2 (en) | 2007-06-18 | 2010-06-08 | Ethicon Endo-Surgery, Inc. | Surgical stapling and cutting instrument with improved anvil opening features |
US7604150B2 (en) | 2007-06-22 | 2009-10-20 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with an anti-back up mechanism |
US7597229B2 (en) | 2007-06-22 | 2009-10-06 | Ethicon Endo-Surgery, Inc. | End effector closure system for a surgical stapling instrument |
US8394090B2 (en) | 2007-06-25 | 2013-03-12 | Terumo Kabushiki Kaisha | Medical device |
US8088062B2 (en) | 2007-06-28 | 2012-01-03 | Ethicon Endo-Surgery, Inc. | Interchangeable endoscopic end effectors |
US20090048486A1 (en) | 2007-08-08 | 2009-02-19 | Wilson-Cook Medical Inc. | Distal Tip for an Endoscope |
US20090054728A1 (en) | 2007-08-21 | 2009-02-26 | Trusty Robert M | Manipulatable guide system and methods for natural orifice translumenal endoscopic surgery |
WO2009029065A1 (en) | 2007-08-24 | 2009-03-05 | Hazem Ezzat | A surgical device and method |
DE102007040358A1 (en) | 2007-08-27 | 2009-03-05 | Technische Universität München | Trocar tube, trocar, obturator or rectoscope for transluminal endoscopic surgery over natural orifices |
US20090062788A1 (en) | 2007-08-31 | 2009-03-05 | Long Gary L | Electrical ablation surgical instruments |
US20090062795A1 (en) | 2007-08-31 | 2009-03-05 | Ethicon Endo-Surgery, Inc. | Electrical ablation surgical instruments |
US8568410B2 (en) | 2007-08-31 | 2013-10-29 | Ethicon Endo-Surgery, Inc. | Electrical ablation surgical instruments |
US8262655B2 (en) | 2007-11-21 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
WO2009032623A2 (en) | 2007-08-31 | 2009-03-12 | Ethicon Endo-Surgery, Inc | Electrical albation surgical instruments |
US8579897B2 (en) | 2007-11-21 | 2013-11-12 | Ethicon Endo-Surgery, Inc. | Bipolar forceps |
US8118738B2 (en) | 2007-09-06 | 2012-02-21 | Daniel Larkin | Vaginal speculum including collapsible and expandable frame |
WO2009036457A1 (en) | 2007-09-14 | 2009-03-19 | Lazure Technologies, Llc | Multi-layer electrode ablation probe and related methods |
JP2009072368A (en) | 2007-09-20 | 2009-04-09 | Olympus Medical Systems Corp | Medical apparatus |
US8097001B2 (en) | 2007-09-24 | 2012-01-17 | Granit Medical Innovations Llc | Medical instrument with stop motion override and associated method |
US8096998B2 (en) | 2007-09-26 | 2012-01-17 | Ebi, Llc | External fixation tensioner |
CA2702203C (en) | 2007-10-09 | 2012-12-04 | Wilson-Cook Medical, Inc. | Magnetic anastomosis device having improved delivery |
US8480657B2 (en) | 2007-10-31 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Detachable distal overtube section and methods for forming a sealable opening in the wall of an organ |
US20090112063A1 (en) | 2007-10-31 | 2009-04-30 | Bakos Gregory J | Endoscopic overtubes |
US20090112059A1 (en) | 2007-10-31 | 2009-04-30 | Nobis Rudolph H | Apparatus and methods for closing a gastrotomy |
US8200334B1 (en) * | 2007-11-09 | 2012-06-12 | Pacesetter, Inc. | Systems and methods for remote monitoring of signals sensed by an implantable medical device during an MRI |
US20090131751A1 (en) | 2007-11-20 | 2009-05-21 | Spivey James T | Anal surgical instrument guides |
US20090143794A1 (en) | 2007-11-29 | 2009-06-04 | Conlon Sean P | Tissue resection device |
US20090143649A1 (en) | 2007-11-30 | 2009-06-04 | Physion Srl | Speculum for the electropharmacological treatment of vaginal diseases |
WO2009076246A2 (en) | 2007-12-06 | 2009-06-18 | Massachusetts Institute Of Technology | Methods to treat unwanted tissue with electric pulses |
US9066655B2 (en) | 2007-12-07 | 2015-06-30 | Ethicon Endo-Surgery, Inc. | Selective stiffening devices and methods |
US20090177219A1 (en) | 2008-01-03 | 2009-07-09 | Conlon Sean P | Flexible tissue-penetration instrument with blunt tip assembly and methods for penetrating tissue |
EP2230987B1 (en) | 2008-01-03 | 2013-02-27 | Cook Medical Technologies LLC | Medical systems for endoscopically suturing perforations |
US20090182332A1 (en) | 2008-01-15 | 2009-07-16 | Ethicon Endo-Surgery, Inc. | In-line electrosurgical forceps |
US20090192344A1 (en) | 2008-01-24 | 2009-07-30 | Ethicon Endo-Surgery, Inc. | Surgical devices for manipulating tissue |
US20090192534A1 (en) | 2008-01-29 | 2009-07-30 | Ethicon Endo-Surgery, Inc. | Sensor trigger |
JP5258314B2 (en) | 2008-02-01 | 2013-08-07 | テルモ株式会社 | Medical manipulator and medical robot system |
WO2009100106A1 (en) | 2008-02-05 | 2009-08-13 | Wilson-Cook Medical, Inc. | Adaptor for endoscopic orientation of an elongate medical device |
US20090210000A1 (en) | 2008-02-15 | 2009-08-20 | Sullivan Humbert G | Percutaneous pedicle plug and method of use |
JP5377991B2 (en) | 2008-02-26 | 2013-12-25 | テルモ株式会社 | manipulator |
US8262680B2 (en) | 2008-03-10 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Anastomotic device |
WO2009121009A2 (en) | 2008-03-27 | 2009-10-01 | The Regents Of The University Of California | Irreversible electroporation device for use in attenuating neointimal |
US8540744B2 (en) | 2008-04-01 | 2013-09-24 | Ethicon Endo-Surgery, Inc. | Tissue penetrating surgical device |
US20090259105A1 (en) | 2008-04-10 | 2009-10-15 | Miyano Hiromichi | Medical treatment system and suturing method |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
EP2280741A4 (en) | 2008-04-29 | 2012-06-13 | Virginia Tech Intell Prop | Irreversible electroporation to create tissue scaffolds |
US20090281559A1 (en) | 2008-05-06 | 2009-11-12 | Ethicon Endo-Surgery, Inc. | Anastomosis patch |
KR101108569B1 (en) | 2008-05-15 | 2012-01-30 | 전명기 | Electrode for radiofrequency tissue ablation |
US20090287236A1 (en) | 2008-05-16 | 2009-11-19 | Ethicon Endo-Surgery, Inc. | Endoscopic rotary access needle |
US8562513B2 (en) | 2008-05-20 | 2013-10-22 | Olympus Medical Systems Corp. | Endoscope device |
US8070759B2 (en) | 2008-05-30 | 2011-12-06 | Ethicon Endo-Surgery, Inc. | Surgical fastening device |
US8679003B2 (en) | 2008-05-30 | 2014-03-25 | Ethicon Endo-Surgery, Inc. | Surgical device and endoscope including same |
US8652150B2 (en) | 2008-05-30 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Multifunction surgical device |
US8771260B2 (en) | 2008-05-30 | 2014-07-08 | Ethicon Endo-Surgery, Inc. | Actuating and articulating surgical device |
US8317806B2 (en) | 2008-05-30 | 2012-11-27 | Ethicon Endo-Surgery, Inc. | Endoscopic suturing tension controlling and indication devices |
US8114072B2 (en) | 2008-05-30 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | Electrical ablation device |
US8906035B2 (en) | 2008-06-04 | 2014-12-09 | Ethicon Endo-Surgery, Inc. | Endoscopic drop off bag |
US8403926B2 (en) | 2008-06-05 | 2013-03-26 | Ethicon Endo-Surgery, Inc. | Manually articulating devices |
EP2392250A3 (en) | 2008-06-19 | 2012-09-19 | Olympus Medical Systems Corporation | Magnetically guiding system and magnetically guiding method |
US8795161B2 (en) | 2008-06-25 | 2014-08-05 | Covidien Lp | Button port |
US8361112B2 (en) | 2008-06-27 | 2013-01-29 | Ethicon Endo-Surgery, Inc. | Surgical suture arrangement |
JP5204564B2 (en) | 2008-06-30 | 2013-06-05 | オリンパスメディカルシステムズ株式会社 | Medical equipment |
US8357170B2 (en) | 2008-07-09 | 2013-01-22 | Ethicon Endo-Surgery, Inc. | Devices and methods for placing occlusion fasteners |
US20100010303A1 (en) | 2008-07-09 | 2010-01-14 | Ethicon Endo-Surgery, Inc. | Inflatable access device |
US20100010294A1 (en) | 2008-07-10 | 2010-01-14 | Ethicon Endo-Surgery, Inc. | Temporarily positionable medical devices |
US8888792B2 (en) | 2008-07-14 | 2014-11-18 | Ethicon Endo-Surgery, Inc. | Tissue apposition clip application devices and methods |
US8262563B2 (en) | 2008-07-14 | 2012-09-11 | Ethicon Endo-Surgery, Inc. | Endoscopic translumenal articulatable steerable overtube |
US20100010298A1 (en) | 2008-07-14 | 2010-01-14 | Ethicon Endo-Surgery, Inc. | Endoscopic translumenal flexible overtube |
US8211125B2 (en) | 2008-08-15 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Sterile appliance delivery device for endoscopic procedures |
US8529563B2 (en) * | 2008-08-25 | 2013-09-10 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US20100048990A1 (en) | 2008-08-25 | 2010-02-25 | Ethicon Endo-Surgery, Inc. | Endoscopic needle for natural orifice translumenal endoscopic surgery |
US8241204B2 (en) | 2008-08-29 | 2012-08-14 | Ethicon Endo-Surgery, Inc. | Articulating end cap |
US8480689B2 (en) | 2008-09-02 | 2013-07-09 | Ethicon Endo-Surgery, Inc. | Suturing device |
US8303581B2 (en) | 2008-09-02 | 2012-11-06 | Covidien Lp | Catheter with remotely extendible instruments |
US20100056862A1 (en) | 2008-09-03 | 2010-03-04 | Ethicon Endo-Surgery, Inc. | Access needle for natural orifice translumenal endoscopic surgery |
US8409200B2 (en) | 2008-09-03 | 2013-04-02 | Ethicon Endo-Surgery, Inc. | Surgical grasping device |
US8114119B2 (en) | 2008-09-09 | 2012-02-14 | Ethicon Endo-Surgery, Inc. | Surgical grasping device |
US20100076451A1 (en) | 2008-09-19 | 2010-03-25 | Ethicon Endo-Surgery, Inc. | Rigidizable surgical instrument |
US8337394B2 (en) | 2008-10-01 | 2012-12-25 | Ethicon Endo-Surgery, Inc. | Overtube with expandable tip |
JP2010093746A (en) | 2008-10-10 | 2010-04-22 | Sony Corp | Solid-state image pickup element and signal processing system |
US9370341B2 (en) | 2008-10-23 | 2016-06-21 | Covidien Lp | Surgical retrieval apparatus |
US20110313415A1 (en) | 2008-11-11 | 2011-12-22 | The Board Of Regents Of The University Of Texas System | Medical Devices, Apparatuses, Systems, and Methods |
US20100331622A2 (en) | 2008-11-25 | 2010-12-30 | Ethicon Endo-Surgery, Inc. | Tissue manipulation devices |
US8157834B2 (en) | 2008-11-25 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Rotational coupling device for surgical instrument with flexible actuators |
US8172772B2 (en) | 2008-12-11 | 2012-05-08 | Ethicon Endo-Surgery, Inc. | Specimen retrieval device |
US20100152539A1 (en) | 2008-12-17 | 2010-06-17 | Ethicon Endo-Surgery, Inc. | Positionable imaging medical devices |
US8828031B2 (en) | 2009-01-12 | 2014-09-09 | Ethicon Endo-Surgery, Inc. | Apparatus for forming an anastomosis |
US20100191050A1 (en) | 2009-01-23 | 2010-07-29 | Ethicon Endo-Surgery, Inc. | Variable length accessory for guiding a flexible endoscopic tool |
US20100191267A1 (en) | 2009-01-26 | 2010-07-29 | Ethicon Endo-Surgery, Inc. | Rotary needle for natural orifice translumenal endoscopic surgery |
US20110306840A1 (en) | 2009-01-30 | 2011-12-15 | The Trustees Of Columbia University In The City Of New York | Controllable magnetic source to fixture intracorporeal apparatus. |
US8252057B2 (en) | 2009-01-30 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Surgical access device |
US9226772B2 (en) | 2009-01-30 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Surgical device |
US8037591B2 (en) | 2009-02-02 | 2011-10-18 | Ethicon Endo-Surgery, Inc. | Surgical scissors |
US20100198248A1 (en) | 2009-02-02 | 2010-08-05 | Ethicon Endo-Surgery, Inc. | Surgical dissector |
US20100249700A1 (en) | 2009-03-27 | 2010-09-30 | Ethicon Endo-Surgery, Inc. | Surgical instruments for in vivo assembly |
US8632534B2 (en) | 2009-04-03 | 2014-01-21 | Angiodynamics, Inc. | Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD) |
WO2010118387A1 (en) | 2009-04-09 | 2010-10-14 | Virginia Tech Intellectual Properties, Inc. | Integration of very short electric pulses for minimally to noninvasive electroporation |
AU2010246028B2 (en) * | 2009-05-07 | 2012-11-29 | Cardiac Pacemakers, Inc. | Application of electric fields to the lung as therapy for pulmonary edema |
US20100298642A1 (en) | 2009-05-19 | 2010-11-25 | Ethicon Endo-Surgery, Inc. | Manipulatable guide system and methods for natural orifice translumenal endoscopic surgery |
US20100312056A1 (en) | 2009-06-03 | 2010-12-09 | Gyrus, ACMI, Inc. | Endoscope shaft |
US8206295B2 (en) | 2009-06-15 | 2012-06-26 | Ashutosh Kaul | Suction-based tissue manipulator |
US20110077719A1 (en) | 2009-09-30 | 2011-03-31 | Broadcom Corporation | Electromagnetic power bio-medical unit |
US20110093009A1 (en) | 2009-10-16 | 2011-04-21 | Ethicon Endo-Surgery, Inc. | Otomy closure device |
US20110098694A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Methods and instruments for treating cardiac tissue through a natural orifice |
US20110098704A1 (en) | 2009-10-28 | 2011-04-28 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US8608652B2 (en) | 2009-11-05 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Vaginal entry surgical devices, kit, system, and method |
US20110112434A1 (en) | 2009-11-06 | 2011-05-12 | Ethicon Endo-Surgery, Inc. | Kits and procedures for natural orifice translumenal endoscopic surgery |
US20110115891A1 (en) | 2009-11-13 | 2011-05-19 | Ethicon Endo-Surgery, Inc. | Energy delivery apparatus, system, and method for deployable medical electronic devices |
US20110152610A1 (en) | 2009-12-17 | 2011-06-23 | Ethicon Endo-Surgery, Inc. | Intralumenal accessory tip for endoscopic sheath arrangements |
US8496574B2 (en) | 2009-12-17 | 2013-07-30 | Ethicon Endo-Surgery, Inc. | Selectively positionable camera for surgical guide tube assembly |
US20110152878A1 (en) | 2009-12-17 | 2011-06-23 | Ethicon Endo-Surgery, Inc. | Interface systems for aiding clinicians in controlling and manipulating at least one endoscopic surgical instrument and a cable controlled guide tube system |
US8353487B2 (en) | 2009-12-17 | 2013-01-15 | Ethicon Endo-Surgery, Inc. | User interface support devices for endoscopic surgical instruments |
US9028483B2 (en) | 2009-12-18 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US8506564B2 (en) | 2009-12-18 | 2013-08-13 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US20110152923A1 (en) | 2009-12-18 | 2011-06-23 | Ethicon Endo-Surgery, Inc. | Incision closure device |
US20110160514A1 (en) | 2009-12-31 | 2011-06-30 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
US9005198B2 (en) | 2010-01-29 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US20110190764A1 (en) | 2010-01-29 | 2011-08-04 | Ethicon Endo-Surgery, Inc. | Surgical instrument comprising an electrode |
US20110245619A1 (en) | 2010-04-01 | 2011-10-06 | Ethicon Endo-Surgery, Inc. | Surgical access device |
US9627120B2 (en) | 2010-05-19 | 2017-04-18 | The Board Of Regents Of The University Of Texas System | Magnetic throttling and control: magnetic control |
US9974944B2 (en) | 2010-07-29 | 2018-05-22 | Cameron Health, Inc. | Subcutaneous leads and methods of implant and explant |
US20120089093A1 (en) | 2010-10-07 | 2012-04-12 | Ethicon Endo-Surgery, Inc. | Seal arrangement for minimally invasive diagnostic or surgical instruments |
US20120089089A1 (en) | 2010-10-12 | 2012-04-12 | Ethicon Endo-Surgery, Inc. | Methods of magnetically guiding and axially aligning distal ends of surgical devices |
US20120088965A1 (en) | 2010-10-12 | 2012-04-12 | Ethicon Endo-Surgery, Inc. | Magnetically manipulatable surgical camera with removable adhesion removal system |
US20120116155A1 (en) | 2010-11-04 | 2012-05-10 | Ethicon Endo-Surgery, Inc. | Light-based, transcutaneous video signal transmission |
US10092291B2 (en) | 2011-01-25 | 2018-10-09 | Ethicon Endo-Surgery, Inc. | Surgical instrument with selectively rigidizable features |
US20120191075A1 (en) | 2011-01-25 | 2012-07-26 | Ethicon Endo-Surgery, Inc. | Method and devices for pulling a tether through an organ wall |
US9254169B2 (en) | 2011-02-28 | 2016-02-09 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
US9233241B2 (en) | 2011-02-28 | 2016-01-12 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices and methods |
WO2012125785A1 (en) | 2011-03-17 | 2012-09-20 | Ethicon Endo-Surgery, Inc. | Hand held surgical device for manipulating an internal magnet assembly within a patient |
US20130090666A1 (en) | 2011-10-06 | 2013-04-11 | Ethicon Endo-Surgery, Inc. | Vacuum assisted tissue manipulation devices and surgical methods |
US20130158348A1 (en) | 2011-12-14 | 2013-06-20 | Ethicon Endo-Surgery, Inc. | Introducer for an internal magnetic camera |
-
2011
- 2011-02-28 US US13/036,908 patent/US9314620B2/en active Active
-
2012
- 2012-02-22 WO PCT/US2012/026049 patent/WO2012118659A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007035537A2 (en) * | 2005-09-20 | 2007-03-29 | Ardian, Inc. | Methods and apparatus for inducing controlled renal neuromodulation |
WO2008101086A2 (en) * | 2007-02-15 | 2008-08-21 | Ethicon Endo-Surgery, Inc | Electroporation ablation apparatus, system, and method |
US20080300571A1 (en) * | 2007-05-30 | 2008-12-04 | Lepivert Patrick | Process and device for selectively treating interstitial tissue |
US20100179530A1 (en) | 2009-01-12 | 2010-07-15 | Ethicon Endo-Surgery, Inc. | Electrical ablation devices |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11786300B2 (en) | 2021-04-07 | 2023-10-17 | Btl Medical Technologies S.R.O. | Pulsed field ablation device and method |
US11832785B2 (en) | 2021-04-07 | 2023-12-05 | Btl Medical Development A.S. | Pulsed field ablation device and method |
US11896298B2 (en) | 2021-07-06 | 2024-02-13 | Btl Medical Development A.S. | Pulsed field ablation device and method |
Also Published As
Publication number | Publication date |
---|---|
US20120220998A1 (en) | 2012-08-30 |
US9314620B2 (en) | 2016-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10258406B2 (en) | Electrical ablation devices and methods | |
US9314620B2 (en) | Electrical ablation devices and methods | |
US10278761B2 (en) | Electrical ablation devices and methods | |
US10342598B2 (en) | Electrosurgical system for delivering a biphasic waveform | |
US10779882B2 (en) | Electrical ablation devices | |
US20180303541A1 (en) | Surgical instrument comprising an electrode | |
US9788888B2 (en) | Endoscopic cap electrode and method for using the same | |
US9005198B2 (en) | Surgical instrument comprising an electrode | |
US20180360535A1 (en) | Electrical ablation devices | |
US8506564B2 (en) | Surgical instrument comprising an electrode |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12711049 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12711049 Country of ref document: EP Kind code of ref document: A1 |